1	The	DT	O	the	det	3	SENT_1	[p1l715t81r752b102],
2	NEW	NNP	O	NEW	nn	3	SENT_1	[p1l765t83r845b102],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_1	[p1l859t83r1034b102],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_1	[p1l1048t83r1214b109],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_1	[p1l1228t81r1444b108],

1	sode	NN	O	sode	_	0	SENT_2	[p1l16t304r162b364],
2	of	IN	O	of	_	0	SENT_2	[p1l186t304r262b364],
3	venous	JJ	O	venous	amod	4	SENT_2	[p1l268t323r496b364],
4	thromboembolism	NN	O	thromboembolism	prep_of	1	SENT_2	[p1l520t304r1155b364],
5	.	.	O	.	_	0	SENT_2	[p1l520t304r1155b364],

1	N	NN	O	n	nn	2	SENT_3	[p1l1180t310r1237b364],
2	EnglJ	NN	O	englj	nsubj	3	SENT_3	[p1l1258t304r1450b381],
3	Med	VBD	O	med	_	0	SENT_3	[p1l1470t304r1612b364],
4	1995	CD	DATE	1995	dobj	3	SENT_3	[p1l1637t309r2150b376, p1l16t405r69b458],
5	;	:	O	;	_	0	SENT_3	[p1l1637t309r2150b376, p1l16t405r69b458],
6	332:16615	CD	NUMBER	332:16615	dep	4	SENT_3	[p1l1637t309r2150b376, p1l16t405r69b458],
7	.	.	O	.	_	0	SENT_3	[p1l1637t309r2150b376, p1l16t405r69b458],

1	4	LS	NUMBER	4	_	0	SENT_4	[p1l13t505r65b557],
2	.	.	O	.	_	0	SENT_4	[p1l13t505r65b557],

1	Kearon	NNP	PERSON	Kearon	nn	4	SENT_5	[p1l143t503r378b559],
2	C.	NNP	PERSON	C.	nn	4	SENT_5	[p1l402t502r466b557],
3	Drug	NNP	PERSON	Drug	nn	4	SENT_5	[p1l493t502r661b574],
4	trials	NNS	O	trial	_	0	SENT_5	[p1l682t497r843b557],
5	that	WDT	O	that	nsubj	7	SENT_5	[p1l869t497r997b557],
6	have	VBP	O	have	aux	7	SENT_5	[p1l1017t497r1162b557],
7	inﬂuenced	VBN	O	inﬂuenced	rcmod	4	SENT_5	[p1l1186t497r1530b557],
8	our	PRP$	O	we	poss	9	SENT_5	[p1l1555t516r1665b557],
9	practice	NN	O	practice	dobj	7	SENT_5	[p1l1686t498r1942b573],
10	in	IN	O	in	_	0	SENT_5	[p1l1965t498r2027b556],
11	the	DT	O	the	det	12	SENT_5	[p1l2052t497r2151b557],
12	treatment	NN	O	treatment	prep_in	7	SENT_5	[p1l15t607r334b654],
13	of	IN	O	of	_	0	SENT_5	[p1l356t594r433b654],
14	venous	JJ	O	venous	amod	15	SENT_5	[p1l441t614r669b654],
15	thromboembolism	NN	O	thromboembolism	prep_of	12	SENT_5	[p1l696t594r1330b654],
16	.	.	O	.	_	0	SENT_5	[p1l696t594r1330b654],

1	Thromb	NNP	O	Thromb	nn	2	SENT_6	[p1l1358t595r1624b654],
2	Haemost	NNP	O	Haemost	_	0	SENT_6	[p1l1651t600r1948b654],
3	1997	CD	DATE	1997	num	2	SENT_6	[p1l1973t599r2148b667],
4	;	:	O	;	_	0	SENT_6	[p1l1973t599r2148b667],
5	78:553	CD	NUMBER	78:553	number	6	SENT_6	[p1l15t695r318b749],
6	-7	CD	NUMBER	-7	dep	2	SENT_6	[p1l15t695r318b749],
7	.	.	O	.	_	0	SENT_6	[p1l15t695r318b749],

1	5	CD	NUMBER	5	_	0	SENT_7	[p1l15t794r65b846],
2	.	.	O	.	_	0	SENT_7	[p1l15t794r65b846],

1	Hirsh	NNP	PERSON	Hirsh	nn	2	SENT_8	[p1l143t786r327b846],
2	J	NNP	PERSON	J	_	0	SENT_8	[p1l353t792r398b859],
3	,	,	O	,	_	0	SENT_8	[p1l353t792r398b859],
4	Dalen	NNP	PERSON	Dalen	nn	5	SENT_8	[p1l434t786r623b846],
5	JE	NNP	O	JE	appos	2	SENT_8	[p1l649t792r738b859],
6	,	,	O	,	_	0	SENT_8	[p1l649t792r738b859],
7	Anderson	NNP	PERSON	Anderson	nn	8	SENT_8	[p1l772t786r1090b846],
8	DR	NN	O	dr	appos	2	SENT_8	[p1l1122t791r1243b859],
9	,	,	O	,	_	0	SENT_8	[p1l1122t791r1243b859],
10	et	FW	O	et	nn	11	SENT_8	[p1l1280t799r1339b846],
11	al.	FW	O	al.	appos	2	SENT_8	[p1l1367t786r1440b846],
12	.	.	O	.	_	0	SENT_8	[p1l1367t786r1440b846],

1	Oral	JJ	O	oral	amod	2	SENT_9	[p1l1477t786r1616b846],
2	anticoagulants	NNS	O	anticoagulant	_	0	SENT_9	[p1l1648t786r2148b863],
3	:	:	O	:	_	0	SENT_9	[p1l1648t786r2148b863],
4	mechanism	NN	O	mechanism	dep	2	SENT_9	[p1l15t884r394b943],
5	of	IN	O	of	_	0	SENT_9	[p1l411t883r488b943],
6	action	NN	O	action	prep_of	4	SENT_9	[p1l491t884r709b956],
7	,	,	O	,	_	0	SENT_9	[p1l491t884r709b956],
8	clinical	JJ	O	clinical	amod	9	SENT_9	[p1l730t883r963b943],
9	effectiveness	NN	O	effectiveness	prep_of	4	SENT_9	[p1l981t883r1413b956],
10	,	,	O	,	_	0	SENT_9	[p1l981t883r1413b956],
11	and	CC	O	and	_	0	SENT_9	[p1l1433t883r1553b943],
12	optimal	JJ	O	optimal	amod	14	SENT_9	[p1l1571t883r1822b960],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_9	[p1l1839t883r2150b960, p1l15t981r91b1040],
14	range	NN	O	range	prep_of	4	SENT_9	[p1l111t1000r312b1057],
15	.	.	O	.	_	0	SENT_9	[p1l111t1000r312b1057],

1	Chest	NN	O	chest	_	0	SENT_10	[p1l336t980r523b1040],
2	2001	CD	DATE	2001	num	1	SENT_10	[p1l540t981r1327b1057],
3	;	:	O	;	_	0	SENT_10	[p1l540t981r1327b1057],
4	119	CD	NUMBER	119	dep	1	SENT_10	[p1l540t981r1327b1057],
5	:	:	O	:	_	0	SENT_10	[p1l540t981r1327b1057],
6	Suppl	NNP	O	Suppl	dep	4	SENT_10	[p1l540t981r1327b1057],
7	:8	CD	NUMBER	:8	num	8	SENT_10	[p1l540t981r1327b1057],
8	S-21S	NN	O	s-21	dep	6	SENT_10	[p1l540t981r1327b1057],
9	.	.	O	.	_	0	SENT_10	[p1l540t981r1327b1057],

1	6	CD	NUMBER	6	_	0	SENT_11	[p1l15t1085r65b1137],
2	.	.	O	.	_	0	SENT_11	[p1l15t1085r65b1137],

1	Hyers	NNP	PERSON	Hyers	nn	2	SENT_12	[p1l143t1083r325b1153],
2	TM	NNP	O	TM	_	0	SENT_12	[p1l343t1082r470b1150],
3	,	,	O	,	_	0	SENT_12	[p1l343t1082r470b1150],
4	Agnelli	NNP	PERSON	Agnelli	nn	5	SENT_12	[p1l489t1077r720b1154],
5	G	NNP	PERSON	G	appos	2	SENT_12	[p1l738t1082r809b1150],
6	,	,	O	,	_	0	SENT_12	[p1l738t1082r809b1150],
7	Hull	NNP	PERSON	Hull	nn	8	SENT_12	[p1l831t1077r970b1137],
8	RD	NNP	O	RD	appos	2	SENT_12	[p1l987t1082r1103b1150],
9	,	,	O	,	_	0	SENT_12	[p1l987t1082r1103b1150],
10	et	FW	O	et	nn	11	SENT_12	[p1l1126t1090r1184b1137],
11	al.	FW	O	al.	appos	2	SENT_12	[p1l1198t1077r1269b1137],
12	.	.	O	.	_	0	SENT_12	[p1l1198t1077r1269b1137],

1	Antithrombotic	JJ	O	antithrombotic	amod	2	SENT_13	[p1l1289t1077r1788b1137],
2	therapy	NN	O	therapy	_	0	SENT_13	[p1l1807t1077r2046b1153],
3	for	IN	O	for	_	0	SENT_13	[p1l2061t1077r2153b1137],
4	venous	JJ	O	venous	amod	6	SENT_13	[p1l11t1194r233b1234],
5	thromboembolic	NN	O	thromboembolic	nn	6	SENT_13	[p1l252t1174r788b1234],
6	disease	NN	O	disease	prep_for	2	SENT_13	[p1l806t1174r1049b1234],
7	.	.	O	.	_	0	SENT_13	[p1l806t1174r1049b1234],

1	Chest	NN	O	chest	_	0	SENT_14	[p1l1071t1175r1253b1234],
2	2001	CD	DATE	2001	num	1	SENT_14	[p1l1267t1175r2148b1251],
3	;	:	O	;	_	0	SENT_14	[p1l1267t1175r2148b1251],
4	119	CD	NUMBER	119	dep	1	SENT_14	[p1l1267t1175r2148b1251],
5	:	:	O	:	_	0	SENT_14	[p1l1267t1175r2148b1251],
6	Suppl	NNP	O	Suppl	dep	4	SENT_14	[p1l1267t1175r2148b1251],
7	:176	CD	NUMBER	:176	num	8	SENT_14	[p1l1267t1175r2148b1251],
8	S-193S	NN	O	s-193	dep	6	SENT_14	[p1l1267t1175r2148b1251],
9	.	.	O	.	_	0	SENT_14	[p1l1267t1175r2148b1251],

1	7	CD	NUMBER	7	_	0	SENT_15	[p1l16t1279r65b1331],
2	.	.	O	.	_	0	SENT_15	[p1l16t1279r65b1331],

1	Hull	NNP	PERSON	Hull	nn	7	SENT_16	[p1l143t1271r282b1331],
2	R	NNP	PERSON	R	nn	7	SENT_16	[p1l298t1276r362b1344],
3	,	,	O	,	_	0	SENT_16	[p1l298t1276r362b1344],
4	HirshJ	NNP	O	HirshJ	appos	7	SENT_16	[p1l383t1271r617b1344],
5	,	,	O	,	_	0	SENT_16	[p1l383t1271r617b1344],
6	Jay	NNP	PERSON	Jay	appos	7	SENT_16	[p1l631t1277r728b1347],
7	R	NNP	PERSON	R	_	0	SENT_16	[p1l741t1276r805b1344],
8	,	,	O	,	_	0	SENT_16	[p1l741t1276r805b1344],
9	et	FW	O	et	nn	10	SENT_16	[p1l826t1284r884b1331],
10	al.	FW	O	al.	appos	7	SENT_16	[p1l897t1271r968b1331],
11	.	.	O	.	_	0	SENT_16	[p1l897t1271r968b1331],

1	Different	JJ	O	different	amod	2	SENT_17	[p1l988t1271r1279b1331],
2	intensities	NNS	O	intensity	_	0	SENT_17	[p1l1292t1272r1619b1331],
3	of	IN	O	of	_	0	SENT_17	[p1l1637t1271r1713b1331],
4	oral	JJ	O	oral	amod	6	SENT_17	[p1l1716t1271r1838b1331],
5	anticoagulant	JJ	O	anticoagulant	amod	6	SENT_17	[p1l1855t1272r2151b1348, p1l15t1368r180b1428],
6	therapy	NN	O	therapy	prep_of	2	SENT_17	[p1l196t1368r435b1445],
7	in	IN	O	in	_	0	SENT_17	[p1l450t1369r512b1427],
8	the	DT	O	the	det	9	SENT_17	[p1l532t1368r630b1428],
9	treatment	NN	O	treatment	prep_in	2	SENT_17	[p1l650t1381r963b1428],
10	of	IN	O	of	_	0	SENT_17	[p1l979t1368r1055b1428],
11	proXimal	JJ	O	proximal	amod	14	SENT_17	[p1l1060t1368r1505b1445],
12	—	NN	O	—	nn	14	SENT_17	[p1l1060t1368r1505b1445],
13	vein	NN	O	vein	nn	14	SENT_17	[p1l1060t1368r1505b1445],
14	thrombosis	NN	O	thrombosis	prep_of	9	SENT_17	[p1l1524t1368r1909b1428],
15	.	.	O	.	_	0	SENT_17	[p1l1524t1368r1909b1428],

1	N	NN	O	n	nn	2	SENT_18	[p1l1932t1374r1988b1428],
2	Engl	NNP	O	Engl	nsubj	3	SENT_18	[p1l2006t1368r2152b1445],
3	JMed	VBD	O	jmed	_	0	SENT_18	[p1l7t1465r191b1534],
4	1982	CD	DATE	1982	dobj	3	SENT_18	[p1l212t1470r813b1538],
5	;	:	O	;	_	0	SENT_18	[p1l212t1470r813b1538],
6	307:1676	CD	NUMBER	307:1676	number	7	SENT_18	[p1l212t1470r813b1538],
7	—	CD	NUMBER	—	dep	4	SENT_18	[p1l212t1470r813b1538],
8	81	CD	NUMBER	81	dep	7	SENT_18	[p1l212t1470r813b1538],
9	.	.	O	.	_	0	SENT_18	[p1l212t1470r813b1538],

1	8	CD	NUMBER	8	_	0	SENT_19	[p1l13t1568r65b1622],
2	.	.	O	.	_	0	SENT_19	[p1l13t1568r65b1622],

1	Levine	NNP	PERSON	Levine	nn	2	SENT_20	[p1l143t1563r346b1622],
2	M	NNP	O	M	_	0	SENT_20	[p1l364t1568r446b1635],
3	,	,	O	,	_	0	SENT_20	[p1l364t1568r446b1635],
4	Hirsh	NNP	PERSON	Hirsh	nn	5	SENT_20	[p1l470t1562r650b1622],
5	J	NNP	PERSON	J	appos	2	SENT_20	[p1l663t1568r707b1635],
6	,	,	O	,	_	0	SENT_20	[p1l663t1568r707b1635],
7	Gent	NNP	O	Gent	nn	8	SENT_20	[p1l731t1567r890b1622],
8	M	NNP	O	M	appos	2	SENT_20	[p1l904t1568r986b1635],
9	,	,	O	,	_	0	SENT_20	[p1l904t1568r986b1635],
10	et	FW	O	et	nn	11	SENT_20	[p1l1010t1575r1068b1622],
11	al.	FW	O	al.	appos	2	SENT_20	[p1l1084t1562r1155b1622],
12	.	.	O	.	_	0	SENT_20	[p1l1084t1562r1155b1622],

1	Double	JJ	O	double	amod	2	SENT_21	[p1l1178t1562r1605b1622],
2	—	NN	O	—	_	0	SENT_21	[p1l1178t1562r1605b1622],
3	blind	JJ	O	blind	amod	5	SENT_21	[p1l1178t1562r1605b1622],
4	randomised	JJ	O	randomised	amod	5	SENT_21	[p1l1624t1562r2007b1622],
5	trial	NN	O	trial	dep	2	SENT_21	[p1l2027t1562r2152b1622],
6	of	IN	O	of	_	0	SENT_21	[p1l15t1659r90b1719],
7	a	DT	O	a	det	11	SENT_21	[p1l98t1680r132b1719],
8	very-low	JJ	O	very-low	amod	11	SENT_21	[p1l148t1659r595b1736],
9	—	NN	O	—	nn	11	SENT_21	[p1l148t1659r595b1736],
10	dose	NN	O	dose	nn	11	SENT_21	[p1l148t1659r595b1736],
11	Warfarin	NN	O	warfarin	prep_of	5	SENT_21	[p1l613t1659r885b1720],
12	for	IN	O	for	_	0	SENT_21	[p1l906t1659r999b1719],
13	prevention	NN	O	prevention	prep_for	11	SENT_21	[p1l1017t1660r1359b1736],
14	of	IN	O	of	_	0	SENT_21	[p1l1381t1659r1457b1719],
15	thromboembolism	NN	O	thromboembolism	prep_of	13	SENT_21	[p1l1465t1659r2070b1719],
16	in	IN	O	in	_	0	SENT_21	[p1l2091t1660r2152b1718],
17	stage	NN	O	stage	nn	20	SENT_21	[p1l16t1769r180b1833],
18	IV	CD	NUMBER	iv	num	20	SENT_21	[p1l198t1762r268b1816],
19	breast	NN	O	breast	nn	20	SENT_21	[p1l284t1757r481b1816],
20	cancer	NN	O	cancer	prep_in	15	SENT_21	[p1l496t1776r715b1816],
21	.	.	O	.	_	0	SENT_21	[p1l496t1776r715b1816],

1	Lancet	NNP	O	Lancet	_	0	SENT_22	[p1l737t1762r950b1816],
2	1994	CD	DATE	1994	num	1	SENT_22	[p1l968t1761r1488b1829],
3	;	:	O	;	_	0	SENT_22	[p1l968t1761r1488b1829],
4	343:886	CD	NUMBER	343:886	number	5	SENT_22	[p1l968t1761r1488b1829],
5	—	CD	NUMBER	—	dep	1	SENT_22	[p1l968t1761r1488b1829],
6	9	CD	NUMBER	9	dep	5	SENT_22	[p1l968t1761r1488b1829],
7	.	.	O	.	_	0	SENT_22	[p1l968t1761r1488b1829],

1	9	CD	NUMBER	9	_	0	SENT_23	[p1l14t1859r66b1911],
2	.	.	O	.	_	0	SENT_23	[p1l14t1859r66b1911],

1	Kearon	NNP	PERSON	Kearon	nn	2	SENT_24	[p1l143t1858r374b1913],
2	C	NNP	O	C	_	0	SENT_24	[p1l393t1857r456b1924],
3	,	,	O	,	_	0	SENT_24	[p1l393t1857r456b1924],
4	Gent	NNP	O	Gent	nn	5	SENT_24	[p1l479t1857r638b1912],
5	M	NNP	O	M	appos	2	SENT_24	[p1l650t1858r733b1924],
6	,	,	O	,	_	0	SENT_24	[p1l650t1858r733b1924],
7	Hirsh	NNP	PERSON	Hirsh	nn	8	SENT_24	[p1l755t1852r936b1911],
8	J	NNP	PERSON	J	appos	2	SENT_24	[p1l947t1858r991b1924],
9	,	,	O	,	_	0	SENT_24	[p1l947t1858r991b1924],
10	et	FW	O	et	nn	11	SENT_24	[p1l1015t1865r1073b1911],
11	al.	FW	O	al.	appos	2	SENT_24	[p1l1087t1852r1159b1912],
12	.	.	O	.	_	0	SENT_24	[p1l1087t1852r1159b1912],

1	A	DT	O	a	det	2	SENT_25	[p1l1178t1858r1228b1910],
2	comparison	NN	O	comparison	_	0	SENT_25	[p1l1245t1853r1626b1927],
3	of	IN	O	of	_	0	SENT_25	[p1l1646t1852r1721b1912],
4	three	CD	DURATION	three	num	5	SENT_25	[p1l1726t1852r1887b1911],
5	months	NNS	NUMBER	month	prep_of	2	SENT_25	[p1l1905t1852r2150b1912],
6	of	IN	O	of	_	0	SENT_25	[p1l15t1949r90b2009],
7	anticoagulation	NN	O	anticoagulation	prep_of	5	SENT_25	[p1l96t1950r595b2026],
8	with	IN	O	with	_	0	SENT_25	[p1l611t1950r754b2009],
9	extended	JJ	O	extended	amod	10	SENT_25	[p1l774t1949r1060b2009],
10	anticoagulation	NN	O	anticoagulation	prep_with	2	SENT_25	[p1l1079t1950r1579b2026],
11	for	IN	O	for	_	0	SENT_25	[p1l1598t1949r1691b2009],
12	a	DT	O	a	det	14	SENT_25	[p1l1708t1970r1742b2009],
13	first	JJ	ORDINAL	first	amod	14	SENT_25	[p1l1761t1949r1891b2009],
14	episode	NN	O	episode	prep_for	2	SENT_25	[p1l1908t1949r2152b2026],
15	of	IN	O	of	_	0	SENT_25	[p1l15t2046r90b2106],
16	idiopathic	JJ	O	idiopathic	amod	18	SENT_25	[p1l105t2046r427b2123],
17	venous	JJ	O	venous	amod	18	SENT_25	[p1l452t2066r675b2106],
18	thromboembolism	NN	O	thromboembolism	prep_of	14	SENT_25	[p1l706t2046r1328b2106],
19	.	.	O	.	_	0	SENT_25	[p1l706t2046r1328b2106],

1	N	NN	O	n	nn	2	SENT_26	[p1l1359t2052r1416b2106],
2	EnglJ	NN	O	englj	nsubj	3	SENT_26	[p1l1442t2047r1638b2123],
3	Med	VBD	O	med	_	0	SENT_26	[p1l1663t2046r1803b2106],
4	1999	CD	DATE	1999	dobj	3	SENT_26	[p1l1835t2051r2149b2119],
5	;	:	O	;	_	0	SENT_26	[p1l1835t2051r2149b2119],
6	340	CD	NUMBER	340	num	8	SENT_26	[p1l1835t2051r2149b2119],
7	:	:	O	:	_	0	SENT_26	[p1l1835t2051r2149b2119],
8	901-7	CD	NUMBER	901-7	dep	4	SENT_26	[p1l15t2148r214b2203],
9	.	.	O	.	_	0	SENT_26	[p1l15t2148r214b2203],

1	[	NN	O	[	nn	2	SENT_27	[p1l244t2148r545b2216],
2	Erratum	NN	O	erratum	_	0	SENT_27	[p1l244t2148r545b2216],
3	,	,	O	,	_	0	SENT_27	[p1l244t2148r545b2216],
4	N	NN	O	n	appos	2	SENT_27	[p1l567t2149r623b2203],
5	EnglJ	NNP	O	EnglJ	nn	6	SENT_27	[p1l640t2143r826b2220],
6	Med	NNP	O	Med	dep	2	SENT_27	[p1l841t2143r981b2203],
7	1999	CD	DATE	1999	rcmod	6	SENT_27	[p1l1003t2148r1483b2216],
8	;	:	O	;	_	0	SENT_27	[p1l1003t2148r1483b2216],
9	341:298	CD	NUMBER	341:298	dep	7	SENT_27	[p1l1003t2148r1483b2216],
10	.	.	O	.	_	0	SENT_27	[p1l1003t2148r1483b2216],
11	]	SYM	O	]	dep	7	SENT_27	[p1l1003t2148r1483b2216],

1	10	CD	NUMBER	10	_	0	SENT_28	[p1l17t2246r103b2300],
2	.	.	O	.	_	0	SENT_28	[p1l17t2246r103b2300],

1	Ridker	NNP	PERSON	Ridker	nn	2	SENT_29	[p1l143t2240r358b2304],
2	PM	NNP	O	PM	_	0	SENT_29	[p1l379t2245r500b2313],
3	,	,	O	,	_	0	SENT_29	[p1l379t2245r500b2313],
4	Goldhaber	NNP	PERSON	Goldhaber	nn	5	SENT_29	[p1l528t2240r871b2300],
5	SZ	NNP	O	SZ	appos	2	SENT_29	[p1l894t2245r989b2313],
6	,	,	O	,	_	0	SENT_29	[p1l894t2245r989b2313],
7	Danielson	NNP	PERSON	Danielson	nn	8	SENT_29	[p1l1016t2240r1340b2300],
8	E	NNP	O	E	appos	2	SENT_29	[p1l1363t2246r1422b2313],
9	,	,	O	,	_	0	SENT_29	[p1l1363t2246r1422b2313],
10	et	FW	O	et	nn	11	SENT_29	[p1l1450t2253r1509b2300],
11	al.	FW	O	al.	appos	2	SENT_29	[p1l1528t2240r1598b2300],
12	.	.	O	.	_	0	SENT_29	[p1l1528t2240r1598b2300],

1	Long-term	JJ	O	long-term	amod	5	SENT_30	[p1l1626t2246r1984b2317],
2	,	,	O	,	_	0	SENT_30	[p1l1626t2246r1984b2317],
3	lowintensity	JJ	O	lowintensity	amod	5	SENT_30	[p1l2011t2240r2151b2300, p1l10t2337r291b2412],
4	Warfarin	NN	MISC	warfarin	nn	5	SENT_30	[p1l311t2336r589b2396],
5	therapy	NN	O	therapy	_	0	SENT_30	[p1l615t2336r859b2412],
6	for	IN	O	for	_	0	SENT_30	[p1l882t2336r977b2395],
7	the	DT	O	the	det	8	SENT_30	[p1l1003t2336r1101b2395],
8	prevention	NN	O	prevention	prep_for	5	SENT_30	[p1l1127t2337r1476b2412],
9	of	IN	O	of	_	0	SENT_30	[p1l1504t2336r1580b2395],
10	recurrent	JJ	O	recurrent	amod	12	SENT_30	[p1l1593t2349r1896b2396],
11	venous	JJ	O	venous	amod	12	SENT_30	[p1l1916t2355r2143b2396],
12	thromboembolism	NN	O	thromboembolism	prep_of	5	SENT_30	[p1l11t2432r639b2491],
13	.	.	O	.	_	0	SENT_30	[p1l11t2432r639b2491],

1	N	NN	O	n	nn	2	SENT_31	[p1l661t2438r717b2492],
2	EnglJ	NN	O	englj	nsubj	3	SENT_31	[p1l733t2433r919b2508],
3	Med	VBD	O	med	_	0	SENT_31	[p1l934t2432r1074b2491],
4	2003	CD	DATE	2003	dobj	3	SENT_31	[p1l1093t2437r1696b2504],
5	;	:	O	;	_	0	SENT_31	[p1l1093t2437r1696b2504],
6	348:1425	CD	NUMBER	348:1425	num	7	SENT_31	[p1l1093t2437r1696b2504],
7	-34	CD	NUMBER	-34	dep	4	SENT_31	[p1l1093t2437r1696b2504],
8	.	.	O	.	_	0	SENT_31	[p1l1093t2437r1696b2504],

1	11	CD	NUMBER	11	_	0	SENT_32	[p1l13t2536r99b2587],
2	.	.	O	.	_	0	SENT_32	[p1l13t2536r99b2587],

1	Kearon	NNP	PERSON	Kearon	nn	2	SENT_33	[p1l139t2534r374b2589],
2	C	NNP	O	C	_	0	SENT_33	[p1l404t2533r468b2600],
3	,	,	O	,	_	0	SENT_33	[p1l404t2533r468b2600],
4	Ginsberg	NNP	PERSON	Ginsberg	nn	5	SENT_33	[p1l503t2528r808b2604],
5	JS	NNP	O	JS	appos	2	SENT_33	[p1l828t2533r914b2600],
6	,	,	O	,	_	0	SENT_33	[p1l828t2533r914b2600],
7	Kovacs	NNP	PERSON	Kovacs	nn	8	SENT_33	[p1l948t2534r1173b2589],
8	M	NNP	O	M	appos	2	SENT_33	[p1l1203t2534r1287b2600],
9	,	,	O	,	_	0	SENT_33	[p1l1203t2534r1287b2600],
10	et	FW	O	et	nn	11	SENT_33	[p1l1321t2541r1380b2587],
11	al.	FW	O	al.	appos	2	SENT_33	[p1l1407t2528r1480b2587],
12	.	.	O	.	_	0	SENT_33	[p1l1407t2528r1480b2587],

1	Low-intensity	JJ	O	low-intensity	dep	6	SENT_34	[p1l1513t2529r1961b2603],
2	(	CD	NUMBER	(	dep	1	SENT_34	[p1l1992t2533r2153b2596],
3	INR	NN	O	inr	dep	6	SENT_34	[p1l1992t2533r2153b2596],
4	1.5-1	CD	NUMBER	1.5-1	num	3	SENT_34	[p1l13t2629r255b2693],
5	.9	CD	NUMBER	.9	number	6	SENT_34	[p1l13t2629r255b2693],
6	)	CD	NUMBER	)	dep	15	SENT_34	[p1l13t2629r255b2693],
7	versus	CC	O	versus	prep	6	SENT_34	[p1l275t2644r472b2684],
8	conventional-intensity	NN	O	conventional-intensity	dep	7	SENT_34	[p1l494t2625r1199b2700],
9	(	CD	NUMBER	(	num	8	SENT_34	[p1l1218t2629r1319b2693],
10	IN	IN	O	in	_	0	SENT_34	[p1l1218t2629r1319b2693],
11	R	NN	O	r	prep_in	8	SENT_34	[p1l1320t2629r1376b2687],
12	2.0-3	CD	NUMBER	2.0-3	num	11	SENT_34	[p1l1386t2629r1631b2693],
13	.0	CD	NUMBER	.0	num	15	SENT_34	[p1l1386t2629r1631b2693],
14	)	NN	O	)	nn	15	SENT_34	[p1l1386t2629r1631b2693],
15	anticoagulation	NN	O	anticoagulation	dep	23	SENT_34	[p1l1653t2624r2146b2700],
16	for	IN	O	for	_	0	SENT_34	[p1l11t2720r103b2779],
17	extended	JJ	O	extended	amod	18	SENT_34	[p1l129t2720r414b2779],
18	treatment	NN	O	treatment	prep_for	15	SENT_34	[p1l442t2733r753b2779],
19	of	IN	O	of	_	0	SENT_34	[p1l778t2720r853b2779],
20	unprovoked	JJ	O	unprovoked	amod	21	SENT_34	[p1l867t2720r1249b2796],
21	VTE	NNP	O	VTE	prep_of	18	SENT_34	[p1l1274t2725r1425b2779],
22	:	:	O	:	_	0	SENT_34	[p1l1274t2725r1425b2779],
23	a	DT	O	a	_	0	SENT_34	[p1l1456t2740r1489b2779],
24	randomized	VBN	O	randomize	partmod	23	SENT_34	[p1l1515t2720r1900b2779],
25	double	JJ	O	double	amod	27	SENT_34	[p1l1929t2720r2145b2780],
26	blind	JJ	O	blind	amod	27	SENT_34	[p1l11t2817r176b2877],
27	trial	NN	O	trial	dobj	24	SENT_34	[p1l195t2817r337b2877],
28	.	.	O	.	_	0	SENT_34	[p1l195t2817r337b2877],

1	Blood	NN	O	blood	_	0	SENT_35	[p1l359t2817r547b2877],
2	2002	CD	DATE	2002	num	1	SENT_35	[p1l566t2822r1059b2890],
3	;	:	O	;	_	0	SENT_35	[p1l566t2822r1059b2890],
4	100:150	CD	NUMBER	100:150	num	5	SENT_35	[p1l566t2822r1059b2890],
5	a.	NN	O	a.	dep	1	SENT_35	[p1l566t2822r1059b2890],
6	abstract	JJ	O	abstract	amod	5	SENT_35	[p1l1081t2818r1350b2877],
7	.	.	O	.	_	0	SENT_35	[p1l1081t2818r1350b2877],

1	12	CD	NUMBER	12	_	0	SENT_36	[p1l13t2921r99b2972],
2	.	.	O	.	_	0	SENT_36	[p1l13t2921r99b2972],

1	Millenson	NNP	PERSON	Millenson	nn	2	SENT_37	[p1l138t2913r467b2972],
2	MM	NN	O	mm	_	0	SENT_37	[p1l504t2918r654b2985],
3	,	,	O	,	_	0	SENT_37	[p1l504t2918r654b2985],
4	Bauer	NNP	PERSON	Bauer	nn	5	SENT_37	[p1l697t2918r885b2972],
5	KA	NN	O	ka	appos	2	SENT_37	[p1l923t2919r1038b2985],
6	,	,	O	,	_	0	SENT_37	[p1l923t2919r1038b2985],
7	Kistler	NNP	PERSON	Kistler	nn	8	SENT_37	[p1l1082t2913r1298b2974],
8	JP	NNP	O	JP	appos	5	SENT_37	[p1l1328t2918r1406b2985],
9	,	,	O	,	_	0	SENT_37	[p1l1328t2918r1406b2985],
10	Barzegar	NNP	LOCATION	Barzegar	nn	11	SENT_37	[p1l1450t2918r1740b2989],
11	S	NNP	LOCATION	S	appos	5	SENT_37	[p1l1779t2918r1832b2985],
12	,	,	O	,	_	0	SENT_37	[p1l1779t2918r1832b2985],
13	Tulin	NNP	PERSON	Tulin	nn	14	SENT_37	[p1l1873t2913r2044b2972],
14	L	NNP	PERSON	L	appos	5	SENT_37	[p1l2083t2919r2139b2985],
15	,	,	O	,	_	0	SENT_37	[p1l2083t2919r2139b2985],
16	Rosenberg	NNP	PERSON	Rosenberg	nn	17	SENT_37	[p1l9t3009r362b3085],
17	RD.	NNP	O	RD.	appos	5	SENT_37	[p1l380t3014r498b3072],
18	.	.	O	.	_	0	SENT_37	[p1l380t3014r498b3072],

1	Monitoring	VBG	O	monitor	dep	9	SENT_38	[p1l522t3010r899b3085],
2	“	CD	NUMBER	“	num	3	SENT_38	[p1l921t3010r1447b3085],
3	mini-intensity	NN	O	mini-intensity	nsubj	5	SENT_38	[p1l921t3010r1447b3085],
4	”	CD	NUMBER	”	num	5	SENT_38	[p1l921t3010r1447b3085],
5	anticoagulation	NN	O	anticoagulation	xcomp	1	SENT_38	[p1l1472t3009r1981b3085],
6	with	IN	O	with	_	0	SENT_38	[p1l1999t3010r2144b3069],
7	Warfarin	NNP	O	Warfarin	prep_with	5	SENT_38	[p1l7t3105r304b3165],
8	:	:	O	:	_	0	SENT_38	[p1l7t3105r304b3165],
9	comparison	NN	O	comparison	_	0	SENT_38	[p1l336t3106r724b3181],
10	of	IN	O	of	_	0	SENT_38	[p1l753t3105r830b3164],
11	the	DT	O	the	det	13	SENT_38	[p1l845t3105r944b3164],
12	prothrombin	NN	O	prothrombin	nn	13	SENT_38	[p1l972t3105r1397b3181],
13	time	NN	O	time	prep_of	9	SENT_38	[p1l1425t3106r1569b3164],
14	using	VBG	O	use	partmod	13	SENT_38	[p1l1597t3106r1779b3181],
15	a	DT	O	a	det	17	SENT_38	[p1l1805t3125r1839b3164],
16	sensitive	JJ	O	sensitive	amod	17	SENT_38	[p1l1867t3106r2144b3165],
17	thromboplastin	NN	O	thromboplastin	dobj	14	SENT_38	[p1l11t3201r521b3277],
18	with	IN	O	with	_	0	SENT_38	[p1l557t3201r702b3261],
19	prothrombin	NN	O	prothrombin	nn	23	SENT_38	[p1l740t3201r1165b3277],
20	fragment	NN	O	fragment	nn	23	SENT_38	[p1l1204t3201r1507b3277],
21	F1	NN	O	f1	nn	23	SENT_38	[p1l1541t3207r1675b3275],
22	+2	NN	NUMBER	+2	nn	23	SENT_38	[p1l1541t3207r1675b3275],
23	levels	NNS	O	level	prep_with	14	SENT_38	[p1l1713t3201r1909b3261],
24	.	.	O	.	_	0	SENT_38	[p1l1713t3201r1909b3261],

1	Blood	NN	O	blood	_	0	SENT_39	[p1l1952t3201r2143b3260],
2	1992	CD	DATE	1992	num	1	SENT_39	[p1l13t3302r545b3369],
3	;	:	O	;	_	0	SENT_39	[p1l13t3302r545b3369],
4	79:2034	CD	NUMBER	79:2034	number	5	SENT_39	[p1l13t3302r545b3369],
5	-8	CD	NUMBER	-8	dep	1	SENT_39	[p1l13t3302r545b3369],
6	.	.	O	.	_	0	SENT_39	[p1l13t3302r545b3369],

1	13	CD	NUMBER	13	_	0	SENT_40	[p1l13t3400r99b3452],
2	.	.	O	.	_	0	SENT_40	[p1l13t3400r99b3452],

1	Takano	NNP	PERSON	Takano	nn	2	SENT_41	[p1l138t3393r371b3453],
2	K	NNP	PERSON	K	nsubj	24	SENT_41	[p1l400t3399r466b3465],
3	,	,	O	,	_	0	SENT_41	[p1l400t3399r466b3465],
4	Iiono	NNP	PERSON	Iiono	nn	5	SENT_41	[p1l497t3394r665b3452],
5	K	NNP	PERSON	K	appos	2	SENT_41	[p1l694t3399r760b3465],
6	,	,	O	,	_	0	SENT_41	[p1l694t3399r760b3465],
7	Ibayashi	NNP	LOCATION	Ibayashi	nn	8	SENT_41	[p1l792t3393r1056b3468],
8	S	NNP	LOCATION	S	appos	2	SENT_41	[p1l1086t3398r1138b3465],
9	,	,	O	,	_	0	SENT_41	[p1l1086t3398r1138b3465],
10	Tagawa	NNP	LOCATION	Tagawa	nn	11	SENT_41	[p1l1168t3398r1410b3469],
11	K	NNP	LOCATION	K	appos	2	SENT_41	[p1l1437t3399r1502b3465],
12	,	,	O	,	_	0	SENT_41	[p1l1437t3399r1502b3465],
13	Sadoshima	NNP	LOCATION	Sadoshima	nn	14	SENT_41	[p1l1536t3393r1888b3452],
14	S	NNP	LOCATION	S	appos	2	SENT_41	[p1l1917t3398r1969b3465],
15	,	,	O	,	_	0	SENT_41	[p1l1917t3398r1969b3465],
16	Fujishima	NNP	PERSON	Fujishima	nn	19	SENT_41	[p1l2001t3394r2144b3468, p1l12t3489r206b3548],
17	M.	NNP	PERSON	M.	nn	19	SENT_41	[p1l225t3495r307b3548],
18	Hypercoagulable	JJ	PERSON	hypercoagulable	amod	19	SENT_41	[p1l333t3489r872b3565],
19	state	NN	O	state	appos	2	SENT_41	[p1l895t3502r1042b3548],
20	under	IN	O	under	_	0	SENT_41	[p1l1064t3489r1252b3549],
21	low-intensity	JJ	O	low-intensity	amod	23	SENT_41	[p1l1271t3489r1690b3565],
22	Warfarin	NNP	MISC	Warfarin	nn	23	SENT_41	[p1l1706t3489r1977b3549],
23	anticoagulation	NN	O	anticoagulation	prep_under	19	SENT_41	[p1l1999t3490r2144b3548, p1l11t3586r385b3661],
24	assessed	VBN	O	assess	_	0	SENT_41	[p1l402t3585r677b3644],
25	with	IN	O	with	_	0	SENT_41	[p1l691t3585r834b3645],
26	hemostatic	JJ	O	hemostatic	amod	27	SENT_41	[p1l852t3585r1205b3644],
27	markers	NNS	O	marker	prep_with	24	SENT_41	[p1l1222t3585r1482b3645],
28	in	IN	O	in	_	0	SENT_41	[p1l1501t3586r1563b3643],
29	cardiac	JJ	O	cardiac	amod	30	SENT_41	[p1l1582t3585r1807b3644],
30	disorders	NNS	O	disorder	prep_in	27	SENT_41	[p1l1825t3585r2140b3644],
31	.	.	O	.	_	0	SENT_41	[p1l1825t3585r2140b3644],

1	AmJ	NN	O	amj	nn	2	SENT_42	[p1l8t3688r160b3751],
2	Cardiol	NN	O	cardiol	_	0	SENT_42	[p1l178t3682r411b3742],
3	1994	CD	DATE	1994	dep	2	SENT_42	[p1l432t3687r912b3755],
4	;	:	O	;	_	0	SENT_42	[p1l432t3687r912b3755],
5	74:935	CD	NUMBER	74:935	number	6	SENT_42	[p1l432t3687r912b3755],
6	—	CD	NUMBER	—	dep	2	SENT_42	[p1l432t3687r912b3755],
7	9	CD	NUMBER	9	dep	6	SENT_42	[p1l432t3687r912b3755],
8	.	.	O	.	_	0	SENT_42	[p1l432t3687r912b3755],

1	14	CD	NUMBER	14	_	0	SENT_43	[p2l13t26r99b77],
2	.	.	O	.	_	0	SENT_43	[p2l13t26r99b77],

1	Falanga	NNP	PERSON	Falanga	nn	2	SENT_44	[p2l139t18r389b94],
2	A	NNP	O	A	_	0	SENT_44	[p2l403t24r468b90],
3	,	,	O	,	_	0	SENT_44	[p2l403t24r468b90],
4	Levine	NNP	PERSON	Levine	nn	5	SENT_44	[p2l489t19r692b78],
5	MN	NN	O	mn	appos	2	SENT_44	[p2l707t24r844b90],
6	,	,	O	,	_	0	SENT_44	[p2l707t24r844b90],
7	Consonni	NNP	O	Consonni	nn	8	SENT_44	[p2l866t19r1178b77],
8	R	NNP	O	R	appos	2	SENT_44	[p2l1193t23r1258b90],
9	,	,	O	,	_	0	SENT_44	[p2l1193t23r1258b90],
10	et	FW	O	et	nn	11	SENT_44	[p2l1280t31r1339b77],
11	al.	FW	O	al.	appos	2	SENT_44	[p2l1351t18r1423b77],
12	.	.	O	.	_	0	SENT_44	[p2l1351t18r1423b77],

1	The	DT	O	the	det	2	SENT_45	[p2l1442t18r1564b77],
2	effect	NN	O	effect	_	0	SENT_45	[p2l1582t18r1758b77],
3	of	IN	O	of	_	0	SENT_45	[p2l1773t18r1849b77],
4	very	RB	O	very	advmod	6	SENT_45	[p2l1849t18r2144b93],
5	—	RB	O	—	advmod	6	SENT_45	[p2l1849t18r2144b93],
6	low	JJ	O	low	amod	9	SENT_45	[p2l1849t18r2144b93],
7	—	NN	O	—	nn	9	SENT_45	[p2l1849t18r2144b93],
8	dose	NN	O	dose	nn	9	SENT_45	[p2l11t114r156b173],
9	Warfarin	NN	O	warfarin	prep_of	2	SENT_45	[p2l175t114r447b174],
10	on	IN	O	on	_	0	SENT_45	[p2l470t133r550b173],
11	markers	NNS	O	marker	prep_on	9	SENT_45	[p2l573t115r832b174],
12	of	IN	O	of	_	0	SENT_45	[p2l857t114r932b173],
13	hypercoagulation	NN	O	hypercoagulation	prep_of	11	SENT_45	[p2l941t115r1495b190],
14	in	IN	O	in	_	0	SENT_45	[p2l1517t115r1579b172],
15	metastatic	JJ	O	metastatic	amod	17	SENT_45	[p2l1601t115r1930b173],
16	breast	NN	O	breast	nn	17	SENT_45	[p2l1952t115r2148b173],
17	cancer	NN	O	cancer	prep_in	13	SENT_45	[p2l11t231r235b271],
18	:	:	O	:	_	0	SENT_45	[p2l11t231r235b271],
19	results	NNS	O	result	dep	2	SENT_45	[p2l257t212r466b271],
20	from	IN	O	from	_	0	SENT_45	[p2l485t211r642b271],
21	a	DT	O	a	det	23	SENT_45	[p2l660t232r693b271],
22	randomized	JJ	O	randomized	amod	23	SENT_45	[p2l710t211r1095b271],
23	trial	NN	O	trial	prep_from	19	SENT_45	[p2l1114t212r1257b271],
24	.	.	O	.	_	0	SENT_45	[p2l1114t212r1257b271],

1	Thromb	NNP	O	Thromb	nn	2	SENT_46	[p2l1277t211r1540b271],
2	Haemost	NNP	O	Haemost	_	0	SENT_46	[p2l1559t217r1851b271],
3	1998	CD	DATE	1998	num	2	SENT_46	[p2l1868t216r2143b284],
4	;	:	O	;	_	0	SENT_46	[p2l1868t216r2143b284],
5	79	CD	NUMBER	79	num	7	SENT_46	[p2l1868t216r2143b284],
6	:	:	O	:	_	0	SENT_46	[p2l1868t216r2143b284],
7	23-7	CD	NUMBER	23-7	dep	2	SENT_46	[p2l11t312r170b366],
8	.	.	O	.	_	0	SENT_46	[p2l11t312r170b366],

1	Copyright	NN	O	copyright	_	0	SENT_47	[p2l12t393r252b458],
2	©	CD	NUMBER	©	num	6	SENT_47	[p2l274t398r327b452],
3	2003	CD	DATE	2003	num	6	SENT_47	[p2l351t396r476b442],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_47	[p2l498t393r861b442],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_47	[p2l881t393r1081b442],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_47	[p2l1099t395r1282b457],
7	.	.	O	.	_	0	SENT_47	[p2l1099t395r1282b457],

1	ls	NNS	O	l	dep	2	SENT_48	[p2l379t538r420b583],
2	Refractory	JJ	O	refractory	_	0	SENT_48	[p2l442t533r708b598],
3	Epilepsy	NNP	O	Epilepsy	nn	4	SENT_48	[p2l728t534r945b598],
4	Due	NNP	O	Due	nsubj	7	SENT_48	[p2l966t538r1071b583],
5	to	TO	O	to	aux	7	SENT_48	[p2l1087t542r1139b583],
6	Genetically	RB	O	genetically	advmod	7	SENT_48	[p2l1157t534r1451b598],
7	Determined	VBN	O	determine	dep	2	SENT_48	[p2l1471t534r1780b583],

1	Resistance	NN	O	resistance	_	0	SENT_49	[p2l627t606r908b653],
2	to	TO	O	to	_	0	SENT_49	[p2l924t613r975b653],
3	Antiepileptic	JJ	O	antiepileptic	amod	4	SENT_49	[p2l992t605r1327b667],
4	Drugs	NNS	O	drug	prep_to	1	SENT_49	[p2l1348t604r1532b668],
5	?	.	O	?	_	0	SENT_49	[p2l1348t604r1532b668],

1	Timothy	NNP	PERSON	Timothy	nn	5	SENT_50	[p2l644t684r786b725],
2	A.	NNP	PERSON	A.	nn	5	SENT_50	[p2l797t686r828b715],
3	Pedley	NNP	PERSON	Pedley	nn	5	SENT_50	[p2l845t684r957b725],
4	,	,	O	,	_	0	SENT_50	[p2l845t684r957b725],
5	M.D.	NNP	O	M.D.	_	0	SENT_50	[p2l974t687r1064b721],
6	,	,	O	,	_	0	SENT_50	[p2l974t687r1064b721],
7	and	CC	O	and	_	0	SENT_50	[p2l1079t684r1138b715],
8	Michio	NNP	PERSON	Michio	nn	9	SENT_50	[p2l1156t684r1270b715],
9	Hirano	NNP	PERSON	Hirano	conj_and	5	SENT_50	[p2l1286t687r1410b721],
10	,	,	O	,	_	0	SENT_50	[p2l1286t687r1410b721],
11	M.D.	NNP	O	M.D.	appos	5	SENT_50	[p2l1427t687r1507b715],

1	Failure	NN	O	failure	nsubj	10	SENT_51	[p2l9t842r299b921],
2	to	TO	O	to	aux	3	SENT_51	[p2l326t858r405b920],
3	respond	VB	O	respond	infmod	1	SENT_51	[p2l432t842r777b942],
4	to	TO	O	to	_	0	SENT_51	[p2l803t858r882b920],
5	antiseizure	JJ	O	antiseizure	amod	6	SENT_51	[p2l909t842r1371b921],
6	drugs	NNS	O	drug	prep_to	3	SENT_51	[p2l1398t842r1636b942],
7	is	VBZ	O	be	cop	10	SENT_51	[p2l1663t842r1728b920],
8	the	DT	O	the	det	10	SENT_51	[p2l1757t841r1885b920],
9	usual	JJ	O	usual	amod	10	SENT_51	[p2l1912t842r2135b921],
10	basis	NN	O	basis	_	0	SENT_51	[p2l11t970r224b1048],
11	for	IN	O	for	_	0	SENT_51	[p2l268t969r392b1048],
12	deﬁning	VBG	O	deﬁning	prepc_for	10	SENT_51	[p2l430t969r796b1070],
13	intractable	JJ	O	intractable	amod	14	SENT_51	[p2l832t970r1294b1048],
14	epilepsy	NN	O	epilepsy	dobj	12	SENT_51	[p2l1335t970r1700b1070],
15	,	,	O	,	_	0	SENT_51	[p2l1335t970r1700b1070],
16	although	IN	O	although	mark	18	SENT_51	[p2l1746t970r2134b1070],
17	there	EX	O	there	expl	18	SENT_51	[p2l11t1097r227b1176],
18	is	VBZ	O	be	advcl	10	SENT_51	[p2l255t1098r319b1176],
19	a	DT	O	a	det	20	SENT_51	[p2l345t1124r390b1176],
20	lack	NN	O	lack	nsubj	18	SENT_51	[p2l412t1097r587b1177],
21	of	IN	O	of	_	0	SENT_51	[p2l608t1097r708b1176],
22	consensus	NN	O	consensus	prep_of	20	SENT_51	[p2l716t1123r1154b1177],
23	about	IN	O	about	_	0	SENT_51	[p2l1180t1098r1424b1177],
24	What	WP	O	what	nsubj	25	SENT_51	[p2l1440t1098r1654b1177],
25	constitutes	VBZ	O	constitute	prepc_about	22	SENT_51	[p2l1674t1098r2133b1177],
26	drug	NN	O	drug	nn	27	SENT_51	[p2l11t1226r209b1326],
27	resistance	NN	O	resistance	dobj	25	SENT_51	[p2l226t1226r643b1304],
28	and	CC	O	and	_	0	SENT_51	[p2l664t1225r818b1304],
29	when	WRB	O	when	advmod	34	SENT_51	[p2l834t1226r1066b1305],
30	this	DT	O	this	det	31	SENT_51	[p2l1087t1226r1237b1304],
31	determination	NN	O	determination	nsubjpass	34	SENT_51	[p2l1261t1225r1855b1304],
32	can	MD	O	can	aux	34	SENT_51	[p2l1877t1251r2019b1304],
33	be	VB	O	be	auxpass	34	SENT_51	[p2l2041t1226r2135b1304],
34	made	VBN	O	make	prepc_about	22	SENT_51	[p2l10t1354r366b1432],
35	.1	CD	NUMBER	.1	num	36	SENT_51	[p2l10t1354r366b1432],
36	>	JJR	O	>	dobj	34	SENT_51	[p2l10t1354r366b1432],
37	2	CD	NUMBER	2	number	40	SENT_51	[p2l10t1354r366b1432],
38	At	IN	O	at	quantmod	40	SENT_51	[p2l384t1361r482b1432],
39	least	JJS	O	least	quantmod	40	SENT_51	[p2l496t1354r688b1432],
40	30	CD	PERCENT	30	num	41	SENT_51	[p2l704t1359r802b1432],
41	percent	NN	PERCENT	percent	nsubj	52	SENT_51	[p2l822t1370r1136b1454],
42	of	IN	O	of	_	0	SENT_51	[p2l1152t1353r1251b1432],
43	patients	NNS	O	patient	prep_of	41	SENT_51	[p2l1251t1354r1579b1454],
44	with	IN	O	with	_	0	SENT_51	[p2l1597t1354r1783b1433],
45	epilepsy	NN	O	epilepsy	prep_with	43	SENT_51	[p2l1803t1353r2140b1454],
46	in	IN	O	in	_	0	SENT_51	[p2l10t1482r91b1559],
47	North	NNP	LOCATION	North	nn	48	SENT_51	[p2l118t1481r372b1560],
48	America	NNP	LOCATION	America	prep_in	45	SENT_51	[p2l398t1482r753b1560],
49	and	CC	O	and	_	0	SENT_51	[p2l780t1481r935b1560],
50	Western	NNP	LOCATION	Western	nn	51	SENT_51	[p2l961t1498r1295b1561],
51	Europe	NNP	LOCATION	Europe	prep_in	45	SENT_51	[p2l1323t1489r1625b1582],
52	continue	VBP	O	continue	rcmod	36	SENT_51	[p2l1656t1482r2024b1561],
53	to	TO	O	to	aux	54	SENT_51	[p2l2055t1498r2134b1560],
54	have	VB	O	have	xcomp	52	SENT_51	[p2l10t1610r201b1689],
55	seizures	NNS	O	seizure	dobj	54	SENT_51	[p2l232t1610r578b1689],
56	despite	IN	O	despite	_	0	SENT_51	[p2l609t1610r916b1710],
57	drug	NN	O	drug	nn	59	SENT_51	[p2l945t1610r1147b1710],
58	treatment	NN	O	treatment	nn	59	SENT_51	[p2l1173t1616r1660b1688],
59	.3	NN	NUMBER	.3	prep_despite	54	SENT_51	[p2l1173t1616r1660b1688],
60	The	DT	O	the	det	61	SENT_51	[p2l1687t1609r1851b1688],
61	ﬁgure	NN	O	ﬁgure	nsubj	65	SENT_51	[p2l1879t1609r2133b1710],
62	may	MD	O	may	aux	65	SENT_51	[p2l10t1764r186b1838],
63	be	VB	O	be	cop	65	SENT_51	[p2l202t1737r298b1816],
64	even	RB	O	even	advmod	65	SENT_51	[p2l319t1763r504b1817],
65	higher	JJR	O	higher	rcmod	59	SENT_51	[p2l525t1738r801b1838],
66	in	IN	O	in	mark	73	SENT_51	[p2l817t1738r898b1815],
67	adults	NNS	O	adult	nsubj	73	SENT_51	[p2l918t1738r1169b1817],
68	with	IN	O	with	_	0	SENT_51	[p2l1188t1738r1375b1817],
69	localization	NN	O	localization	nn	71	SENT_51	[p2l1394t1737r2134b1816],
70	—	CD	NUMBER	—	num	71	SENT_51	[p2l1394t1737r2134b1816],
71	relat	NN	O	relat	prep_with	67	SENT_51	[p2l1394t1737r2134b1816],
72	—	CD	NUMBER	—	num	71	SENT_51	[p2l1394t1737r2134b1816],
73	ed	VBD	O	ed	ccomp	65	SENT_51	[p2l11t1865r107b1944],
74	epilepsy	NN	O	epilepsy	nn	75	SENT_51	[p2l128t1866r526b1966],
75	.4	NN	NUMBER	.4	dobj	73	SENT_51	[p2l128t1866r526b1966],
76	This	DT	O	this	det	77	SENT_51	[p2l544t1866r727b1944],
77	situation	NN	O	situation	nsubj	80	SENT_51	[p2l753t1866r1117b1945],
78	has	VBZ	O	have	aux	80	SENT_51	[p2l1139t1866r1279b1944],
79	not	RB	O	not	neg	80	SENT_51	[p2l1303t1882r1445b1944],
80	changed	VBN	O	change	rcmod	75	SENT_51	[p2l1463t1865r1816b1966],
81	despite	IN	O	despite	_	0	SENT_51	[p2l1838t1866r2135b1966],
82	the	DT	O	the	det	83	SENT_51	[p2l11t1994r139b2072],
83	introduction	NN	O	introduction	prep_despite	80	SENT_51	[p2l158t1994r683b2073],
84	of	IN	O	of	_	0	SENT_51	[p2l704t1993r804b2072],
85	a	DT	O	a	det	86	SENT_51	[p2l805t2020r849b2072],
86	number	NN	O	number	prep_of	83	SENT_51	[p2l868t1994r1201b2073],
87	of	IN	O	of	_	0	SENT_51	[p2l1219t1993r1319b2072],
88	antiseizure	JJ	O	antiseizure	amod	89	SENT_51	[p2l1320t1994r1777b2073],
89	drugs	NNS	O	drug	prep_of	86	SENT_51	[p2l1798t1994r2033b2094],
90	in	IN	O	in	_	0	SENT_51	[p2l2055t1994r2135b2071],
91	the	DT	DATE	the	det	93	SENT_51	[p2l11t2121r142b2200],
92	past	JJ	DATE	past	amod	93	SENT_51	[p2l171t2138r354b2222],
93	decade	NN	DATE	decade	prep_in	89	SENT_51	[p2l380t2122r699b2200],
94	.	.	O	.	_	0	SENT_51	[p2l380t2122r699b2200],

1	Refractory	JJ	O	refractory	amod	2	SENT_52	[p2l735t2121r1184b2222],
2	epilepsy	NN	O	epilepsy	nsubjpass	4	SENT_52	[p2l1211t2122r1564b2222],
3	is	VBZ	O	be	auxpass	4	SENT_52	[p2l1589t2122r1655b2200],
4	associated	VBN	O	associate	_	0	SENT_52	[p2l1687t2121r2134b2200],
5	with	IN	O	with	_	0	SENT_52	[p2l6t2250r195b2329],
6	memory	NN	O	memory	nn	7	SENT_52	[p2l223t2275r577b2350],
7	loss	NN	O	loss	prep_with	4	SENT_52	[p2l599t2250r788b2345],
8	,	,	O	,	_	0	SENT_52	[p2l599t2250r788b2345],
9	lower	JJR	O	lower	amod	10	SENT_52	[p2l820t2250r1058b2329],
10	levels	NNS	O	level	prep_with	4	SENT_52	[p2l1081t2249r1309b2329],
11	of	IN	O	of	_	0	SENT_52	[p2l1339t2249r1440b2328],
12	school	NN	O	school	nn	13	SENT_52	[p2l1450t2249r1727b2328],
13	performance	NN	O	performance	prep_of	10	SENT_52	[p2l1753t2249r2134b2350, p2l10t2403r222b2473],
14	,	,	O	,	_	0	SENT_52	[p2l1753t2249r2134b2350, p2l10t2403r222b2473],
15	depression	NN	O	depression	prep_with	4	SENT_52	[p2l251t2378r731b2478],
16	,	,	O	,	_	0	SENT_52	[p2l251t2378r731b2478],
17	impaired	JJ	O	impaired	amod	18	SENT_52	[p2l758t2378r1135b2478],
18	psychosocial	JJ	O	psychosocial	amod	19	SENT_52	[p2l1157t2378r1692b2478],
19	skills	NNS	O	skill	appos	15	SENT_52	[p2l1716t2377r1953b2473],
20	,	,	O	,	_	0	SENT_52	[p2l1716t2377r1953b2473],
21	and	CC	O	and	_	0	SENT_52	[p2l1981t2377r2135b2456],
22	an	DT	O	a	det	24	SENT_52	[p2l10t2531r109b2584],
23	increased	VBN	O	increase	amod	24	SENT_52	[p2l129t2505r522b2584],
24	risk	NN	O	risk	conj_and	7	SENT_52	[p2l542t2506r701b2585],
25	of	IN	O	of	_	0	SENT_52	[p2l718t2505r817b2584],
26	death	NN	O	death	prep_of	24	SENT_52	[p2l820t2506r1069b2584],
27	.	.	O	.	_	0	SENT_52	[p2l820t2506r1069b2584],

1	It	PRP	O	it	nsubj	5	SENT_53	[p2l1095t2513r1159b2584],
2	is	VBZ	O	be	cop	5	SENT_53	[p2l1174t2506r1238b2584],
3	therefore	RB	O	therefore	advmod	5	SENT_53	[p2l1261t2505r1636b2584],
4	not	RB	O	not	neg	5	SENT_53	[p2l1657t2522r1798b2584],
5	surprising	JJ	O	surprising	_	0	SENT_53	[p2l1815t2506r2135b2606, p2l10t2634r151b2734],
6	that	IN	O	that	complm	12	SENT_53	[p2l176t2634r347b2712],
7	persistent	JJ	O	persistent	amod	10	SENT_53	[p2l369t2634r819b2734],
8	,	,	O	,	_	0	SENT_53	[p2l369t2634r819b2734],
9	uncontrolled	JJ	O	uncontrolled	amod	10	SENT_53	[p2l854t2633r1411b2713],
10	seizures	NNS	O	seizure	nsubj	19	SENT_53	[p2l1441t2634r1787b2713],
11	are	VBP	O	be	aux	12	SENT_53	[p2l1817t2660r1945b2712],
12	disabling	VBG	O	disable	ccomp	5	SENT_53	[p2l1975t2634r2133b2712, p2l10t2761r284b2862],
13	to	TO	O	to	_	0	SENT_53	[p2l318t2778r397b2840],
14	patients	NNS	O	patient	prep_to	12	SENT_53	[p2l431t2762r766b2862],
15	and	CC	O	and	_	0	SENT_53	[p2l802t2761r957b2840],
16	their	PRP$	O	they	poss	17	SENT_53	[p2l992t2762r1189b2840],
17	families	NNS	O	family	prep_to	12	SENT_53	[p2l1221t2761r1554b2840],
18	and	CC	O	and	_	0	SENT_53	[p2l1590t2761r1746b2840],
19	costly	JJ	O	costly	conj_and	12	SENT_53	[p2l1781t2762r2024b2862],
20	to	TO	O	to	_	0	SENT_53	[p2l2055t2778r2134b2840],
21	society	NN	O	society	prep_to	19	SENT_53	[p2l12t2890r355b2989],
22	.5	CD	NUMBER	.5	num	21	SENT_53	[p2l12t2890r355b2989],

1	Some	DT	O	some	det	2	SENT_54	[p2l141t3023r373b3096],
2	causes	NNS	O	cause	nsubj	9	SENT_54	[p2l395t3044r664b3097],
3	of	IN	O	of	_	0	SENT_54	[p2l689t3017r789b3096],
4	seemingly	RB	O	seemingly	advmod	5	SENT_54	[p2l793t3018r1220b3118],
5	uncontrolled	JJ	O	uncontrolled	amod	6	SENT_54	[p2l1237t3018r1776b3097],
6	seizures	NNS	O	seizure	prep_of	2	SENT_54	[p2l1799t3018r2134b3097],
7	are	VBP	O	be	cop	9	SENT_54	[p2l10t3172r138b3224],
8	potentially	RB	O	potentially	advmod	9	SENT_54	[p2l163t3145r624b3246],
9	remediable	JJ	O	remediable	_	0	SENT_54	[p2l646t3145r1152b3241],
10	,	,	O	,	_	0	SENT_54	[p2l646t3145r1152b3241],
11	including	VBG	O	include	_	0	SENT_54	[p2l1183t3146r1598b3246],
12	an	DT	O	a	det	14	SENT_54	[p2l1621t3171r1722b3224],
13	incorrect	JJ	O	incorrect	amod	14	SENT_54	[p2l1748t3146r2139b3224],
14	diagnosis	NN	O	diagnosis	prep_including	9	SENT_54	[p2l11t3274r423b3374],
15	and	CC	O	and	_	0	SENT_54	[p2l458t3274r614b3352],
16	ineffective	JJ	O	ineffective	amod	17	SENT_54	[p2l645t3273r1077b3353],
17	treatment	NN	O	treatment	prep_including	9	SENT_54	[p2l1110t3290r1543b3352],
18	.	.	O	.	_	0	SENT_54	[p2l1110t3290r1543b3352],

1	For	IN	O	for	_	0	SENT_55	[p2l1580t3281r1724b3352],
2	example	NN	O	example	prep_for	22	SENT_55	[p2l1754t3274r2129b3374],
3	,	,	O	,	_	0	SENT_55	[p2l1754t3274r2129b3374],
4	drug	NN	O	drug	nn	5	SENT_55	[p2l11t3402r214b3502],
5	treatment	NN	O	treatment	nsubj	7	SENT_55	[p2l244t3418r667b3480],
6	may	MD	O	may	aux	7	SENT_55	[p2l695t3428r874b3502],
7	fail	VB	O	fail	dep	22	SENT_55	[p2l903t3401r1038b3480],
8	to	TO	O	to	aux	9	SENT_55	[p2l1071t3418r1151b3480],
9	control	VB	O	control	xcomp	7	SENT_55	[p2l1186t3402r1495b3480],
10	seizures	NNS	O	seizure	dobj	9	SENT_55	[p2l1530t3402r1876b3481],
11	if	IN	O	if	mark	16	SENT_55	[p2l1910t3401r1987b3479],
12	the	DT	O	the	det	14	SENT_55	[p2l2002t3402r2134b3480],
13	Wrong	JJ	O	wrong	amod	14	SENT_55	[p2l6t3555r290b3630],
14	drug	NN	O	drug	nsubjpass	16	SENT_55	[p2l309t3530r509b3630],
15	is	VBZ	O	be	auxpass	16	SENT_55	[p2l526t3530r591b3608],
16	used	VBN	O	use	advcl	9	SENT_55	[p2l615t3530r833b3625],
17	,	,	O	,	_	0	SENT_55	[p2l615t3530r833b3625],
18	the	DT	O	the	det	20	SENT_55	[p2l860t3530r989b3608],
19	right	JJ	O	right	amod	20	SENT_55	[p2l1011t3530r1219b3630],
20	drug	NN	O	drug	nsubjpass	22	SENT_55	[p2l1237t3529r1436b3630],
21	is	VBZ	O	be	auxpass	22	SENT_55	[p2l1453t3530r1518b3608],
22	given	VBN	O	give	_	0	SENT_55	[p2l1541t3530r1765b3630],
23	in	IN	O	in	_	0	SENT_55	[p2l1786t3530r1867b3607],
24	insufﬁcient	JJ	O	insufﬁcient	amod	25	SENT_55	[p2l1888t3529r2134b3609, p2l10t3657r276b3736],
25	amounts	NNS	O	amount	prep_in	22	SENT_55	[p2l292t3674r659b3737],
26	or	CC	O	or	_	0	SENT_55	[p2l684t3683r773b3736],
27	administered	VBN	O	administer	conj_or	22	SENT_55	[p2l792t3657r1343b3736],
28	inappropriately	RB	O	inappropriately	advmod	27	SENT_55	[p2l1365t3658r2021b3758],
29	,	,	O	,	_	0	SENT_55	[p2l1365t3658r2021b3758],
30	or	CC	O	or	_	0	SENT_55	[p2l2050t3683r2139b3736],
31	there	EX	O	there	expl	32	SENT_55	[p3l11t21r223b99],
32	are	VBP	O	be	conj_or	22	SENT_55	[p3l246t47r372b99],
33	unrecognized	JJ	O	unrecognized	amod	35	SENT_55	[p3l395t20r975b121],
34	drug	NN	O	drug	nn	35	SENT_55	[p3l998t21r1198b121],
35	interactions	NNS	O	interaction	nsubj	32	SENT_55	[p3l1217t21r1743b116],
36	,	,	O	,	_	0	SENT_55	[p3l1217t21r1743b116],
37	drug	NN	O	drug	nn	38	SENT_55	[p3l1772t20r1972b121],
38	tolerance	NN	O	tolerance	nsubj	32	SENT_55	[p3l1993t21r2134b99, p3l11t174r301b244],
39	,	,	O	,	_	0	SENT_55	[p3l1993t21r2134b99, p3l11t174r301b244],
40	or	CC	O	or	_	0	SENT_55	[p3l327t174r415b227],
41	noncompliance	NN	O	noncompliance	conj_or	35	SENT_55	[p3l431t148r1099b249],
42	.	.	O	.	_	0	SENT_55	[p3l431t148r1099b249],

1	A	DT	O	a	det	3	SENT_56	[p3l1120t156r1186b226],
2	greater	JJR	O	greater	amod	3	SENT_56	[p3l1202t165r1493b249],
3	challenge	NN	O	challenge	nsubj	7	SENT_56	[p3l1510t149r1904b249],
4	is	VBZ	O	be	cop	7	SENT_56	[p3l1923t149r1987b227],
5	the	DT	O	the	det	7	SENT_56	[p3l2008t149r2135b227],
6	large	JJ	O	large	amod	7	SENT_56	[p3l9t277r222b377],
7	number	NN	O	number	_	0	SENT_56	[p3l256t276r597b356],
8	of	IN	O	of	_	0	SENT_56	[p3l629t276r730b355],
9	patients	NNS	O	patient	prep_of	7	SENT_56	[p3l744t277r1086b377],
10	with	IN	O	with	_	0	SENT_56	[p3l1118t277r1310b356],
11	epilepsy	NN	O	epilepsy	prep_with	9	SENT_56	[p3l1345t277r1697b377],
12	Who	WP	O	who	nsubj	24	SENT_56	[p3l1722t276r1907b356],
13	have	VBP	O	have	aux	24	SENT_56	[p3l1942t276r2134b356],
14	no	DT	O	no	det	15	SENT_56	[p3l10t431r117b484],
15	response	NN	O	response	advmod	24	SENT_56	[p3l143t431r529b506],
16	to	TO	O	to	_	0	SENT_56	[p3l554t422r635b484],
17	treatment	NN	O	treatment	prep_to	15	SENT_56	[p3l660t422r1084b484],
18	with	IN	O	with	_	0	SENT_56	[p3l1099t407r1291b486],
19	several	JJ	O	several	amod	21	SENT_56	[p3l1317t407r1607b485],
20	appropriate	JJ	O	appropriate	amod	21	SENT_56	[p3l1631t407r2134b506],
21	drugs	NNS	O	drug	prep_with	17	SENT_56	[p3l11t535r253b635],
22	at	IN	O	at	prep	15	SENT_56	[p3l293t551r372b613],
23	maximally	RB	O	maximally	pcomp	22	SENT_56	[p3l403t534r845b635],
24	tolerated	VBN	O	tolerate	rcmod	7	SENT_56	[p3l877t535r1248b613],
25	doses	NNS	O	dose	dobj	24	SENT_56	[p3l1285t534r1545b613],
26	.	.	O	.	_	0	SENT_56	[p3l1285t534r1545b613],

1	A	DT	O	a	det	2	SENT_57	[p3l1584t542r1650b612],
2	number	NN	O	number	nsubj	6	SENT_57	[p3l1682t535r2019b614],
3	of	IN	O	of	_	0	SENT_57	[p3l2053t534r2153b613],
4	prognostic	JJ	O	prognostic	amod	5	SENT_57	[p3l9t663r468b763],
5	factors	NNS	O	factor	prep_of	2	SENT_57	[p3l494t662r779b741],
6	characterize	VBP	O	characterize	_	0	SENT_57	[p3l810t663r1318b741],
7	this	DT	O	this	det	8	SENT_57	[p3l1346t663r1499b741],
8	group	NN	O	group	dobj	6	SENT_57	[p3l1528t688r1804b763],
9	,	,	O	,	_	0	SENT_57	[p3l1528t688r1804b763],
10	including	VBG	O	include	_	0	SENT_57	[p3l1837t663r2134b742, p3l10t791r146b891],
11	a	DT	O	a	det	13	SENT_57	[p3l162t817r207b869],
12	young	JJ	O	young	amod	13	SENT_57	[p3l221t816r484b891],
13	age	NN	O	age	prep_including	8	SENT_57	[p3l500t817r641b891],
14	at	IN	O	at	_	0	SENT_57	[p3l660t807r738b869],
15	onset	NN	O	onset	prep_at	13	SENT_57	[p3l754t807r1001b886],
16	;	:	O	;	_	0	SENT_57	[p3l754t807r1001b886],
17	frequent	JJ	O	frequent	dobj	6	SENT_57	[p3l1025t790r1379b891],
18	generalized	VBN	O	generalize	partmod	17	SENT_57	[p3l1394t790r1895b891],
19	,	,	O	,	_	0	SENT_57	[p3l1394t790r1895b891],
20	atonic	JJ	O	atonic	dobj	18	SENT_57	[p3l1919t807r2134b869, p3l10t919r99b1014],
21	,	,	O	,	_	0	SENT_57	[p3l1919t807r2134b869, p3l10t919r99b1014],
22	or	CC	O	or	_	0	SENT_57	[p3l126t944r214b997],
23	atypical	JJ	O	atypical	amod	25	SENT_57	[p3l229t919r543b1019],
24	absence	NN	O	absence	nn	25	SENT_57	[p3l562t919r890b997],
25	seizures	NNS	O	seizure	conj_or	20	SENT_57	[p3l912t919r1269b1014],
26	;	:	O	;	_	0	SENT_57	[p3l912t919r1269b1014],
27	difficulty	NN	O	difficulty	conj_and	8	SENT_57	[p3l1293t918r1661b1019],
28	controlling	VBG	O	control	partmod	27	SENT_57	[p3l1677t919r2139b1019],
29	the	DT	O	the	det	30	SENT_57	[p3l11t1045r142b1123],
30	condition	NN	O	condition	dobj	28	SENT_57	[p3l170t1046r610b1140],
31	;	:	O	;	_	0	SENT_57	[p3l170t1046r610b1140],
32	evidence	NN	O	evidence	dep	27	SENT_57	[p3l642t1045r1010b1124],
33	of	IN	O	of	_	0	SENT_57	[p3l1038t1045r1140b1124],
34	structural	JJ	O	structural	amod	38	SENT_57	[p3l1150t1046r1563b1124],
35	or	CC	O	or	_	0	SENT_57	[p3l1591t1071r1681b1124],
36	metabolic	JJ	O	metabolic	amod	38	SENT_57	[p3l1705t1046r2135b1124],
37	brain	NN	O	brain	nn	38	SENT_57	[p3l11t1174r226b1252],
38	disease	NN	O	disease	prep_of	32	SENT_57	[p3l250t1173r571b1269],
39	;	:	O	;	_	0	SENT_57	[p3l250t1173r571b1269],
40	severe	JJ	O	severe	amod	41	SENT_57	[p3l599t1200r849b1253],
41	abnormality	NN	O	abnormality	dep	27	SENT_57	[p3l871t1173r1376b1274],
42	on	IN	O	on	_	0	SENT_57	[p3l1396t1199r1501b1252],
43	electroenceph	JJ	O	electroenceph	amod	45	SENT_57	[p3l1525t1173r2135b1274],
44	—	NN	O	—	nn	45	SENT_57	[p3l1525t1173r2135b1274],
45	alography	NN	O	alography	prep_on	41	SENT_57	[p3l10t1302r445b1402],
46	;	:	O	;	_	0	SENT_57	[p3l10t1302r445b1402],
47	and	CC	O	and	_	0	SENT_57	[p3l474t1302r630b1380],
48	mental	JJ	O	mental	amod	49	SENT_57	[p3l657t1301r953b1380],
49	retardation	NN	O	retardation	dobj	6	SENT_57	[p3l980t1301r1582b1380],
50	.1	CD	NUMBER	.1	num	51	SENT_57	[p3l980t1301r1582b1380],
51	»	NN	O	»	nsubj	60	SENT_57	[p3l980t1301r1582b1380],
52	5	CD	NUMBER	5	num	54	SENT_57	[p3l980t1301r1582b1380],
53	Such	JJ	O	such	amod	54	SENT_57	[p3l1613t1302r1816b1381],
54	associations	NNS	O	association	dep	51	SENT_57	[p3l1843t1302r2132b1380, p3l10t1430r264b1508],
55	are	VBP	O	be	cop	56	SENT_57	[p3l288t1456r414b1508],
56	nonspeciﬁc	JJ	O	nonspeciﬁc	rcmod	49	SENT_57	[p3l435t1429r925b1530],
57	and	CC	O	and	_	0	SENT_57	[p3l945t1430r1101b1508],
58	do	VBP	O	do	aux	60	SENT_57	[p3l1123t1430r1226b1508],
59	not	RB	O	not	neg	60	SENT_57	[p3l1249t1446r1392b1508],
60	offer	VB	O	offer	rcmod	49	SENT_57	[p3l1410t1429r1611b1508],
61	a	DT	O	a	det	63	SENT_57	[p3l1629t1456r1674b1508],
62	mechanistic	JJ	O	mechanistic	amod	63	SENT_57	[p3l1693t1430r2133b1508, p3l11t1558r112b1636],
63	explanation	NN	O	explanation	dobj	60	SENT_57	[p3l150t1557r655b1658],
64	of	IN	O	of	_	0	SENT_57	[p3l695t1557r796b1636],
65	drug	NN	O	drug	nn	66	SENT_57	[p3l817t1557r1020b1658],
66	resistance	NN	O	resistance	prep_of	63	SENT_57	[p3l1055t1558r1511b1636],
67	.	.	O	.	_	0	SENT_57	[p3l1055t1558r1511b1636],

1	Furthermore	RB	O	furthermore	advmod	4	SENT_58	[p3l1554t1558r2128b1653],
2	,	,	O	,	_	0	SENT_58	[p3l1554t1558r2128b1653],
3	there	EX	O	there	expl	4	SENT_58	[p3l11t1685r227b1764],
4	are	VBP	O	be	_	0	SENT_58	[p3l259t1712r384b1764],
5	many	JJ	O	many	amod	6	SENT_58	[p3l414t1711r648b1786],
6	exceptions	NNS	O	exception	nsubj	4	SENT_58	[p3l673t1686r1120b1786],
7	to	TO	O	to	_	0	SENT_58	[p3l1152t1702r1231b1764],
8	the	DT	O	the	det	12	SENT_58	[p3l1262t1685r1391b1764],
9	foregoing	JJ	O	foregoing	amod	12	SENT_58	[p3l1420t1685r1838b1786],
10	gener	NN	O	gener	nn	12	SENT_58	[p3l1864t1711r2133b1786],
11	—	NN	O	—	nn	12	SENT_58	[p3l1864t1711r2133b1786],
12	alizations	NNS	O	alization	prep_to	6	SENT_58	[p3l10t1813r451b1892],
13	.	.	O	.	_	0	SENT_58	[p3l10t1813r451b1892],

1	Indeed	RB	O	indeed	advmod	34	SENT_59	[p3l496t1813r815b1909],
2	,	,	O	,	_	0	SENT_59	[p3l496t1813r815b1909],
3	the	DT	O	the	det	4	SENT_59	[p3l861t1814r993b1892],
4	heterogeneity	NN	O	heterogeneity	nsubj	34	SENT_59	[p3l1033t1814r1624b1914],
5	among	IN	O	among	_	0	SENT_59	[p3l1658t1839r1962b1914],
6	patients	NNS	O	patient	prep_among	4	SENT_59	[p3l1998t1840r2132b1914, p3l11t1942r236b2020],
7	with	IN	O	with	_	0	SENT_59	[p3l253t1941r440b2021],
8	intractable	JJ	O	intractable	amod	9	SENT_59	[p3l459t1942r901b2020],
9	epilepsy	NN	O	epilepsy	prep_with	6	SENT_59	[p3l922t1941r1260b2042],
10	and	CC	O	and	_	0	SENT_59	[p3l1274t1941r1429b2020],
11	the	DT	O	the	det	12	SENT_59	[p3l1448t1942r1575b2020],
12	fact	NN	O	fact	conj_and	6	SENT_59	[p3l1595t1941r1749b2020],
13	that	IN	O	that	complm	16	SENT_59	[p3l1764t1942r1928b2020],
14	such	JJ	O	such	amod	15	SENT_59	[p3l1944t1942r2136b2021],
15	patients	NNS	O	patient	nsubj	16	SENT_59	[p3l9t2070r343b2170],
16	tend	VBP	O	tend	dep	12	SENT_59	[p3l375t2069r560b2148],
17	to	TO	O	to	aux	19	SENT_59	[p3l589t2086r668b2148],
18	be	VB	O	be	cop	19	SENT_59	[p3l698t2070r793b2148],
19	resistant	JJ	O	resistant	xcomp	16	SENT_59	[p3l822t2070r1190b2148],
20	to	TO	O	to	_	0	SENT_59	[p3l1215t2086r1294b2148],
21	most	RBS	O	most	prep_to	19	SENT_59	[p3l1323t2086r1540b2148],
22	if	IN	O	if	mark	26	SENT_59	[p3l1563t2069r1638b2147],
23	not	RB	O	not	neg	26	SENT_59	[p3l1648t2086r1792b2148],
24	all	DT	O	all	det	26	SENT_59	[p3l1815t2069r1913b2148],
25	antiseizure	JJ	O	antiseizure	amod	26	SENT_59	[p3l1941t2070r2134b2148, p3l12t2198r305b2277],
26	drugs	NNS	O	drug	advcl	19	SENT_59	[p3l328t2197r563b2298],
27	Without	IN	O	without	dep	26	SENT_59	[p3l584t2198r915b2277],
28	regard	NN	O	regard	pcomp	27	SENT_59	[p3l932t2198r1202b2298],
29	to	TO	O	to	_	0	SENT_59	[p3l1225t2214r1303b2276],
30	their	PRP$	O	they	poss	31	SENT_59	[p3l1327t2198r1522b2276],
31	mechanism	NN	O	mechanism	prep_to	28	SENT_59	[p3l1541t2198r2031b2276],
32	of	IN	O	of	_	0	SENT_59	[p3l2054t2197r2154b2276],
33	action	NN	O	action	prep_of	31	SENT_59	[p3l10t2326r268b2404],
34	suggest	VBP	O	suggest	_	0	SENT_59	[p3l293t2342r619b2426],
35	that	IN	O	that	complm	37	SENT_59	[p3l638t2326r804b2404],
36	there	EX	O	there	expl	37	SENT_59	[p3l823t2326r1035b2404],
37	are	VBP	O	be	ccomp	34	SENT_59	[p3l1058t2352r1184b2404],
38	likely	JJ	O	likely	acomp	37	SENT_59	[p3l1206t2325r1432b2426],
39	to	TO	O	to	aux	41	SENT_59	[p3l1451t2342r1530b2404],
40	be	VB	O	be	auxpass	41	SENT_59	[p3l1555t2326r1651b2404],
41	intrinsic	JJ	O	intrinsic	xcomp	38	SENT_59	[p3l1674t2326r2025b2404],
42	or	CC	O	or	_	0	SENT_59	[p3l2048t2351r2137b2404],
43	acquired	VBN	O	acquire	conj_or	41	SENT_59	[p3l10t2453r374b2554],
44	causes	NNS	O	cause	dobj	43	SENT_59	[p3l397t2480r668b2533],
45	of	IN	O	of	_	0	SENT_59	[p3l693t2453r793b2532],
46	drug	NN	O	drug	nn	47	SENT_59	[p3l797t2454r997b2554],
47	resistance	NN	O	resistance	prep_of	44	SENT_59	[p3l1015t2454r1437b2532],
48	that	WDT	O	that	nsubj	50	SENT_59	[p3l1460t2453r1626b2532],
49	are	VBP	O	be	cop	50	SENT_59	[p3l1642t2480r1768b2532],
50	nonspeciﬁc	JJ	O	nonspeciﬁc	rcmod	44	SENT_59	[p3l1790t2479r2133b2554, p3l11t2581r184b2660],
51	but	CC	O	but	_	0	SENT_59	[p3l219t2581r360b2661],
52	that	WDT	O	that	nsubj	55	SENT_59	[p3l390t2581r557b2660],
53	can	MD	O	can	aux	55	SENT_59	[p3l586t2607r730b2660],
54	broadly	RB	O	broadly	advmod	55	SENT_59	[p3l766t2581r1085b2682],
55	affect	VB	O	affect	conj_but	37	SENT_59	[p3l1114t2581r1350b2660],
56	responsiveness	NN	O	responsiveness	dobj	55	SENT_59	[p3l1379t2582r2017b2682],
57	to	TO	O	to	_	0	SENT_59	[p3l2054t2598r2133b2660],
58	multiple	JJ	O	multiple	amod	60	SENT_59	[p3l10t2710r364b2810],
59	antiseizure	NN	O	antiseizure	nn	60	SENT_59	[p3l389t2710r851b2789],
60	drugs	NNS	O	drug	prep_to	55	SENT_59	[p3l877t2709r1140b2810],
61	.	.	O	.	_	0	SENT_59	[p3l877t2709r1140b2810],

1	Drug	NN	O	drug	nn	2	SENT_60	[p3l138t2844r357b2938],
2	resistance	NN	O	resistance	nsubjpass	5	SENT_60	[p3l382t2838r805b2916],
3	has	VBZ	O	have	aux	5	SENT_60	[p3l833t2838r974b2916],
4	been	VBN	O	be	auxpass	5	SENT_60	[p3l1006t2837r1205b2916],
5	studied	VBN	O	study	_	0	SENT_60	[p3l1235t2837r1543b2917],
6	extensively	RB	O	extensively	advmod	5	SENT_60	[p3l1572t2838r2030b2938],
7	in	IN	O	in	_	0	SENT_60	[p3l2053t2838r2135b2915],
8	cancer	NN	O	cancer	prep_in	5	SENT_60	[p3l11t2991r303b3061],
9	,	,	O	,	_	0	SENT_60	[p3l11t2991r303b3061],
10	and	CC	O	and	_	0	SENT_60	[p3l336t2966r491b3044],
11	a	DT	O	a	det	12	SENT_60	[p3l519t2992r563b3044],
12	family	NN	O	family	nsubjpass	28	SENT_60	[p3l590t2965r855b3066],
13	of	IN	O	of	_	0	SENT_60	[p3l880t2965r980b3044],
14	multidrug	JJ	O	multidrug	amod	17	SENT_60	[p3l990t2965r1932b3066],
15	—	NN	O	—	nn	17	SENT_60	[p3l990t2965r1932b3066],
16	transporter	NN	O	transporter	nn	17	SENT_60	[p3l990t2965r1932b3066],
17	proteins	NNS	O	protein	prep_of	12	SENT_60	[p3l1956t2991r2133b3066, p3l11t3094r209b3172],
18	belonging	VBG	O	belong	partmod	17	SENT_60	[p3l237t3093r669b3194],
19	to	TO	O	to	_	0	SENT_60	[p3l691t3110r770b3172],
20	the	DT	O	the	det	25	SENT_60	[p3l797t3094r926b3172],
21	ATP	NN	O	atp	nn	25	SENT_60	[p3l948t3094r1492b3194],
22	—	NN	O	—	nn	25	SENT_60	[p3l948t3094r1492b3194],
23	binding	NN	O	binding	nn	25	SENT_60	[p3l948t3094r1492b3194],
24	cassette	NN	O	cassette	nn	25	SENT_60	[p3l1515t3110r1842b3172],
25	superfamily	NN	O	superfamily	prep_to	18	SENT_60	[p3l1869t3120r2133b3194, p3l10t3221r273b3322],
26	has	VBZ	O	have	aux	28	SENT_60	[p3l288t3222r428b3300],
27	been	VBN	O	be	auxpass	28	SENT_60	[p3l452t3222r650b3300],
28	associated	VBN	O	associate	conj_and	5	SENT_60	[p3l669t3222r1101b3300],
29	with	IN	O	with	_	0	SENT_60	[p3l1117t3222r1304b3301],
30	resistance	NN	O	resistance	prep_with	28	SENT_60	[p3l1324t3222r1742b3300],
31	of	IN	O	of	_	0	SENT_60	[p3l1763t3221r1863b3300],
32	cancer	NN	O	cancer	nn	33	SENT_60	[p3l1866t3247r2138b3300],
33	cells	NNS	O	cell	prep_of	30	SENT_60	[p3l11t3349r193b3428],
34	to	TO	O	to	_	0	SENT_60	[p3l219t3366r297b3428],
35	antineoplastic	JJ	O	antineoplastic	amod	36	SENT_60	[p3l321t3349r917b3450],
36	agents	NNS	O	agent	prep_to	33	SENT_60	[p3l938t3357r1282b3450],
37	.7	CD	NUMBER	.7	npadvmod	38	SENT_60	[p3l938t3357r1282b3450],
38	More	RBR	O	more	advmod	28	SENT_60	[p3l1302t3357r1525b3428],
39	recently	RB	DATE	recently	advmod	28	SENT_60	[p3l1547t3349r1892b3450],
40	,	,	O	,	_	0	SENT_60	[p3l1547t3349r1892b3450],
41	studies	NNS	O	study	nsubj	45	SENT_60	[p3l1922t3350r2132b3429, p3l10t3478r118b3556],
42	in	IN	O	in	_	0	SENT_60	[p3l141t3478r222b3555],
43	epilepsy	NN	O	epilepsy	prep_in	41	SENT_60	[p3l243t3477r582b3578],
44	have	VBP	O	have	aux	45	SENT_60	[p3l598t3478r784b3557],
45	implicated	VBN	O	implicate	dep	28	SENT_60	[p3l804t3477r1243b3578],
46	multidrug	JJ	O	multidrug	amod	49	SENT_60	[p3l1264t3477r2135b3578],
47	—	NN	O	—	nn	49	SENT_60	[p3l1264t3477r2135b3578],
48	resistance	NN	O	resistance	nn	49	SENT_60	[p3l1264t3477r2135b3578],
49	proteins	NNS	O	protein	dobj	45	SENT_60	[p3l9t3606r357b3706],
50	as	IN	O	as	_	0	SENT_60	[p3l385t3632r470b3684],
51	potentially	RB	O	potentially	advmod	52	SENT_60	[p3l497t3606r948b3706],
52	important	JJ	O	important	amod	53	SENT_60	[p3l971t3606r1403b3706],
53	factors	NNS	O	factor	prep_as	45	SENT_60	[p3l1425t3605r1710b3684],
54	in	IN	O	in	_	0	SENT_60	[p3l1738t3606r1820b3683],
55	the	DT	O	the	det	56	SENT_60	[p3l1847t3606r1976b3684],
56	deVelopment	NN	O	development	prep_in	53	SENT_60	[p3l2005t3606r2133b3684, p4l6t21r455b121],

1	of	IN	O	of	_	0	SENT_61	[p4l473t20r574b99],
2	refractory	JJ	O	refractory	amod	3	SENT_61	[p4l577t20r984b121],
3	epilepsy	NN	O	epilepsy	pobj	1	SENT_61	[p4l1003t20r1355b121],
4	.	.	O	.	_	0	SENT_61	[p4l1003t20r1355b121],

1	Overexpression	NN	O	overexpression	nsubjpass	11	SENT_62	[p4l1383t21r2030b121],
2	of	IN	O	of	_	0	SENT_62	[p4l2054t20r2154b99],
3	multidrug	JJ	O	multidrug	amod	4	SENT_62	[p4l10t148r435b249],
4	transporters	NNS	O	transporter	prep_of	1	SENT_62	[p4l454t165r963b249],
5	or	CC	O	or	_	0	SENT_62	[p4l988t174r1076b227],
6	their	PRP$	O	they	poss	7	SENT_62	[p4l1096t149r1291b227],
7	genes	NNS	O	gene	conj_or	4	SENT_62	[p4l1310t174r1548b249],
8	has	VBZ	O	have	aux	11	SENT_62	[p4l1572t149r1712b227],
9	now	RB	DATE	now	advmod	11	SENT_62	[p4l1736t174r1919b228],
10	been	VBN	O	be	auxpass	11	SENT_62	[p4l1937t149r2135b227],
11	described	VBN	O	describe	_	0	SENT_62	[p4l11t276r417b355],
12	in	IN	O	in	_	0	SENT_62	[p4l439t277r520b354],
13	endothelial	JJ	O	endothelial	amod	14	SENT_62	[p4l544t277r1018b355],
14	cells	NNS	O	cell	prep_in	11	SENT_62	[p4l1041t277r1223b355],
15	isolated	VBN	O	isolate	partmod	14	SENT_62	[p4l1248t276r1577b355],
16	from	IN	O	from	_	0	SENT_62	[p4l1600t276r1807b355],
17	temporal	JJ	O	temporal	amod	20	SENT_62	[p4l1831t293r2133b377, p4l10t405r335b483],
18	—	NN	O	—	nn	20	SENT_62	[p4l1831t293r2133b377, p4l10t405r335b483],
19	lobe	NN	O	lobe	nn	20	SENT_62	[p4l1831t293r2133b377, p4l10t405r335b483],
20	tissue	NN	O	tissue	prep_from	15	SENT_62	[p4l365t405r606b484],
21	from	IN	O	from	_	0	SENT_62	[p4l634t404r842b483],
22	patients	NNS	O	patient	prep_from	15	SENT_62	[p4l869t405r1203b505],
23	with	IN	O	with	_	0	SENT_62	[p4l1229t405r1419b484],
24	epilepsy	NN	O	epilepsy	prep_with	22	SENT_62	[p4l1448t405r1813b505],
25	;	:	O	;	_	0	SENT_62	[p4l1448t405r1813b505],
26	epileptogenic	JJ	O	epileptogenic	amod	27	SENT_62	[p4l1847t405r2133b505, p4l11t533r329b633],
27	lesions	NNS	O	lesion	dep	22	SENT_62	[p4l356t533r684b628],
28	,	,	O	,	_	0	SENT_62	[p4l356t533r684b628],
29	including	VBG	O	include	_	0	SENT_62	[p4l718t532r1134b633],
30	dysembryoplastic	JJ	O	dysembryoplastic	amod	32	SENT_62	[p4l1160t532r1914b633],
31	neuroepithelial	JJ	O	neuroepithelial	amod	32	SENT_62	[p4l1942t558r2132b612, p4l10t660r504b761],
32	tumors	NNS	O	tumor	prep_including	27	SENT_62	[p4l541t677r874b756],
33	,	,	O	,	_	0	SENT_62	[p4l541t677r874b756],
34	focal	JJ	O	focal	amod	36	SENT_62	[p4l917t660r1124b739],
35	cortical	JJ	O	cortical	amod	36	SENT_62	[p4l1161t661r1479b739],
36	dysplasia	NN	O	dysplasium	appos	32	SENT_62	[p4l1516t661r1935b761],
37	,	,	O	,	_	0	SENT_62	[p4l1516t661r1935b761],
38	and	CC	O	and	advmod	36	SENT_62	[p4l1976t660r2134b739],

1	1480	CD	DATE	1480	num	4	SENT_63	[p4l149t840r225b862],
2	N	NN	O	n	nn	4	SENT_63	[p4l902t842r916b858],
3	ENGLJ	NN	O	englj	nn	4	SENT_63	[p4l931t842r1015b864],
4	MED	NN	O	med	_	0	SENT_63	[p4l1030t842r1083b857],
5	348	CD	NUMBER	348	dep	4	SENT_63	[p4l1095t836r1175b864],
6	;	:	O	;	_	0	SENT_63	[p4l1095t836r1175b864],
7	15	CD	NUMBER	15	dep	4	SENT_63	[p4l1095t836r1175b864],
8	WWW	NNP	O	WWW	dep	7	SENT_63	[p4l1210t842r1322b858],
9	.	.	O	.	_	0	SENT_63	[p4l1210t842r1322b858],

1	NE	NNS	O	ne	nsubj	2	SENT_64	[p4l1210t842r1322b858],
2	M.ORG	VBP	O	m.org	_	0	SENT_64	[p4l1338t842r1421b858],
3	APRlL	NN	O	aprll	nn	5	SENT_64	[p4l1458t842r1577b862],
4	'	''	O	'	_	0	SENT_64	[p4l1458t842r1577b862],
5	|	NN	O	|	dobj	2	SENT_64	[p4l1458t842r1577b862],
6	o	NN	O	o	dep	5	SENT_64	[p4l1458t842r1577b862],
7	,	,	O	,	_	0	SENT_64	[p4l1458t842r1577b862],
8	2003	CD	DATE	2003	appos	6	SENT_64	[p4l1591t842r1654b864],

1	The	DT	O	the	det	5	SENT_65	[p4l935t875r986b899],
2	New	NNP	O	New	nn	5	SENT_65	[p4l995t876r1057b899],
3	England	NNP	O	England	nn	5	SENT_65	[p4l1066t875r1177b906],
4	Journal	NNP	O	Journal	nn	5	SENT_65	[p4l1186t875r1283b899],
5	o	NN	O	o	_	0	SENT_65	[p4l1293t883r1308b899],
6	edicine	NN	O	edicine	dep	5	SENT_65	[p4l1359t875r1454b899],

1	Downloaded	VBN	O	download	_	0	SENT_66	[p4l377t916r547b939],
2	from	IN	O	from	_	0	SENT_66	[p4l556t916r620b939],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_66	[p4l629t916r747b946],
4	at	IN	O	at	_	0	SENT_66	[p4l758t920r781b939],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_66	[p4l789t916r972b939],
6	on	IN	O	on	_	0	SENT_66	[p4l981t923r1014b939],
7	January	NNP	DATE	January	prep_on	1	SENT_66	[p4l1022t916r1125b946],
8	5	CD	DATE	5	num	7	SENT_66	[p4l1135t916r1158b943],
9	,	,	DATE	,	_	0	SENT_66	[p4l1135t916r1158b943],
10	2014	CD	DATE	2014	num	7	SENT_66	[p4l1169t916r1241b939],
11	.	.	O	.	_	0	SENT_66	[p4l1169t916r1241b939],

1	For	IN	O	for	_	0	SENT_67	[p4l1251t916r1298b939],
2	personal	JJ	O	personal	amod	3	SENT_67	[p4l1306t916r1418b946],
3	use	NN	O	use	pobj	1	SENT_67	[p4l1427t923r1471b939],
4	only	RB	O	only	advmod	3	SENT_67	[p4l1481t916r1545b946],
5	.	.	O	.	_	0	SENT_67	[p4l1481t916r1545b946],

1	No	DT	O	no	det	3	SENT_68	[p4l1556t916r1596b939],
2	other	JJ	O	other	amod	3	SENT_68	[p4l1606t916r1674b939],
3	uses	NNS	O	use	_	0	SENT_68	[p4l1682t923r1738b939],
4	without	IN	O	without	_	0	SENT_68	[p4l1748t916r1849b939],
5	permission	NN	O	permission	prep_without	3	SENT_68	[p4l1858t916r2010b946],
6	.	.	O	.	_	0	SENT_68	[p4l1858t916r2010b946],

1	Copyright	NN	O	copyright	_	0	SENT_69	[p4l727t957r862b988],
2	©	CD	NUMBER	©	num	6	SENT_69	[p4l871t957r895b981],
3	2003	CD	DATE	2003	num	6	SENT_69	[p4l905t957r969b981],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_69	[p4l979t957r1170b981],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_69	[p4l1180t957r1288b981],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_69	[p4l1299t957r1404b988],
7	.	.	O	.	_	0	SENT_69	[p4l1299t957r1404b988],

1	All	DT	O	all	det	2	SENT_70	[p4l1415t957r1456b981],
2	rights	NNS	O	rights	nsubj	3	SENT_70	[p4l1465t957r1540b988],
3	reserved	VBN	O	reserve	_	0	SENT_70	[p4l1550t957r1669b981],
4	.	.	O	.	_	0	SENT_70	[p4l1550t957r1669b981],

1	EDITORIALS	NNS	O	editorial	_	0	SENT_71	[p4l979t1063r1181b1082],

1	hippocampal	JJ	O	hippocampal	dep	107	SENT_72	[p4l11t1276r579b1377],
2	sclerosis8	NN	O	sclerosis8	dep	107	SENT_72	[p4l608t1277r1100b1372],
3	»	CD	NUMBER	»	dep	107	SENT_72	[p4l608t1277r1100b1372],
4	9	CD	NUMBER	9	dep	107	SENT_72	[p4l608t1277r1100b1372],
5	;	:	O	;	_	0	SENT_72	[p4l608t1277r1100b1372],
6	and	CC	O	and	dep	107	SENT_72	[p4l1131t1276r1286b1355],
7	an	DT	O	a	dep	107	SENT_72	[p4l1313t1302r1414b1355],
8	animal	NN	O	animal	dep	107	SENT_72	[p4l1441t1277r1731b1355],
9	model	NN	O	model	dep	107	SENT_72	[p4l1758t1276r2025b1355],
10	of	IN	O	of	dep	107	SENT_72	[p4l2053t1276r2153b1355],
11	genetic	JJ	O	genetic	dep	107	SENT_72	[p4l10t1405r314b1505],
12	epilepsy	NN	O	epilepsy	dep	107	SENT_72	[p4l343t1405r785b1505],
13	.1	NN	NUMBER	.1	dep	107	SENT_72	[p4l343t1405r785b1505],
14	°	CD	NUMBER	°	dep	107	SENT_72	[p4l343t1405r785b1505],
15	Overexpression	NN	MISC	overexpression	dep	107	SENT_72	[p4l815t1405r1469b1505],
16	seems	VBZ	O	seem	dep	107	SENT_72	[p4l1499t1431r1757b1483],
17	to	TO	O	to	dep	107	SENT_72	[p4l1788t1421r1867b1483],
18	be	VB	O	be	dep	107	SENT_72	[p4l1897t1405r1993b1483],
19	regionally	RB	O	regionally	dep	107	SENT_72	[p4l2022t1431r2133b1483, p4l10t1532r350b1633],
20	selective	JJ	O	selective	dep	107	SENT_72	[p4l375t1533r748b1628],
21	,	,	O	,	_	0	SENT_72	[p4l375t1533r748b1628],
22	involving	VBG	O	involve	dep	107	SENT_72	[p4l781t1532r1172b1633],
23	mainly	RB	O	mainly	dep	107	SENT_72	[p4l1197t1533r1487b1633],
24	capillary	JJ	O	capillary	dep	107	SENT_72	[p4l1511t1533r1869b1633],
25	endothelial	JJ	O	endothelial	dep	107	SENT_72	[p4l1893t1532r2134b1611, p4l11t1660r278b1739],
26	cells	NNS	O	cell	dep	107	SENT_72	[p4l311t1661r498b1739],
27	and	CC	O	and	dep	107	SENT_72	[p4l532t1660r690b1739],
28	astrocytes	NNS	O	astrocyte	dep	107	SENT_72	[p4l722t1677r1148b1761],
29	in	IN	O	in	dep	107	SENT_72	[p4l1182t1661r1264b1738],
30	epileptogenic	JJ	O	epileptogenic	dep	107	SENT_72	[p4l1297t1661r1882b1761],
31	areas	NNS	O	area	dep	107	SENT_72	[p4l1913t1687r2132b1739],
32	of	IN	O	of	dep	107	SENT_72	[p4l11t1788r113b1867],
33	the	DT	O	the	dep	107	SENT_72	[p4l123t1789r254b1867],
34	brain	NN	O	brain	dep	107	SENT_72	[p4l283t1789r676b1867],
35	.9	NN	NUMBER	.9	dep	107	SENT_72	[p4l283t1789r676b1867],
36	»	CD	NUMBER	»	dep	107	SENT_72	[p4l283t1789r676b1867],
37	11	CD	NUMBER	11	dep	107	SENT_72	[p4l283t1789r676b1867],
38	Immunohistochemical	JJ	O	immunohistochemical	dep	107	SENT_72	[p4l700t1789r1669b1868],
39	analysis	NN	O	analysis	dep	107	SENT_72	[p4l1693t1789r2024b1889],
40	of	IN	O	of	dep	107	SENT_72	[p4l2052t1788r2153b1867],
41	the	DT	O	the	dep	107	SENT_72	[p4l11t1917r140b1995],
42	expression	NN	O	expression	dep	107	SENT_72	[p4l167t1917r620b2017],
43	of	IN	O	of	dep	107	SENT_72	[p4l646t1916r747b1995],
44	multidrug	JJ	O	multidrug	dep	107	SENT_72	[p4l754t1917r1183b2017],
45	transporters	NNS	O	transporter	dep	107	SENT_72	[p4l1205t1933r1719b2017],
46	in	IN	O	in	dep	107	SENT_72	[p4l1746t1917r1828b1994],
47	hippocampal	JJ	O	hippocampal	dep	107	SENT_72	[p4l1853t1917r2133b2017, p4l11t2045r316b2145],
48	sclerosis	NN	O	sclerosis	dep	107	SENT_72	[p4l339t2044r699b2123],
49	and	CC	O	and	dep	107	SENT_72	[p4l723t2045r878b2123],
50	cortical	JJ	O	cortical	dep	107	SENT_72	[p4l901t2045r1211b2123],
51	dysplasia	NN	O	dysplasium	dep	107	SENT_72	[p4l1233t2045r1620b2145],
52	has	VBZ	O	have	dep	107	SENT_72	[p4l1639t2044r1780b2123],
53	demonstrated	VBN	O	demonstrate	dep	107	SENT_72	[p4l1805t2044r2133b2123, p4l12t2173r298b2251],
54	intense	JJ	O	intense	dep	107	SENT_72	[p4l320t2173r625b2251],
55	antibody	NN	O	antibody	dep	107	SENT_72	[p4l648t2172r1020b2273],
56	reactivity	NN	O	reactivity	dep	107	SENT_72	[p4l1039t2173r1418b2273],
57	in	IN	O	in	dep	107	SENT_72	[p4l1436t2173r1517b2250],
58	lesional	JJ	O	lesional	dep	107	SENT_72	[p4l1540t2173r1868b2251],
59	astro	NN	O	astro	dep	107	SENT_72	[p4l1891t2189r2133b2251],
60	—	NN	O	—	dep	107	SENT_72	[p4l1891t2189r2133b2251],
61	cytes	NNS	O	cyte	dep	107	SENT_72	[p4l11t2317r212b2401],
62	and	CC	O	and	dep	107	SENT_72	[p4l241t2300r397b2379],
63	blood	NN	O	blood	dep	107	SENT_72	[p4l425t2300r667b2379],
64	vessels	NNS	O	vessel	dep	107	SENT_72	[p4l690t2300r979b2380],
65	but	CC	O	but	dep	107	SENT_72	[p4l1010t2300r1151b2380],
66	not	RB	O	not	dep	107	SENT_72	[p4l1173t2317r1317b2379],
67	in	IN	O	in	dep	107	SENT_72	[p4l1338t2301r1419b2378],
68	unaffected	JJ	O	unaffected	dep	107	SENT_72	[p4l1447t2300r1891b2380],
69	areas	NNS	O	area	dep	107	SENT_72	[p4l1918t2327r2132b2379],
70	of	IN	O	of	dep	107	SENT_72	[p4l11t2428r113b2507],
71	the	DT	O	the	dep	107	SENT_72	[p4l119t2428r250b2507],
72	brain	NN	O	brain	dep	107	SENT_72	[p4l276t2429r612b2507],
73	.12	CD	NUMBER	.12	dep	107	SENT_72	[p4l276t2429r612b2507],
74	Because	IN	O	because	dep	107	SENT_72	[p4l635t2435r982b2508],
75	multidrug	JJ	O	multidrug	dep	107	SENT_72	[p4l1007t2428r1444b2529],
76	transporters	NNS	O	transporter	dep	107	SENT_72	[p4l1466t2445r1992b2529],
77	restrict	VBP	O	restrict	dep	107	SENT_72	[p4l2018t2455r2132b2507, p4l12t2557r221b2635],
78	the	DT	O	the	dep	107	SENT_72	[p4l237t2556r363b2635],
79	entry	NN	O	entry	dep	107	SENT_72	[p4l384t2573r593b2657],
80	of	IN	O	of	dep	107	SENT_72	[p4l610t2556r709b2635],
81	lipophilic	JJ	O	lipophilic	dep	107	SENT_72	[p4l709t2556r1104b2657],
82	molecules	NNS	O	molecule	dep	107	SENT_72	[p4l1123t2556r1540b2636],
83	into	IN	O	into	dep	107	SENT_72	[p4l1562t2557r1723b2635],
84	the	DT	O	the	dep	107	SENT_72	[p4l1745t2557r1873b2635],
85	brain	NN	O	brain	dep	107	SENT_72	[p4l1893t2557r2131b2652],
86	,	,	O	,	_	0	SENT_72	[p4l1893t2557r2131b2652],
87	including	VBG	O	include	dep	107	SENT_72	[p4l10t2685r425b2785],
88	many	JJ	O	many	dep	107	SENT_72	[p4l455t2710r691b2785],
89	antiepileptic	JJ	O	antiepileptic	dep	107	SENT_72	[p4l718t2685r1255b2785],
90	drugs	NNS	O	drug	dep	107	SENT_72	[p4l1287t2685r1556b2785],
91	,	,	O	,	_	0	SENT_72	[p4l1287t2685r1556b2785],
92	their	PRP$	O	they	dep	107	SENT_72	[p4l1594t2685r1795b2763],
93	overexpression	NN	O	overexpression	dep	107	SENT_72	[p4l1825t2710r2132b2764, p4l9t2813r379b2913],
94	could	MD	O	could	dep	107	SENT_72	[p4l417t2812r649b2892],
95	reduce	VB	O	reduce	dep	107	SENT_72	[p4l685t2813r964b2892],
96	the	DT	O	the	dep	107	SENT_72	[p4l1001t2813r1130b2891],
97	effective	JJ	O	effective	dep	107	SENT_72	[p4l1167t2812r1512b2892],
98	concentration	NN	O	concentration	dep	107	SENT_72	[p4l1549t2813r2135b2891],
99	of	IN	O	of	dep	107	SENT_72	[p4l11t2940r112b3019],
100	antiseizure	JJ	O	antiseizure	dep	107	SENT_72	[p4l119t2941r581b3020],
101	drugs	NNS	O	drug	dep	107	SENT_72	[p4l608t2940r846b3041],
102	at	IN	O	at	dep	107	SENT_72	[p4l874t2957r953b3019],
103	target	NN	O	target	dep	107	SENT_72	[p4l974t2957r1224b3041],
104	sites	NNS	O	site	dep	107	SENT_72	[p4l1246t2941r1429b3019],
105	in	IN	O	in	dep	107	SENT_72	[p4l1457t2941r1538b3018],
106	epileptogenic	JJ	O	epileptogenic	dep	107	SENT_72	[p4l1565t2941r2136b3041],
107	tissue	NN	O	tissue	_	0	SENT_72	[p4l11t3070r276b3149],
108	.	.	O	.	_	0	SENT_72	[p4l11t3070r276b3149],

1	As	IN	O	as	dep	2	SENT_73	[p4l136t3205r240b3276],
2	reported	VBN	O	report	_	0	SENT_73	[p4l270t3198r629b3298],
3	in	IN	O	in	_	0	SENT_73	[p4l656t3198r738b3275],
4	this	DT	O	this	det	5	SENT_73	[p4l766t3198r918b3276],
5	issue	NN	O	issue	prep_in	2	SENT_73	[p4l948t3198r1159b3277],
6	of	IN	O	of	_	0	SENT_73	[p4l1188t3197r1289b3276],
7	thejoumal	JJ	O	thejoumal	prep_of	5	SENT_73	[p4l1299t3197r1750b3298],
8	,	,	O	,	_	0	SENT_73	[p4l1299t3197r1750b3298],
9	Siddiqui	NNP	PERSON	Siddiqui	prep_of	5	SENT_73	[p4l1785t3197r2135b3298],
10	and	CC	O	and	_	0	SENT_73	[p4l10t3326r166b3404],
11	colleagues	NNS	O	colleague	prep_of	5	SENT_73	[p4l198t3325r637b3426],
12	have	VBP	O	have	aux	13	SENT_73	[p4l672t3326r860b3405],
13	identiﬁed	VBN	O	identiﬁed	dep	2	SENT_73	[p4l892t3325r1296b3404],
14	a	DT	O	a	det	15	SENT_73	[p4l1327t3352r1371b3404],
15	polymorphism	NN	O	polymorphism	dobj	13	SENT_73	[p4l1401t3325r2029b3426],
16	at	IN	O	at	_	0	SENT_73	[p4l2061t3342r2140b3404],
17	position	NN	O	position	prep_at	13	SENT_73	[p4l9t3454r351b3554],
18	3435	CD	DATE	3435	num	17	SENT_73	[p4l372t3459r571b3532],
19	in	IN	O	in	_	0	SENT_73	[p4l594t3454r673b3531],
20	the	DT	O	the	det	21	SENT_73	[p4l694t3454r821b3532],
21	gene	NN	O	gene	prep_in	17	SENT_73	[p4l841t3479r1036b3554],
22	encoding	VBG	O	encode	partmod	21	SENT_73	[p4l1057t3454r1445b3554],
23	the	DT	O	the	det	30	SENT_73	[p4l1461t3454r1589b3532],
24	ATP	NN	O	atp	nn	30	SENT_73	[p4l1605t3454r2140b3554],
25	—	NN	O	—	nn	30	SENT_73	[p4l1605t3454r2140b3554],
26	binding	NN	O	binding	nn	30	SENT_73	[p4l1605t3454r2140b3554],
27	cassette	NN	O	cassette	nn	30	SENT_73	[p4l11t3598r335b3660],
28	subfamily	NN	O	subfamily	nn	30	SENT_73	[p4l362t3581r775b3682],
29	B	NN	O	b	nn	30	SENT_73	[p4l794t3588r849b3660],
30	member	NN	O	member	dobj	22	SENT_73	[p4l876t3582r1230b3660],
31	1	CD	NUMBER	1	number	32	SENT_73	[p4l1256t3587r1300b3659],
32	(	CD	NUMBER	(	dep	30	SENT_73	[p4l1330t3587r1686b3673],
33	ABCB1	NN	O	abcb1	nn	36	SENT_73	[p4l1330t3587r1686b3673],
34	)	CD	NUMBER	)	num	36	SENT_73	[p4l1330t3587r1686b3673],
35	transporter	NN	O	transporter	nn	36	SENT_73	[p4l1716t3598r2135b3682, p4l11t3736r93b3788],
36	(	NN	O	(	dep	32	SENT_73	[p4l123t3710r324b3801],
37	also	RB	O	also	advmod	38	SENT_73	[p4l123t3710r324b3801],
38	known	VBN	O	know	partmod	30	SENT_73	[p4l353t3710r649b3789],
39	as	IN	O	as	_	0	SENT_73	[p4l677t3736r762b3788],
40	MDR1	NN	O	mdr1	prep_as	38	SENT_73	[p4l789t3715r1068b3793],
41	and	CC	O	and	_	0	SENT_73	[p4l1096t3709r1254b3788],
42	P	NN	O	p	prep_as	38	SENT_73	[p4l1281t3709r1914b3810],
43	—	CD	NUMBER	—	num	46	SENT_73	[p4l1281t3709r1914b3810],
44	glycoprotein	NN	O	glycoprotein	nn	46	SENT_73	[p4l1281t3709r1914b3810],
45	170	CD	NUMBER	170	num	46	SENT_73	[p4l1945t3715r2128b3801],
46	)	NN	O	)	nsubj	2	SENT_73	[p4l1945t3715r2128b3801],

1	that	IN	O	that	nsubjpass	3	SENT_74	[p5l11t23r181b101],
2	Was	VBD	O	be	auxpass	3	SENT_74	[p5l198t49r360b102],
3	associated	VBN	O	associate	dep	17	SENT_74	[p5l387t22r823b101],
4	with	IN	O	with	_	0	SENT_74	[p5l844t23r1034b102],
5	a	DT	O	a	det	6	SENT_74	[p5l1059t49r1104b101],
6	lack	NN	O	lack	prep_with	3	SENT_74	[p5l1127t23r1300b102],
7	of	IN	O	of	_	0	SENT_74	[p5l1323t22r1423b101],
8	response	NN	O	response	prep_of	6	SENT_74	[p5l1430t48r1810b123],
9	to	TO	O	to	_	0	SENT_74	[p5l1836t39r1914b101],
10	antiseizure	JJ	O	antiseizure	amod	11	SENT_74	[p5l1941t23r2134b101, p5l12t151r316b230],
11	drugs	NNS	O	drug	prep_to	3	SENT_74	[p5l350t151r705b251],
12	.13	CD	NUMBER	.13	num	13	SENT_74	[p5l350t151r705b251],
13	ABCB1	NN	O	abcb1	nsubj	17	SENT_74	[p5l737t156r1044b229],
14	is	VBZ	O	be	cop	17	SENT_74	[p5l1077t151r1143b229],
15	a	DT	O	a	det	17	SENT_74	[p5l1178t177r1223b229],
16	transmembrane	JJ	O	transmembrane	amod	17	SENT_74	[p5l1255t151r1943b229],
17	glycoprotein	NN	O	glycoprotein	_	0	SENT_74	[p5l1976t151r2132b251, p5l11t279r424b379],
18	that	WDT	O	that	nsubj	19	SENT_74	[p5l462t279r632b357],
19	functions	VBZ	O	function	rcmod	17	SENT_74	[p5l664t278r1071b358],
20	as	IN	O	as	mark	31	SENT_74	[p5l1110t305r1194b357],
21	an	DT	O	a	det	26	SENT_74	[p5l1234t304r1335b357],
22	active	JJ	O	active	amod	26	SENT_74	[p5l1372t279r1612b358],
23	drug	NN	O	drug	nn	26	SENT_74	[p5l1651t278r2137b379],
24	—	NN	O	—	nn	26	SENT_74	[p5l1651t278r2137b379],
25	efﬂux	NN	O	efﬂux	nn	26	SENT_74	[p5l1651t278r2137b379],
26	pump14	NN	O	pump14	nsubjpass	31	SENT_74	[p5l9t412r337b507],
27	and	CC	O	and	_	0	SENT_74	[p5l357t407r510b485],
28	that	DT	O	that	nsubjpass	31	SENT_74	[p5l531t406r694b485],
29	may	MD	O	may	aux	31	SENT_74	[p5l709t433r884b507],
30	be	VB	O	be	auxpass	31	SENT_74	[p5l901t407r995b485],
31	involved	VBN	O	involve	advcl	19	SENT_74	[p5l1015t406r1358b486],
32	in	IN	O	in	_	0	SENT_74	[p5l1377t407r1458b484],
33	maintaining	VBG	O	maintain	prepc_in	31	SENT_74	[p5l1478t407r1991b507],
34	the	DT	O	the	det	37	SENT_74	[p5l2009t407r2136b485],
35	blood	NN	O	blood	nn	37	SENT_74	[p5l11t534r530b613],
36	—	NN	O	—	nn	37	SENT_74	[p5l11t534r530b613],
37	brain	NN	O	brain	dobj	33	SENT_74	[p5l11t534r530b613],
38	barrier	NN	O	barrier	tmod	33	SENT_74	[p5l554t534r939b613],
39	.15	CD	NUMBER	.15	num	38	SENT_74	[p5l554t534r939b613],
40	It	PRP	O	it	nsubj	42	SENT_74	[p5l964t542r1030b613],
41	is	VBZ	O	be	cop	42	SENT_74	[p5l1048t535r1113b613],
42	one	CD	NUMBER	one	rcmod	38	SENT_74	[p5l1139t560r1291b613],
43	of	IN	O	of	_	0	SENT_74	[p5l1315t534r1415b613],
44	a	DT	O	a	det	45	SENT_74	[p5l1420t561r1464b613],
45	group	NN	O	group	prep_of	42	SENT_74	[p5l1485t560r1736b635],
46	of	IN	O	of	_	0	SENT_74	[p5l1761t534r1861b613],
47	intrinsic	JJ	O	intrinsic	amod	49	SENT_74	[p5l1866t535r2134b613, p5l12t663r123b741],
48	membrane	NN	O	membrane	nn	49	SENT_74	[p5l144t663r602b741],
49	proteins	NNS	O	protein	prep_of	45	SENT_74	[p5l622t663r970b763],
50	that	WDT	O	that	nsubj	53	SENT_74	[p5l994t663r1161b741],
51	are	VBP	O	be	cop	53	SENT_74	[p5l1177t689r1303b741],
52	closely	RB	O	closely	advmod	53	SENT_74	[p5l1325t662r1611b763],
53	related	JJ	O	related	rcmod	42	SENT_74	[p5l1629t663r1937b741],
54	.	.	O	.	_	0	SENT_74	[p5l1629t663r1937b741],

1	Several	JJ	O	several	amod	3	SENT_75	[p5l1967t668r2134b742, p5l11t791r163b869],
2	methodologic	JJ	O	methodologic	amod	3	SENT_75	[p5l186t790r771b891],
3	aspects	NNS	O	aspect	nsubj	7	SENT_75	[p5l794t807r1096b891],
4	of	IN	O	of	_	0	SENT_75	[p5l1123t790r1223b869],
5	this	DT	O	this	det	6	SENT_75	[p5l1229t791r1379b869],
6	report	NN	O	report	prep_of	3	SENT_75	[p5l1405t807r1665b891],
7	strengthen	VB	O	strengthen	_	0	SENT_75	[p5l1685t791r2136b891],
8	its	PRP$	O	its	poss	9	SENT_75	[p5l10t919r104b997],
9	validity	NN	O	validity	dobj	7	SENT_75	[p5l123t919r441b1019],
10	:	:	O	:	_	0	SENT_75	[p5l123t919r441b1019],
11	DNA	NN	O	dna	nn	12	SENT_75	[p5l465t925r675b998],
12	analyses	NNS	O	analysis	nsubjpass	14	SENT_75	[p5l692t919r1033b1019],
13	Were	VBD	O	be	auxpass	14	SENT_75	[p5l1052t945r1251b998],
14	conducted	VBN	O	conduct	parataxis	7	SENT_75	[p5l1273t918r1704b998],
15	in	IN	O	in	_	0	SENT_75	[p5l1724t919r1804b996],
16	a	DT	O	a	det	18	SENT_75	[p5l1825t945r1869b997],
17	blinded	JJ	O	blinded	amod	18	SENT_75	[p5l1889t918r2135b997, p5l11t1046r108b1125],
18	fashion	NN	O	fashion	prep_in	14	SENT_75	[p5l143t1046r490b1142],
19	,	,	O	,	_	0	SENT_75	[p5l143t1046r490b1142],
20	all	DT	O	all	det	21	SENT_75	[p5l530t1046r631b1125],
21	patients	NNS	O	patient	appos	18	SENT_75	[p5l664t1047r1006b1147],
22	—	IN	O	—	_	0	SENT_75	[p5l1039t1092r1147b1099],
23	both	CC	O	both	preconj	24	SENT_75	[p5l1178t1047r1374b1125],
24	those	DT	O	those	prep_—	14	SENT_75	[p5l1409t1046r1641b1125],
25	with	IN	O	with	_	0	SENT_75	[p5l1671t1047r1864b1126],
26	drugresponsive	JJ	O	drugresponsive	amod	27	SENT_75	[p5l1900t1047r2132b1147, p5l11t1175r470b1275],
27	epilepsy	NN	O	epilepsy	prep_with	24	SENT_75	[p5l496t1175r849b1275],
28	and	CC	O	and	_	0	SENT_75	[p5l868t1175r1026b1253],
29	those	DT	O	those	prep_—	14	SENT_75	[p5l1051t1175r1282b1253],
30	with	IN	O	with	_	0	SENT_75	[p5l1304t1175r1496b1254],
31	drug	NN	O	drug	npadvmod	33	SENT_75	[p5l1522t1174r2139b1275],
32	—	CD	NUMBER	—	num	31	SENT_75	[p5l1522t1174r2139b1275],
33	resistant	JJ	O	resistant	amod	34	SENT_75	[p5l1522t1174r2139b1275],
34	epilepsy	NN	O	epilepsy	prep_with	14	SENT_75	[p5l11t1302r352b1403],
35	.	.	O	.	_	0	SENT_75	[p5l366t1329r686b1382],

1	—	NN	O	—	_	0	SENT_76	[p5l366t1329r686b1382],
2	.	.	O	.	_	0	SENT_76	[p5l366t1329r686b1382],

1	Were	VBD	O	be	auxpass	2	SENT_77	[p5l366t1329r686b1382],
2	consecutive	JJ	O	consecutive	ccomp	14	SENT_77	[p5l708t1303r1190b1382],
3	and	CC	O	and	_	0	SENT_77	[p5l1212t1302r1366b1381],
4	recruited	VBN	O	recruit	ccomp	14	SENT_77	[p5l1387t1303r1759b1382],
5	from	IN	O	from	_	0	SENT_77	[p5l1780t1302r1985b1381],
6	the	DT	O	the	det	9	SENT_77	[p5l2007t1303r2135b1381],
7	same	JJ	O	same	amod	9	SENT_77	[p5l12t1457r228b1509],
8	epilepsy	NN	O	epilepsy	nn	9	SENT_77	[p5l251t1430r592b1531],
9	clinic	NN	O	clinic	prep_from	4	SENT_77	[p5l610t1431r856b1526],
10	,	,	O	,	_	0	SENT_77	[p5l610t1431r856b1526],
11	drug	NN	O	drug	nn	12	SENT_77	[p5l884t1430r1082b1531],
12	resistance	NN	O	resistance	nsubjpass	14	SENT_77	[p5l1101t1431r1518b1509],
13	was	VBD	O	be	auxpass	14	SENT_77	[p5l1536t1457r1696b1510],
14	deﬁned	VBN	O	deﬁned	_	0	SENT_77	[p5l1722t1430r2034b1509],
15	in	IN	O	in	_	0	SENT_77	[p5l2055t1431r2136b1508],
16	a	DT	O	a	det	21	SENT_77	[p5l10t1585r54b1637],
17	clear	JJ	O	clear	amod	21	SENT_77	[p5l75t1559r273b1637],
18	and	CC	O	and	_	0	SENT_77	[p5l291t1559r446b1637],
19	clinically	RB	O	clinically	advmod	20	SENT_77	[p5l468t1559r838b1659],
20	relevant	JJ	O	relevant	conj_and	17	SENT_77	[p5l855t1559r1187b1638],
21	manner	NN	O	manner	prep_in	14	SENT_77	[p5l1203t1584r1548b1654],
22	,	,	O	,	_	0	SENT_77	[p5l1203t1584r1548b1654],
23	and	CC	O	and	_	0	SENT_77	[p5l1574t1559r1728b1637],
24	polymorphic	JJ	O	polymorphic	amod	26	SENT_77	[p5l1749t1559r2134b1659, p5l9t1687r189b1787],
25	insertion	NN	O	insertion	nn	26	SENT_77	[p5l207t1687r578b1765],
26	markers	NNS	O	marker	nsubjpass	34	SENT_77	[p5l597t1686r935b1766],
27	that	WDT	O	that	nsubjpass	30	SENT_77	[p5l957t1687r1121b1765],
28	were	VBD	O	be	auxpass	30	SENT_77	[p5l1130t1713r1328b1766],
29	not	RB	O	not	neg	30	SENT_77	[p5l1348t1703r1489b1765],
30	linked	VBN	O	link	rcmod	26	SENT_77	[p5l1502t1686r1761b1766],
31	to	TO	O	to	_	0	SENT_77	[p5l1781t1703r1858b1765],
32	ABCB1	NN	O	abcb1	prep_to	30	SENT_77	[p5l1872t1692r2132b1765],
33	Were	VBD	O	be	auxpass	34	SENT_77	[p5l6t1841r208b1894],
34	used	VBN	O	use	conj_and	14	SENT_77	[p5l243t1815r438b1894],
35	to	TO	O	to	aux	36	SENT_77	[p5l473t1831r552b1893],
36	control	VB	O	control	xcomp	34	SENT_77	[p5l589t1815r891b1893],
37	for	IN	O	for	_	0	SENT_77	[p5l926t1814r1049b1893],
38	unrecognized	JJ	O	unrecognized	amod	41	SENT_77	[p5l1081t1814r1660b1915],
39	systematic	JJ	O	systematic	amod	41	SENT_77	[p5l1696t1815r2136b1915],
40	genetic	JJ	O	genetic	amod	41	SENT_77	[p5l10t1943r314b2043],
41	differences	NNS	O	difference	prep_for	36	SENT_77	[p5l339t1942r802b2021],
42	among	IN	O	among	_	0	SENT_77	[p5l829t1968r1128b2043],
43	the	DT	O	the	det	45	SENT_77	[p5l1150t1943r1279b2021],
44	study	NN	O	study	nn	45	SENT_77	[p5l1306t1942r1531b2043],
45	subjects	NNS	O	subject	prep_among	41	SENT_77	[p5l1554t1942r1914b2043],
46	.	.	O	.	_	0	SENT_77	[p5l1554t1942r1914b2043],

1	It	PRP	O	it	nsubj	3	SENT_78	[p5l138t2078r204b2149],
2	is	VBZ	O	be	cop	3	SENT_78	[p5l220t2071r285b2149],
3	necessary	JJ	O	necessary	_	0	SENT_78	[p5l309t2096r712b2171],
4	to	TO	O	to	aux	5	SENT_78	[p5l731t2087r809b2149],
5	put	VB	O	put	xcomp	3	SENT_78	[p5l831t2087r974b2171],
6	the	DT	O	the	det	7	SENT_78	[p5l991t2071r1119b2149],
7	finding	NN	O	finding	dobj	5	SENT_78	[p5l1142t2070r1450b2171],
8	of	IN	O	of	_	0	SENT_78	[p5l1470t2070r1570b2149],
9	Siddiqui	NNP	PERSON	Siddiqui	prep_of	7	SENT_78	[p5l1576t2070r1922b2171],
10	et	FW	O	et	nn	11	SENT_78	[p5l1945t2087r2021b2149],
11	al.	FW	O	al.	npadvmod	5	SENT_78	[p5l2037t2071r2130b2149],
12	in	IN	O	in	_	0	SENT_78	[p5l10t2199r90b2276],
13	context	NN	O	context	prep_in	5	SENT_78	[p5l113t2215r422b2277],
14	and	CC	O	and	_	0	SENT_78	[p5l438t2199r593b2277],
15	recognize	VB	O	recognize	conj_and	5	SENT_78	[p5l615t2199r1022b2299],
16	What	WP	O	what	nsubj	18	SENT_78	[p5l1040t2199r1252b2278],
17	remains	VBZ	O	remain	cop	18	SENT_78	[p5l1269t2199r1605b2277],
18	uncertain	JJ	O	uncertain	ccomp	15	SENT_78	[p5l1629t2199r2027b2278],
19	or	CC	O	or	_	0	SENT_78	[p5l2050t2224r2139b2277],
20	unknown	JJ	O	unknown	ccomp	15	SENT_78	[p5l11t2326r434b2405],
21	.	.	O	.	_	0	SENT_78	[p5l11t2326r434b2405],

1	First	RB	ORDINAL	first	advmod	36	SENT_79	[p5l460t2326r670b2420],
2	,	,	O	,	_	0	SENT_79	[p5l460t2326r670b2420],
3	as	IN	O	as	mark	7	SENT_79	[p5l697t2352r780b2403],
4	the	DT	O	the	det	5	SENT_79	[p5l805t2325r933b2403],
5	authors	NNS	O	author	nsubj	7	SENT_79	[p5l954t2326r1271b2404],
6	themselves	PRP	O	themselves	advmod	7	SENT_79	[p5l1295t2326r1754b2404],
7	indicate	VBP	O	indicate	advcl	36	SENT_79	[p5l1777t2326r2130b2420],
8	,	,	O	,	_	0	SENT_79	[p5l1777t2326r2130b2420],
9	the	DT	O	the	det	12	SENT_79	[p5l11t2454r138b2532],
10	C343	NN	O	c343	nn	12	SENT_79	[p5l158t2459r371b2532],
11	5T	NN	O	5t	nn	12	SENT_79	[p5l380t2459r488b2532],
12	polymorphism	NN	O	polymorphism	dobj	7	SENT_79	[p5l504t2454r1121b2554],
13	itself	PRP	O	itself	nsubj	15	SENT_79	[p5l1141t2453r1359b2532],
14	is	VBZ	O	be	cop	15	SENT_79	[p5l1360t2454r1424b2532],
15	unlikely	JJ	O	unlikely	rcmod	12	SENT_79	[p5l1447t2454r1776b2554],
16	to	TO	O	to	aux	20	SENT_79	[p5l1793t2470r1871b2532],
17	be	VB	O	be	cop	20	SENT_79	[p5l1893t2454r1988b2532],
18	the	DT	O	the	det	20	SENT_79	[p5l2009t2454r2136b2532],
19	direct	JJ	O	direct	amod	20	SENT_79	[p5l11t2582r254b2660],
20	cause	NN	O	cause	xcomp	15	SENT_79	[p5l279t2608r509b2661],
21	of	IN	O	of	_	0	SENT_79	[p5l541t2581r641b2660],
22	drug	NN	O	drug	nn	23	SENT_79	[p5l654t2582r854b2682],
23	resistance	NN	O	resistance	prep_of	20	SENT_79	[p5l880t2582r1326b2677],
24	,	,	O	,	_	0	SENT_79	[p5l880t2582r1326b2677],
25	because	IN	O	because	mark	29	SENT_79	[p5l1363t2582r1695b2661],
26	it	PRP	O	it	nsubj	29	SENT_79	[p5l1724t2582r1784b2660],
27	is	VBZ	O	be	cop	29	SENT_79	[p5l1809t2582r1874b2660],
28	silent	JJ	O	silent	amod	29	SENT_79	[p5l1907t2582r2140b2660],
29	(	NN	O	(	advcl	15	SENT_79	[p5l15t2709r212b2801],
30	that	WDT	O	that	nsubj	31	SENT_79	[p5l15t2709r212b2801],
31	is	VBZ	O	be	rcmod	29	SENT_79	[p5l233t2710r324b2805],
32	,	,	O	,	_	0	SENT_79	[p5l233t2710r324b2805],
33	it	PRP	O	it	nsubj	36	SENT_79	[p5l355t2710r415b2788],
34	does	VBZ	O	do	aux	36	SENT_79	[p5l437t2710r628b2788],
35	not	RB	O	not	neg	36	SENT_79	[p5l657t2726r801b2788],
36	alter	VB	O	alter	_	0	SENT_79	[p5l821t2710r1010b2788],
37	the	DT	O	the	det	41	SENT_79	[p5l1034t2710r1163b2788],
38	amino	NN	O	amino	nn	41	SENT_79	[p5l1189t2710r1458b2788],
39	acid	NN	O	acid	nn	41	SENT_79	[p5l1485t2710r1656b2788],
40	sequence	NN	O	sequence	nn	41	SENT_79	[p5l1684t2716r2130b2810],
41	)	NN	O	)	dobj	36	SENT_79	[p5l1684t2716r2130b2810],
42	.	.	O	.	_	0	SENT_79	[p5l1684t2716r2130b2810],

1	Nevertheless	RB	O	nevertheless	advmod	5	SENT_80	[p5l8t2838r573b2933],
2	,	,	O	,	_	0	SENT_80	[p5l8t2838r573b2933],
3	the	DT	O	the	det	4	SENT_80	[p5l602t2838r731b2916],
4	polymorphism	NN	O	polymorphism	nsubj	5	SENT_80	[p5l753t2838r1382b2938],
5	lies	VBZ	O	lie	_	0	SENT_80	[p5l1404t2837r1543b2916],
6	Within	IN	O	within	_	0	SENT_80	[p5l1564t2838r1839b2917],
7	a	DT	O	a	det	9	SENT_80	[p5l1861t2864r1906b2916],
8	large	JJ	O	large	amod	9	SENT_80	[p5l1927t2838r2135b2938],
9	block	NN	O	block	prep_within	14	SENT_80	[p5l11t2965r246b3045],
10	of	IN	O	of	_	0	SENT_80	[p5l264t2965r365b3044],
11	linkage	NN	O	linkage	nn	12	SENT_80	[p5l366t2966r676b3066],
12	disequilibrium	NN	O	disequilibrium	prep_of	9	SENT_80	[p5l699t2965r1322b3066],
13	that	WDT	O	that	nsubj	14	SENT_80	[p5l1344t2966r1510b3044],
14	spans	VBZ	O	span	ccomp	5	SENT_80	[p5l1528t2991r1767b3066],
15	much	RB	O	much	dobj	14	SENT_80	[p5l1791t2966r2031b3045],
16	of	IN	O	of	_	0	SENT_80	[p5l2053t2965r2154b3044],
17	the	DT	O	the	det	18	SENT_80	[p5l11t3094r140b3172],
18	gene	NN	O	gene	prep_of	15	SENT_80	[p5l169t3119r392b3194],
19	,	,	O	,	_	0	SENT_80	[p5l169t3119r392b3194],
20	and	CC	O	and	_	0	SENT_80	[p5l426t3094r582b3172],
21	in	IN	O	in	_	0	SENT_80	[p5l610t3094r691b3171],
22	the	DT	O	the	det	24	SENT_80	[p5l720t3093r850b3172],
23	homozygous	JJ	O	homozygous	amod	24	SENT_80	[p5l879t3093r1423b3194],
24	state	NN	O	state	prep_in	28	SENT_80	[p5l1456t3110r1651b3172],
25	it	PRP	O	it	nsubjpass	28	SENT_80	[p5l1679t3094r1739b3172],
26	has	VBZ	O	have	aux	28	SENT_80	[p5l1763t3094r1904b3172],
27	been	VBN	O	be	auxpass	28	SENT_80	[p5l1936t3093r2135b3172],
28	associated	VBN	O	associate	conj_and	5	SENT_80	[p5l10t3222r442b3300],
29	with	IN	O	with	_	0	SENT_80	[p5l459t3222r646b3301],
30	altered	JJ	O	altered	amod	31	SENT_80	[p5l666t3222r949b3300],
31	expression	NN	O	expression	prep_with	28	SENT_80	[p5l971t3222r1420b3322],
32	of	IN	O	of	_	0	SENT_80	[p5l1442t3221r1542b3300],
33	ABCB1	NN	O	abcb1	prep_of	31	SENT_80	[p5l1541t3226r1950b3300],
34	.16	CD	NUMBER	.16	num	33	SENT_80	[p5l1541t3226r1950b3300],
35	Siddiqui	NNP	PERSON	Siddiqui	nsubj	39	SENT_80	[p5l1974t3222r2134b3300, p5l11t3350r227b3450],
36	et	FW	O	et	nn	37	SENT_80	[p5l248t3366r325b3428],
37	al.	FW	O	al.	dep	35	SENT_80	[p5l340t3349r433b3428],
38	correctly	RB	O	correctly	advmod	39	SENT_80	[p5l461t3350r827b3450],
39	point	VB	O	point	dep	5	SENT_80	[p5l843t3350r1072b3450],
40	out	RP	O	out	prt	39	SENT_80	[p5l1089t3366r1229b3429],
41	that	IN	O	that	complm	44	SENT_80	[p5l1247t3350r1414b3428],
42	it	PRP	O	it	nsubj	44	SENT_80	[p5l1429t3350r1489b3428],
43	is	VBZ	O	be	cop	44	SENT_80	[p5l1505t3350r1570b3428],
44	premature	JJ	O	premature	ccomp	39	SENT_80	[p5l1593t3366r2032b3450],
45	to	TO	O	to	aux	46	SENT_80	[p5l2055t3366r2134b3428],
46	use	VB	O	use	xcomp	44	SENT_80	[p5l11t3504r150b3557],
47	the	DT	O	the	det	50	SENT_80	[p5l174t3477r303b3556],
48	ABCB1	NN	O	abcb1	nn	50	SENT_80	[p5l322t3483r624b3556],
49	3435	CD	NUMBER	3435	num	50	SENT_80	[p5l648t3483r851b3556],
50	polymorphism	NN	O	polymorphism	dobj	46	SENT_80	[p5l876t3478r1505b3578],
51	to	TO	O	to	aux	52	SENT_80	[p5l1528t3494r1607b3556],
52	predict	VB	O	predict	xcomp	46	SENT_80	[p5l1630t3478r1930b3578],
53	clinical	JJ	O	clinical	amod	55	SENT_80	[p5l1949t3477r2134b3556, p5l10t3605r157b3684],
54	drug	NN	O	drug	nn	55	SENT_80	[p5l196t3605r398b3706],
55	resistance	NN	O	resistance	dobj	52	SENT_80	[p5l433t3606r890b3701],
56	,	,	O	,	_	0	SENT_80	[p5l433t3606r890b3701],
57	and	CC	O	and	_	0	SENT_80	[p5l932t3605r1090b3684],
58	other	JJ	O	other	amod	59	SENT_80	[p5l1129t3606r1357b3684],
59	associations	NNS	O	association	nsubj	61	SENT_80	[p5l1391t3606r1919b3684],
60	may	MD	O	may	aux	61	SENT_80	[p5l1959t3632r2139b3706],
61	emerge	VB	O	emerge	conj_and	5	SENT_80	[p6l11t47r327b121],
62	in	IN	O	in	_	0	SENT_80	[p6l353t21r434b98],
63	different	JJ	O	different	amod	65	SENT_80	[p6l460t20r827b99],
64	study	NN	O	study	nn	65	SENT_80	[p6l848t20r1074b121],
65	populations	NNS	O	population	prep_in	61	SENT_80	[p6l1093t21r1624b121],
66	.	.	O	.	_	0	SENT_80	[p6l1093t21r1624b121],

1	Second	RB	ORDINAL	second	advmod	24	SENT_81	[p6l142t148r469b244],
2	,	,	O	,	_	0	SENT_81	[p6l142t148r469b244],
3	just	RB	O	just	advmod	12	SENT_81	[p6l486t149r653b249],
4	as	IN	O	as	dep	12	SENT_81	[p6l672t175r756b227],
5	a	DT	O	a	det	6	SENT_81	[p6l782t175r827b227],
6	number	NN	O	number	nsubjpass	12	SENT_81	[p6l850t148r1186b228],
7	of	IN	O	of	_	0	SENT_81	[p6l1208t148r1309b227],
8	clinical	JJ	O	clinical	amod	9	SENT_81	[p6l1316t148r1616b227],
9	characteristics	NNS	O	characteristic	prep_of	6	SENT_81	[p6l1642t149r2134b227, p6l11t277r151b355],
10	have	VBP	O	have	aux	12	SENT_81	[p6l190t277r378b356],
11	been	VBN	O	be	auxpass	12	SENT_81	[p6l416t277r616b355],
12	identiﬁed	VBN	O	identiﬁed	dep	24	SENT_81	[p6l652t276r1056b355],
13	that	WDT	O	that	nsubj	15	SENT_81	[p6l1093t276r1260b355],
14	are	VBP	O	be	cop	15	SENT_81	[p6l1292t303r1418b355],
15	predictive	JJ	O	predictive	ccomp	12	SENT_81	[p6l1453t276r1865b377],
16	of	IN	O	of	_	0	SENT_81	[p6l1903t276r2003b355],
17	refractory	JJ	O	refractory	amod	18	SENT_81	[p6l2022t303r2134b355, p6l11t404r341b505],
18	epilepsy	NN	O	epilepsy	prep_of	15	SENT_81	[p6l362t405r720b505],
19	,	,	O	,	_	0	SENT_81	[p6l362t405r720b505],
20	this	DT	O	this	det	21	SENT_81	[p6l752t405r905b483],
21	study	NN	O	study	nsubj	24	SENT_81	[p6l934t405r1161b505],
22	has	VBZ	O	have	aux	24	SENT_81	[p6l1182t405r1324b483],
23	similarly	RB	O	similarly	advmod	24	SENT_81	[p6l1352t405r1722b505],
24	identiﬁed	VBN	O	identiﬁed	_	0	SENT_81	[p6l1742t404r2148b483],
25	only	RB	O	only	advmod	27	SENT_81	[p6l11t532r192b633],
26	an	DT	O	a	det	27	SENT_81	[p6l210t558r310b611],
27	association	NN	O	association	dobj	24	SENT_81	[p6l332t533r804b611],
28	between	IN	O	between	_	0	SENT_81	[p6l827t533r1176b612],
29	the	DT	O	the	det	30	SENT_81	[p6l1199t533r1328b611],
30	phenotype	NN	O	phenotype	prep_between	27	SENT_81	[p6l1348t532r1791b633],
31	of	IN	O	of	_	0	SENT_81	[p6l1814t532r1914b611],
32	drugresistant	JJ	O	drugresistant	amod	33	SENT_81	[p6l1919t532r2148b633, p6l11t661r381b739],
33	epilepsy	NN	O	epilepsy	prep_of	30	SENT_81	[p6l402t660r748b761],
34	and	CC	O	and	_	0	SENT_81	[p6l768t660r925b739],
35	a	DT	O	a	det	37	SENT_81	[p6l948t687r994b739],
36	particular	JJ	O	particular	amod	37	SENT_81	[p6l1016t660r1429b761],
37	genotype	NN	O	genotype	prep_of	30	SENT_81	[p6l1451t677r1860b761],
38	.	.	O	.	_	0	SENT_81	[p6l1451t677r1860b761],

1	A	DT	O	a	det	2	SENT_82	[p6l1887t668r1953b738],
2	limitation	NN	O	limitation	nsubj	6	SENT_82	[p6l1974t661r2147b738, p6l10t789r288b867],
3	ofassociational	JJ	O	ofassociational	amod	5	SENT_82	[p6l319t788r986b867],
4	genetic	JJ	O	genetic	amod	5	SENT_82	[p6l1016t789r1322b889],
5	studies	NNS	O	study	dep	2	SENT_82	[p6l1354t788r1649b868],
6	is	VBZ	O	be	_	0	SENT_82	[p6l1682t789r1747b867],
7	that	IN	O	that	complm	12	SENT_82	[p6l1781t789r1949b867],
8	they	PRP	O	they	nsubj	12	SENT_82	[p6l1975t789r2153b889],
9	do	VBP	O	do	aux	12	SENT_82	[p6l11t916r114b995],
10	not	RB	O	not	neg	12	SENT_82	[p6l137t933r279b995],
11	directly	RB	O	directly	advmod	12	SENT_82	[p6l295t916r603b1017],
12	identify	VB	O	identify	ccomp	6	SENT_82	[p6l620t916r937b1017],
13	functionally	RB	O	functionally	advmod	14	SENT_82	[p6l953t916r1454b1017],
14	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_82	[p6l1472t916r1917b1017],
15	alterations	NNS	O	alteration	dobj	12	SENT_82	[p6l1932t916r2148b995, p6l10t1045r299b1140],
16	,	,	O	,	_	0	SENT_82	[p6l1932t916r2148b995, p6l10t1045r299b1140],
17	and	CC	O	and	_	0	SENT_82	[p6l336t1045r495b1123],
18	their	PRP$	O	they	poss	19	SENT_82	[p6l528t1045r730b1123],
19	ﬁndings	NNS	O	ﬁndings	nsubjpass	23	SENT_82	[p6l760t1044r1119b1145],
20	must	MD	O	must	aux	23	SENT_82	[p6l1153t1061r1374b1124],
21	therefore	RB	O	therefore	advmod	23	SENT_82	[p6l1402t1044r1796b1123],
22	be	VB	O	be	auxpass	23	SENT_82	[p6l1830t1045r1926b1123],
23	supported	VBN	O	support	conj_and	6	SENT_82	[p6l1961t1071r2145b1145, p6l10t1172r293b1273],
24	by	IN	O	by	_	0	SENT_82	[p6l324t1172r422b1273],
25	additional	JJ	O	additional	amod	27	SENT_82	[p6l445t1172r876b1251],
26	biochemical	JJ	O	biochemical	amod	27	SENT_82	[p6l904t1173r1423b1251],
27	studies	NNS	O	study	agent	23	SENT_82	[p6l1452t1173r1773b1252],
28	.	.	O	.	_	0	SENT_82	[p6l1452t1173r1773b1252],

1	Because	IN	O	because	mark	7	SENT_83	[p6l1806t1179r2148b1252],
2	the	DT	O	the	det	4	SENT_83	[p6l11t1301r141b1379],
3	ABCB1	NN	O	abcb1	nn	4	SENT_83	[p6l158t1306r425b1379],
4	gene	NN	O	gene	nsubjpass	7	SENT_83	[p6l452t1326r652b1401],
5	was	VBD	O	be	auxpass	7	SENT_83	[p6l672t1327r833b1380],
6	not	RB	O	not	neg	7	SENT_83	[p6l860t1317r1004b1379],
7	sequenced	VBN	O	sequence	advcl	12	SENT_83	[p6l1025t1301r1494b1401],
8	,	,	O	,	_	0	SENT_83	[p6l1025t1301r1494b1401],
9	it	PRP	O	it	nsubjpass	12	SENT_83	[p6l1522t1301r1583b1379],
10	is	VBZ	O	be	auxpass	12	SENT_83	[p6l1601t1301r1666b1379],
11	not	RB	O	not	neg	12	SENT_83	[p6l1692t1317r1836b1379],
12	known	VBN	O	know	_	0	SENT_83	[p6l1855t1300r2148b1380],
13	whether	IN	O	whether	complm	15	SENT_83	[p6l6t1429r359b1508],
14	there	EX	O	there	expl	15	SENT_83	[p6l397t1429r611b1507],
15	are	VBP	O	be	ccomp	12	SENT_83	[p6l651t1455r777b1507],
16	mutations	NNS	O	mutation	nsubj	15	SENT_83	[p6l817t1429r1251b1508],
17	in	IN	O	in	_	0	SENT_83	[p6l1292t1429r1374b1506],
18	the	DT	O	the	det	19	SENT_83	[p6l1414t1429r1544b1507],
19	patients	NNS	O	patient	prep_in	16	SENT_83	[p6l1583t1429r1920b1529],
20	with	IN	O	with	_	0	SENT_83	[p6l1958t1429r2148b1508],
21	drug	NN	O	drug	npadvmod	23	SENT_83	[p6l11t1556r618b1657],
22	—	CD	NUMBER	—	num	21	SENT_83	[p6l11t1556r618b1657],
23	resistant	JJ	O	resistant	amod	24	SENT_83	[p6l11t1556r618b1657],
24	epilepsy	NN	O	epilepsy	prep_with	19	SENT_83	[p6l646t1557r993b1657],
25	that	WDT	O	that	nsubj	27	SENT_83	[p6l1020t1557r1188b1635],
26	might	MD	O	might	aux	27	SENT_83	[p6l1214t1557r1474b1657],
27	affect	VB	O	affect	rcmod	16	SENT_83	[p6l1500t1556r1738b1635],
28	the	DT	O	the	det	29	SENT_83	[p6l1765t1557r1895b1635],
29	function	NN	O	function	dobj	27	SENT_83	[p6l1927t1556r2147b1636, p6l11t1685r176b1763],
30	of	IN	O	of	_	0	SENT_83	[p6l199t1684r300b1763],
31	its	PRP$	O	its	poss	32	SENT_83	[p6l303t1685r398b1763],
32	product	NN	O	product	prep_of	29	SENT_83	[p6l422t1685r878b1785],
33	—	CD	NUMBER	—	tmod	27	SENT_83	[p6l422t1685r878b1785],
34	namely	RB	O	namely	advmod	33	SENT_83	[p6l896t1685r1215b1785],
35	,	,	O	,	_	0	SENT_83	[p6l896t1685r1215b1785],
36	P	NN	O	p	nn	38	SENT_83	[p6l1240t1684r1880b1785],
37	—	CD	NUMBER	—	num	38	SENT_83	[p6l1240t1684r1880b1785],
38	glycoprotein	NN	O	glycoprotein	appos	33	SENT_83	[p6l1240t1684r1880b1785],
39	.	.	O	.	_	0	SENT_83	[p6l1240t1684r1880b1785],

1	There	EX	O	there	expl	5	SENT_84	[p6l1905t1685r2148b1763],
2	may	MD	O	may	aux	5	SENT_84	[p6l11t1839r187b1913],
3	also	RB	O	also	advmod	5	SENT_84	[p6l202t1813r368b1891],
4	be	VB	O	be	cop	5	SENT_84	[p6l391t1813r486b1891],
5	differences	NNS	O	difference	_	0	SENT_84	[p6l508t1812r965b1891],
6	in	IN	O	in	_	0	SENT_84	[p6l988t1813r1068b1890],
7	the	DT	O	the	det	11	SENT_84	[p6l1090t1813r1218b1891],
8	promoter	NN	O	promoter	nn	11	SENT_84	[p6l1238t1829r1638b1913],
9	or	CC	O	or	_	0	SENT_84	[p6l1657t1838r1746b1891],
10	enhancer	NN	O	enhancer	nn	11	SENT_84	[p6l1765t1813r2152b1891],
11	regions	NNS	O	region	prep_in	5	SENT_84	[p6l11t1941r327b2041],
12	of	IN	O	of	_	0	SENT_84	[p6l361t1940r462b2019],
13	the	DT	O	the	det	15	SENT_84	[p6l476t1941r606b2019],
14	ABCB1	NN	O	abcb1	nn	15	SENT_84	[p6l631t1946r898b2019],
15	gene	NN	O	gene	prep_of	11	SENT_84	[p6l933t1966r1133b2041],
16	itself	PRP	O	itself	advmod	11	SENT_84	[p6l1165t1940r1390b2019],
17	that	IN	O	that	nsubj	18	SENT_84	[p6l1404t1941r1571b2019],
18	affect	VBP	O	affect	rcmod	11	SENT_84	[p6l1597t1940r1835b2019],
19	the	DT	O	the	det	20	SENT_84	[p6l1862t1941r1992b2019],
20	expression	NN	O	expression	dobj	18	SENT_84	[p6l2026t1967r2147b2019, p6l10t2069r381b2169],
21	of	IN	O	of	_	0	SENT_84	[p6l413t2068r515b2147],
22	P	NN	O	p	nn	24	SENT_84	[p6l526t2069r1189b2169],
23	—	CD	NUMBER	—	num	24	SENT_84	[p6l526t2069r1189b2169],
24	glycoprotein	NN	O	glycoprotein	prep_of	20	SENT_84	[p6l526t2069r1189b2169],
25	.	.	O	.	_	0	SENT_84	[p6l526t2069r1189b2169],

1	Furthermore	RB	O	furthermore	advmod	24	SENT_85	[p6l1223t2069r1801b2164],
2	,	,	O	,	_	0	SENT_85	[p6l1223t2069r1801b2164],
3	despite	IN	O	despite	_	0	SENT_85	[p6l1839t2069r2147b2169],
4	speculation	NN	O	speculation	prep_despite	24	SENT_85	[p6l12t2197r535b2297],
5	,	,	O	,	_	0	SENT_85	[p6l12t2197r535b2297],
6	no	DT	O	no	det	7	SENT_85	[p6l565t2222r672b2275],
7	link	NN	O	link	nsubjpass	24	SENT_85	[p6l695t2197r864b2276],
8	between	IN	O	between	_	0	SENT_85	[p6l884t2197r1236b2276],
9	the	DT	O	the	det	10	SENT_85	[p6l1260t2197r1390b2275],
10	function	NN	O	function	prep_between	7	SENT_85	[p6l1414t2196r1773b2276],
11	of	IN	O	of	_	0	SENT_85	[p6l1798t2196r1899b2275],
12	P	NN	O	p	nn	14	SENT_85	[p6l1903t2197r2147b2297, p6l11t2325r418b2425],
13	—	CD	NUMBER	—	num	14	SENT_85	[p6l1903t2197r2147b2297, p6l11t2325r418b2425],
14	glycoprotein	NN	O	glycoprotein	prep_of	10	SENT_85	[p6l1903t2197r2147b2297, p6l11t2325r418b2425],
15	and	CC	O	and	_	0	SENT_85	[p6l452t2325r608b2403],
16	the	DT	O	the	det	18	SENT_85	[p6l643t2324r773b2403],
17	clinical	JJ	O	clinical	amod	18	SENT_85	[p6l808t2325r1111b2403],
18	effectiveness	NN	O	effectiveness	conj_and	10	SENT_85	[p6l1145t2324r1682b2404],
19	of	IN	O	of	_	0	SENT_85	[p6l1719t2324r1820b2403],
20	antiseizure	JJ	O	antiseizure	amod	21	SENT_85	[p6l1835t2325r2147b2403, p6l10t2479r193b2532],
21	drugs	NNS	O	drug	prep_of	18	SENT_85	[p6l219t2453r458b2553],
22	has	VBZ	O	have	aux	24	SENT_85	[p6l485t2453r627b2531],
23	been	VBN	O	be	auxpass	24	SENT_85	[p6l655t2453r855b2531],
24	established	VBN	O	establish	_	0	SENT_85	[p6l881t2453r1386b2531],
25	.	.	O	.	_	0	SENT_85	[p6l881t2453r1386b2531],

1	Third	NNP	ORDINAL	Third	_	0	SENT_86	[p6l137t2580r398b2676],
2	,	,	O	,	_	0	SENT_86	[p6l137t2580r398b2676],
3	seizures	NNS	O	seizure	appos	1	SENT_86	[p6l435t2581r775b2660],
4	themselves	PRP	O	themselves	nsubjpass	7	SENT_86	[p6l807t2581r1273b2660],
5	have	VBP	O	have	aux	7	SENT_86	[p6l1305t2581r1494b2660],
6	been	VBN	O	be	auxpass	7	SENT_86	[p6l1525t2580r1725b2659],
7	shown	VBN	O	show	rcmod	3	SENT_86	[p6l1756t2580r2038b2660],
8	to	TO	O	to	aux	9	SENT_86	[p6l2067t2597r2147b2659],
9	induce	VB	O	induce	xcomp	7	SENT_86	[p6l10t2710r293b2789],
10	multidrug	JJ	O	multidrug	amod	13	SENT_86	[p6l317t2709r1211b2810],
11	—	NN	O	—	nn	13	SENT_86	[p6l317t2709r1211b2810],
12	resistance	NN	O	resistance	nn	13	SENT_86	[p6l317t2709r1211b2810],
13	genes	NNS	O	gene	dobj	9	SENT_86	[p6l1234t2735r1476b2810],
14	in	IN	O	in	_	0	SENT_86	[p6l1500t2710r1582b2787],
15	animal	NN	O	animal	nn	16	SENT_86	[p6l1605t2710r1897b2788],
16	models	NNS	O	model	prep_in	9	SENT_86	[p6l1920t2709r2147b2788, p6l11t2838r347b2933],
17	,1	CD	NUMBER	,1	number	18	SENT_86	[p6l1920t2709r2147b2788, p6l11t2838r347b2933],
18	°	CD	NUMBER	°	num	19	SENT_86	[p6l1920t2709r2147b2788, p6l11t2838r347b2933],
19	’17	CD	NUMBER	’17	dep	9	SENT_86	[p6l1920t2709r2147b2788, p6l11t2838r347b2933],
20	and	CC	O	and	_	0	SENT_86	[p6l387t2837r546b2916],
21	this	DT	O	this	nsubj	22	SENT_86	[p6l588t2838r745b2916],
22	would	MD	O	would	rcmod	3	SENT_86	[p6l783t2837r1055b2917],
23	most	RBS	O	most	advmod	24	SENT_86	[p6l1096t2854r1317b2916],
24	likely	JJ	O	likely	amod	25	SENT_86	[p6l1352t2837r1586b2938],
25	result	NN	O	result	dep	22	SENT_86	[p6l1622t2838r1870b2917],
26	in	IN	O	in	_	0	SENT_86	[p6l1905t2838r1988b2915],
27	increased	VBN	O	increase	amod	28	SENT_86	[p6l2028t2838r2145b2915, p6l11t2966r335b3044],
28	concentrations	NNS	O	concentration	prep_in	25	SENT_86	[p6l386t2966r1032b3044],
29	of	IN	O	of	_	0	SENT_86	[p6l1086t2965r1187b3044],
30	transporter	NN	O	transporter	nn	31	SENT_86	[p6l1220t2982r1710b3066],
31	proteins	NNS	O	protein	prep_of	28	SENT_86	[p6l1757t2966r2141b3066],
32	.	.	O	.	_	0	SENT_86	[p6l1757t2966r2141b3066],

1	Thus	RB	O	thus	advmod	12	SENT_87	[p6l7t3094r242b3189],
2	,	,	O	,	_	0	SENT_87	[p6l7t3094r242b3189],
3	an	DT	O	a	det	5	SENT_87	[p6l268t3119r367b3172],
4	epileptogenic	JJ	O	epileptogenic	amod	5	SENT_87	[p6l389t3094r950b3194],
5	region	NN	O	region	nsubj	12	SENT_87	[p6l970t3094r1239b3194],
6	of	IN	O	of	_	0	SENT_87	[p6l1260t3093r1360b3172],
7	the	DT	O	the	det	8	SENT_87	[p6l1362t3094r1491b3172],
8	brain	NN	O	brain	prep_of	5	SENT_87	[p6l1512t3093r1729b3172],
9	might	MD	O	might	aux	12	SENT_87	[p6l1749t3093r2004b3194],
10	become	VB	O	become	cop	12	SENT_87	[p6l2021t3093r2148b3172, p6l11t3247r236b3300],
11	increasingly	RB	O	increasingly	advmod	12	SENT_87	[p6l262t3222r780b3322],
12	resistant	JJ	O	resistant	_	0	SENT_87	[p6l802t3222r1172b3300],
13	to	TO	O	to	_	0	SENT_87	[p6l1194t3238r1273b3300],
14	antiseizure	JJ	O	antiseizure	amod	15	SENT_87	[p6l1301t3222r1766b3301],
15	drugs	NNS	O	drug	prep_to	12	SENT_87	[p6l1794t3222r2033b3322],
16	as	IN	O	as	_	0	SENT_87	[p6l2062t3248r2146b3300],
17	a	DT	O	a	det	18	SENT_87	[p6l10t3376r54b3428],
18	result	NN	O	result	prep_as	12	SENT_87	[p6l77t3349r320b3429],
19	of	IN	O	of	_	0	SENT_87	[p6l340t3349r441b3428],
20	continued	JJ	O	continued	amod	22	SENT_87	[p6l448t3350r875b3429],
21	seizure	NN	O	seizure	nn	22	SENT_87	[p6l900t3350r1199b3429],
22	activity	NN	O	activity	prep_of	18	SENT_87	[p6l1223t3350r1532b3450],
23	.	.	O	.	_	0	SENT_87	[p6l1223t3350r1532b3450],

1	This	DT	O	this	det	2	SENT_88	[p6l1558t3350r1744b3428],
2	hypothesis	NN	O	hypothesis	nsubj	4	SENT_88	[p6l1771t3350r2147b3450, p6l12t3478r119b3556],
3	could	MD	O	could	aux	4	SENT_88	[p6l155t3477r388b3557],
4	serve	VB	O	serve	_	0	SENT_88	[p6l423t3504r633b3557],
5	as	RB	O	as	advmod	6	SENT_88	[p6l665t3504r750b3556],
6	yet	RB	O	yet	advmod	4	SENT_88	[p6l781t3494r906b3578],
7	another	DT	O	another	det	8	SENT_88	[p6l933t3478r1265b3556],
8	argument	NN	O	argument	dobj	4	SENT_88	[p6l1294t3494r1713b3578],
9	to	TO	O	to	aux	10	SENT_88	[p6l1741t3494r1821b3556],
10	initiate	VB	O	initiate	infmod	8	SENT_88	[p6l1854t3478r2148b3556],
11	aggressive	JJ	O	aggressive	amod	12	SENT_88	[p6l10t3606r445b3706],
12	treatment	NN	O	treatment	dobj	10	SENT_88	[p6l469t3622r882b3684],
13	as	RB	O	as	advmod	14	SENT_88	[p6l899t3632r984b3684],
14	soon	RB	O	soon	advmod	10	SENT_88	[p6l1011t3631r1213b3684],
15	as	IN	O	as	mark	16	SENT_88	[p6l1236t3632r1320b3684],
16	possible	JJ	O	possible	advcl	10	SENT_88	[p6l1344t3605r1693b3706],
17	in	IN	O	in	_	0	SENT_88	[p6l1716t3606r1797b3683],
18	order	NN	O	order	prep_in	16	SENT_88	[p6l1821t3606r2048b3684],
19	to	TO	O	to	aux	20	SENT_88	[p6l2068t3622r2148b3684],
20	suppress	VB	O	suppress	xcomp	10	SENT_88	[p7l12t47r379b121],
21	the	DT	O	the	det	22	SENT_88	[p7l402t21r529b99],
22	seizures	NNS	O	seizure	dobj	20	SENT_88	[p7l551t21r884b100],
23	completely	RB	O	completely	advmod	20	SENT_88	[p7l907t21r1373b121],
24	.	.	O	.	_	0	SENT_88	[p7l907t21r1373b121],

1	Studies	NNS	O	study	nsubj	5	SENT_89	[p7l1401t20r1699b100],
2	in	IN	O	in	_	0	SENT_89	[p7l1720t21r1800b98],
3	animals	NNS	O	animal	prep_in	1	SENT_89	[p7l1820t21r2147b99],
4	also	RB	O	also	advmod	5	SENT_89	[p7l10t149r179b227],
5	indicate	VBP	O	indicate	_	0	SENT_89	[p7l201t149r536b227],
6	that	IN	O	that	complm	12	SENT_89	[p7l559t149r726b227],
7	antiseizure	JJ	O	antiseizure	amod	8	SENT_89	[p7l742t149r1208b228],
8	drugs	NNS	O	drug	nsubj	12	SENT_89	[p7l1230t149r1469b249],
9	can	MD	O	can	aux	12	SENT_89	[p7l1494t174r1638b227],
10	up	RB	O	up	advmod	12	SENT_89	[p7l1660t149r2148b249],
11	—	CD	NUMBER	—	pobj	10	SENT_89	[p7l1660t149r2148b249],
12	regulate	VBP	O	regulate	ccomp	5	SENT_89	[p7l1660t149r2148b249],
13	some	DT	O	some	det	15	SENT_89	[p7l12t302r235b355],
14	multidrug	JJ	O	multidrug	amod	15	SENT_89	[p7l255t277r678b377],
15	transporters	NNS	O	transporter	dobj	12	SENT_89	[p7l695t293r1225b377],
16	,	,	O	,	_	0	SENT_89	[p7l695t293r1225b377],
17	including	VBG	O	include	_	0	SENT_89	[p7l1250t276r1651b377],
18	P	NN	O	p	nn	20	SENT_89	[p7l1666t276r2148b377],
19	—	NN	O	—	nn	20	SENT_89	[p7l1666t276r2148b377],
20	glycopro	NN	O	glycopro	prep_including	15	SENT_89	[p7l1666t276r2148b377],
21	—	CD	NUMBER	—	num	22	SENT_89	[p7l1666t276r2148b377],
22	tein	NN	O	tein	dep	20	SENT_89	[p7l11t405r379b500],
23	,18	CD	NUMBER	,18	number	24	SENT_89	[p7l11t405r379b500],
24	»	CD	NUMBER	»	num	25	SENT_89	[p7l11t405r379b500],
25	19	CD	NUMBER	19	dep	22	SENT_89	[p7l11t405r379b500],
26	but	CC	O	but	_	0	SENT_89	[p7l412t405r553b484],
27	it	PRP	O	it	nsubjpass	30	SENT_89	[p7l579t405r639b483],
28	is	VBZ	O	be	auxpass	30	SENT_89	[p7l665t405r730b483],
29	not	RB	O	not	neg	30	SENT_89	[p7l764t421r908b483],
30	known	VBN	O	know	ccomp	5	SENT_89	[p7l934t405r1227b484],
31	to	TO	O	to	_	0	SENT_89	[p7l1258t421r1338b483],
32	what	WP	O	what	det	33	SENT_89	[p7l1366t405r1581b484],
33	extent	NN	O	extent	dobj	37	SENT_89	[p7l1608t421r1868b483],
34	this	DT	O	this	nsubj	37	SENT_89	[p7l1895t405r2048b483],
35	is	VBZ	O	be	cop	37	SENT_89	[p7l2081t405r2146b483],
36	functionally	RB	O	functionally	advmod	37	SENT_89	[p7l11t533r520b634],
37	important	JJ	O	important	prepc_to	30	SENT_89	[p7l557t534r993b634],
38	or	CC	O	or	_	0	SENT_89	[p7l1031t559r1121b612],
39	whether	IN	O	whether	complm	43	SENT_89	[p7l1155t534r1508b613],
40	different	JJ	O	different	amod	42	SENT_89	[p7l1548t533r1917b612],
41	antiseizure	JJ	O	antiseizure	amod	42	SENT_89	[p7l1953t534r2147b612, p7l12t662r311b741],
42	drugs	NNS	O	drug	nsubj	43	SENT_89	[p7l337t661r576b762],
43	have	VBP	O	have	conj_or	12	SENT_89	[p7l603t662r793b741],
44	differential	JJ	O	differential	amod	45	SENT_89	[p7l818t661r1286b740],
45	effects	NNS	O	effect	dobj	43	SENT_89	[p7l1312t661r1609b740],
46	.	.	O	.	_	0	SENT_89	[p7l1312t661r1609b740],

1	Fourth	JJ	ORDINAL	fourth	advmod	17	SENT_90	[p7l139t789r449b885],
2	,	,	O	,	_	0	SENT_90	[p7l139t789r449b885],
3	members	NNS	O	member	nsubjpass	32	SENT_90	[p7l489t789r886b868],
4	of	IN	O	of	_	0	SENT_90	[p7l922t789r1024b868],
5	the	DT	O	the	det	9	SENT_90	[p7l1039t789r1168b868],
6	multidrug	JJ	O	multidrug	amod	9	SENT_90	[p7l1202t789r2151b890],
7	—	NN	O	—	nn	9	SENT_90	[p7l1202t789r2151b890],
8	resistance	NN	O	resistance	nn	9	SENT_90	[p7l1202t789r2151b890],
9	—	NN	O	—	prep_of	3	SENT_90	[p7l1202t789r2151b890],
10	associated	VBN	O	associate	partmod	9	SENT_90	[p7l10t917r450b996],
11	(	CD	NUMBER	(	num	14	SENT_90	[p7l485t924r747b1009],
12	MRP	NN	ORGANIZATION	mrp	nn	14	SENT_90	[p7l485t924r747b1009],
13	)	NN	O	)	nn	14	SENT_90	[p7l485t924r747b1009],
14	family	NN	O	family	dobj	10	SENT_90	[p7l783t917r1051b1018],
15	of	IN	O	of	_	0	SENT_90	[p7l1078t917r1179b996],
16	transporters	NNS	O	transporter	prep_of	14	SENT_90	[p7l1192t934r1710b1018],
17	have	VBP	O	have	_	0	SENT_90	[p7l1743t918r1933b997],
18	substrate	JJ	O	substrate	amod	19	SENT_90	[p7l1966t918r2147b997, p7l12t1062r243b1124],
19	speciﬁcity	NN	O	speciﬁcity	dobj	17	SENT_90	[p7l283t1045r710b1146],
20	that	WDT	O	that	dep	21	SENT_90	[p7l743t1046r911b1124],
21	overlaps	VBZ	O	overlap	rcmod	19	SENT_90	[p7l944t1046r1294b1146],
22	that	DT	O	that	dobj	21	SENT_90	[p7l1334t1046r1502b1124],
23	of	IN	O	of	_	0	SENT_90	[p7l1535t1045r1636b1124],
24	P	NN	O	p	prep_of	22	SENT_90	[p7l1654t1046r2147b1146],
25	—	CD	NUMBER	—	num	28	SENT_90	[p7l1654t1046r2147b1146],
26	glycopro	NN	O	glycopro	nn	28	SENT_90	[p7l1654t1046r2147b1146],
27	—	CD	NUMBER	—	num	28	SENT_90	[p7l1654t1046r2147b1146],
28	tein	NN	O	tein	nsubj	21	SENT_90	[p7l11t1174r170b1252],
29	and	CC	O	and	_	0	SENT_90	[p7l196t1174r353b1252],
30	are	VBP	O	be	auxpass	32	SENT_90	[p7l380t1200r506b1252],
31	also	RB	O	also	advmod	32	SENT_90	[p7l533t1174r701b1252],
32	expressed	VBN	O	express	conj_and	17	SENT_90	[p7l731t1174r1148b1274],
33	in	IN	O	in	_	0	SENT_90	[p7l1175t1174r1256b1251],
34	the	DT	O	the	det	37	SENT_90	[p7l1284t1173r1414b1252],
35	blood	NN	O	blood	nn	37	SENT_90	[p7l1443t1173r1965b1252],
36	—	NN	O	—	nn	37	SENT_90	[p7l1443t1173r1965b1252],
37	brain	NN	O	brain	prep_in	32	SENT_90	[p7l1443t1173r1965b1252],
38	and	CC	O	and	_	0	SENT_90	[p7l1992t1173r2148b1252],
39	blood	NN	O	blood	nn	40	SENT_90	[p7l11t1301r912b1402],
40	—	NN	O	—	prep_in	32	SENT_90	[p7l11t1301r912b1402],
41	cerebrospinal	JJ	O	cerebrospinal	amod	43	SENT_90	[p7l11t1301r912b1402],
42	ﬂuid	NN	O	ﬂuid	nn	43	SENT_90	[p7l955t1301r1155b1381],
43	barriers	NNS	O	barrier	dobj	17	SENT_90	[p7l1199t1302r1714b1380],
44	.7	CD	NUMBER	.7	num	48	SENT_90	[p7l1199t1302r1714b1380],
45	»	CD	NUMBER	»	num	48	SENT_90	[p7l1199t1302r1714b1380],
46	14	CD	NUMBER	14	num	48	SENT_90	[p7l1199t1302r1714b1380],
47	Different	JJ	O	different	amod	48	SENT_90	[p7l1754t1301r2152b1380],
48	members	NNS	O	member	nsubjpass	53	SENT_90	[p7l11t1430r415b1508],
49	of	IN	O	of	_	0	SENT_90	[p7l446t1429r546b1508],
50	the	DT	O	the	det	51	SENT_90	[p7l555t1430r685b1508],
51	family	NN	O	family	prep_of	48	SENT_90	[p7l712t1429r978b1530],
52	are	VBP	O	be	auxpass	53	SENT_90	[p7l1000t1456r1127b1508],
53	found	VBN	O	find	rcmod	43	SENT_90	[p7l1153t1429r1406b1509],
54	in	IN	O	in	_	0	SENT_90	[p7l1431t1430r1513b1507],
55	different	JJ	O	different	amod	56	SENT_90	[p7l1540t1429r1909b1508],
56	areas	NNS	O	area	prep_in	53	SENT_90	[p7l1930t1456r2146b1508],
57	of	IN	O	of	_	0	SENT_90	[p7l11t1557r113b1636],
58	the	DT	O	the	det	59	SENT_90	[p7l120t1557r249b1636],
59	brain	NN	O	brain	prep_of	56	SENT_90	[p7l276t1558r520b1636],
60	.	.	O	.	_	0	SENT_90	[p7l276t1558r520b1636],

1	Like	IN	O	like	_	0	SENT_91	[p7l550t1558r728b1637],
2	P	NN	O	p	nn	4	SENT_91	[p7l752t1557r1398b1658],
3	—	CD	NUMBER	—	num	4	SENT_91	[p7l752t1557r1398b1658],
4	glycoprotein	NN	O	glycoprotein	prep_like	10	SENT_91	[p7l752t1557r1398b1658],
5	,	,	O	,	_	0	SENT_91	[p7l752t1557r1398b1658],
6	MRP1	NN	O	mrp1	nsubjpass	10	SENT_91	[p7l1426t1563r1685b1641],
7	and	CC	O	and	_	0	SENT_91	[p7l1710t1557r1867b1636],
8	MRP2	NN	O	mrp2	nsubjpass	10	SENT_91	[p7l1889t1563r2147b1641],
9	are	VBP	O	be	auxpass	10	SENT_91	[p7l10t1712r136b1764],
10	overexpressed	VBN	O	overexpress	_	0	SENT_91	[p7l173t1685r773b1786],
11	in	IN	O	in	_	0	SENT_91	[p7l807t1686r889b1763],
12	epileptogenic	JJ	O	epileptogenic	amod	13	SENT_91	[p7l925t1686r1500b1786],
13	tissue	NN	O	tissue	prep_in	10	SENT_91	[p7l1535t1686r1953b1765],
14	.9,11	CD	NUMBER	.9,11	num	13	SENT_91	[p7l1535t1686r1953b1765],
15	The	DT	O	the	det	17	SENT_91	[p7l1985t1686r2147b1764],
16	relative	JJ	O	relative	amod	17	SENT_91	[p7l11t1814r314b1893],
17	contribution	NN	O	contribution	nsubj	26	SENT_91	[p7l342t1814r875b1893],
18	of	IN	O	of	_	0	SENT_91	[p7l904t1813r1005b1892],
19	these	DT	O	these	det	21	SENT_91	[p7l1016t1814r1235b1892],
20	multidrug	JJ	O	multidrug	amod	21	SENT_91	[p7l1264t1814r1695b1914],
21	transporters	NNS	O	transporter	prep_of	17	SENT_91	[p7l1721t1830r2147b1914, p7l11t1968r131b2020],
22	to	TO	O	to	_	0	SENT_91	[p7l159t1958r238b2020],
23	refractory	JJ	O	refractory	amod	24	SENT_91	[p7l265t1941r679b2042],
24	epilepsy	NN	O	epilepsy	prep_to	21	SENT_91	[p7l700t1942r1047b2042],
25	is	VBZ	O	be	cop	26	SENT_91	[p7l1067t1942r1132b2020],
26	unknown	JJ	O	unknown	rcmod	13	SENT_91	[p7l1160t1942r1589b2021],
27	.	.	O	.	_	0	SENT_91	[p7l1160t1942r1589b2021],

1	Intractable	JJ	O	intractable	amod	2	SENT_92	[p7l139t2069r594b2148],
2	epilepsy	NN	O	epilepsy	nsubj	3	SENT_92	[p7l616t2069r959b2170],
3	has	VBZ	O	have	_	0	SENT_92	[p7l976t2070r1117b2148],
4	many	JJ	O	many	amod	5	SENT_92	[p7l1140t2095r1374b2170],
5	causes	NNS	O	cause	dobj	3	SENT_92	[p7l1392t2096r1688b2165],
6	,	,	O	,	_	0	SENT_92	[p7l1392t2096r1688b2165],
7	and	CC	O	and	_	0	SENT_92	[p7l1715t2069r1870b2148],
8	resistance	NN	O	resistance	nsubj	16	SENT_92	[p7l1892t2070r2148b2148, p7l10t2223r201b2276],
9	to	TO	O	to	_	0	SENT_92	[p7l222t2214r301b2276],
10	therapy	NN	O	therapy	prep_to	8	SENT_92	[p7l323t2197r638b2298],
11	with	IN	O	with	_	0	SENT_92	[p7l650t2198r838b2277],
12	antiseizure	JJ	O	antiseizure	amod	13	SENT_92	[p7l859t2198r1319b2277],
13	drugs	NNS	O	drug	prep_with	10	SENT_92	[p7l1340t2197r1577b2298],
14	is	VBZ	O	be	cop	16	SENT_92	[p7l1599t2198r1664b2276],
15	almost	RB	O	almost	advmod	16	SENT_92	[p7l1685t2198r1976b2276],
16	cer	NN	O	cer	conj_and	3	SENT_92	[p7l1992t2224r2148b2276],
17	—	CD	NUMBER	—	num	16	SENT_92	[p7l1992t2224r2148b2276],
18	tainly	RB	O	tainly	advmod	16	SENT_92	[p7l11t2325r247b2426],
19	due	JJ	O	due	_	0	SENT_92	[p7l269t2326r420b2405],
20	to	TO	O	to	_	0	SENT_92	[p7l446t2342r525b2404],
21	multiple	JJ	O	multiple	amod	22	SENT_92	[p7l552t2325r908b2426],
22	factors	NNS	O	factor	prep_due_to	16	SENT_92	[p7l934t2325r1246b2404],
23	.	.	O	.	_	0	SENT_92	[p7l934t2325r1246b2404],

1	One	CD	NUMBER	one	nsubj	5	SENT_93	[p7l1278t2331r1451b2404],
2	of	IN	O	of	_	0	SENT_93	[p7l1478t2325r1579b2404],
3	these	DT	O	these	prep_of	1	SENT_93	[p7l1587t2326r1807b2404],
4	is	VBZ	O	be	cop	5	SENT_93	[p7l1832t2326r1898b2404],
5	likely	JJ	O	likely	_	0	SENT_93	[p7l1925t2325r2153b2426],
6	to	TO	O	to	aux	8	SENT_93	[p7l11t2470r91b2532],
7	be	VB	O	be	cop	8	SENT_93	[p7l114t2453r210b2532],
8	genetic	JJ	O	genetic	xcomp	5	SENT_93	[p7l231t2454r559b2554],
9	.	.	O	.	_	0	SENT_93	[p7l231t2454r559b2554],

1	Whether	IN	O	whether	complm	2	SENT_94	[p7l582t2454r956b2532],
2	intrinsic	JJ	O	intrinsic	ccomp	38	SENT_94	[p7l973t2454r1328b2532],
3	or	CC	O	or	_	0	SENT_94	[p7l1348t2479r1438b2532],
4	acquired	VBN	O	acquire	ccomp	38	SENT_94	[p7l1456t2453r1822b2554],
5	overexpression	NN	O	overexpression	dobj	4	SENT_94	[p7l1844t2479r2147b2533, p7l9t2582r374b2682],
6	of	IN	O	of	_	0	SENT_94	[p7l408t2581r510b2660],
7	multidrug	JJ	O	multidrug	amod	8	SENT_94	[p7l525t2581r956b2682],
8	transporters	NNS	O	transporter	prep_of	5	SENT_94	[p7l987t2598r1505b2682],
9	accounts	NNS	O	account	dep	5	SENT_94	[p7l1541t2598r1915b2661],
10	for	IN	O	for	_	0	SENT_94	[p7l1951t2581r2075b2660],
11	a	DT	O	a	det	13	SENT_94	[p7l2105t2608r2149b2660],
12	few	JJ	O	few	amod	13	SENT_94	[p7l11t2709r163b2789],
13	cases	NNS	O	case	prep_for	9	SENT_94	[p7l183t2736r401b2788],
14	or	CC	O	or	_	0	SENT_94	[p7l428t2735r517b2788],
15	many	JJ	O	many	prep_for	9	SENT_94	[p7l537t2735r773b2810],
16	or	CC	O	or	_	0	SENT_94	[p7l792t2735r881b2788],
17	whether	IN	O	whether	dep	19	SENT_94	[p7l898t2709r1251b2789],
18	it	PRP	O	it	nsubj	19	SENT_94	[p7l1270t2710r1330b2788],
19	has	VBZ	O	have	conj_or	9	SENT_94	[p7l1348t2710r1490b2788],
20	only	RB	O	only	advmod	22	SENT_94	[p7l1517t2709r1699b2810],
21	a	DT	O	a	det	22	SENT_94	[p7l1717t2736r1761b2788],
22	supporting	NN	O	supporting	dobj	19	SENT_94	[p7l1784t2726r2147b2810, p7l10t2838r170b2938],
23	,	,	O	,	_	0	SENT_94	[p7l1784t2726r2147b2810, p7l10t2838r170b2938],
24	perhaps	RB	O	perhaps	advmod	22	SENT_94	[p7l208t2838r548b2938],
25	minor	JJ	O	minor	amod	26	SENT_94	[p7l585t2838r849b2916],
26	role	NN	O	role	dep	22	SENT_94	[p7l880t2838r1065b2933],
27	,	,	O	,	_	0	SENT_94	[p7l880t2838r1065b2933],
28	the	DT	O	the	det	29	SENT_94	[p7l1105t2838r1235b2916],
29	study	NN	O	study	nsubj	38	SENT_94	[p7l1271t2837r1499b2938],
30	of	IN	O	of	_	0	SENT_94	[p7l1529t2837r1630b2916],
31	these	DT	O	these	det	32	SENT_94	[p7l1647t2838r1866b2916],
32	transporters	NNS	O	transporter	prep_of	29	SENT_94	[p7l1901t2854r2147b2916, p7l9t2982r311b3066],
33	is	VBZ	O	be	cop	38	SENT_94	[p7l338t2966r403b3044],
34	a	DT	O	a	det	38	SENT_94	[p7l429t2992r474b3044],
35	fruitful	JJ	O	fruitful	amod	38	SENT_94	[p7l498t2965r795b3045],
36	and	CC	O	and	_	0	SENT_94	[p7l820t2965r976b3044],
37	exciting	JJ	O	exciting	amod	38	SENT_94	[p7l1002t2966r1338b3066],
38	area	NN	O	area	_	0	SENT_94	[p7l1359t2992r1535b3044],
39	of	IN	O	of	_	0	SENT_94	[p7l1559t2965r1660b3044],
40	epilepsy	NN	O	epilepsy	nn	41	SENT_94	[p7l1667t2966r2014b3066],
41	research	NN	O	research	prep_of	38	SENT_94	[p7l2035t2992r2147b3044, p7l12t3094r304b3172],
42	.	.	O	.	_	0	SENT_94	[p7l2035t2992r2147b3044, p7l12t3094r304b3172],

1	Multidrug	JJ	O	multidrug	amod	2	SENT_95	[p7l328t3094r758b3194],
2	transporters	NNS	O	transporter	nsubj	3	SENT_95	[p7l776t3110r1288b3194],
3	exist	VBP	O	exist	_	0	SENT_95	[p7l1312t3094r1506b3172],
4	normally	RB	O	normally	advmod	3	SENT_95	[p7l1522t3094r1901b3194],
5	in	IN	O	in	_	0	SENT_95	[p7l1918t3094r1999b3171],
6	the	DT	O	the	det	7	SENT_95	[p7l2019t3094r2148b3172],
7	brain	NN	O	brain	prep_in	3	SENT_95	[p7l11t3221r255b3317],
8	,	,	O	,	_	0	SENT_95	[p7l11t3221r255b3317],
9	where	WRB	O	where	advmod	13	SENT_95	[p7l282t3222r543b3301],
10	they	PRP	O	they	nsubj	13	SENT_95	[p7l569t3222r747b3322],
11	may	MD	O	may	aux	13	SENT_95	[p7l768t3248r946b3322],
12	be	VB	O	be	cop	13	SENT_95	[p7l968t3222r1063b3300],
13	part	NN	O	part	rcmod	7	SENT_95	[p7l1087t3238r1262b3322],
14	of	IN	O	of	_	0	SENT_95	[p7l1283t3221r1384b3300],
15	the	DT	O	the	det	17	SENT_95	[p7l1391t3222r1521b3300],
16	barrier	NN	O	barrier	nn	17	SENT_95	[p7l1548t3222r1835b3300],
17	system	NN	O	system	prep_of	13	SENT_95	[p7l1859t3238r2148b3322],

1	N	NN	O	n	nn	3	SENT_96	[p7l510t3403r524b3418],
2	ENGLJ	NN	O	englj	nn	3	SENT_96	[p7l539t3403r623b3424],
3	MED	NN	O	med	_	0	SENT_96	[p7l638t3403r691b3418],
4	348	CD	NUMBER	348	dep	3	SENT_96	[p7l703t3397r783b3424],
5	;	:	O	;	_	0	SENT_96	[p7l703t3397r783b3424],
6	15	CD	NUMBER	15	num	8	SENT_96	[p7l703t3397r783b3424],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_96	[p7l818t3403r1029b3424],
8	APRIL	NNP	DATE	APRIL	dep	4	SENT_96	[p7l1066t3403r1138b3418],
9	10	CD	DATE	10	num	8	SENT_96	[p7l1150t3403r1186b3422],
10	,	,	O	,	_	0	SENT_96	[p7l1150t3403r1186b3422],
11	meg	NN	O	meg	appos	8	SENT_96	[p7l1199t3403r1262b3424],
12	1481	CD	DATE	1481	num	11	SENT_96	[p7l1940t3401r2016b3422],

1	The	DT	O	the	det	4	SENT_97	[p7l702t3435r753b3458],
2	New	NNP	O	New	nn	4	SENT_97	[p7l762t3436r824b3458],
3	England	NNP	O	England	nn	4	SENT_97	[p7l833t3435r944b3465],
4	Journal	NNP	O	Journal	_	0	SENT_97	[p7l952t3435r1050b3458],
5	of	IN	O	of	_	0	SENT_97	[p7l1060t3435r1088b3458],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_97	[p7l1095t3435r1220b3458],

1	Downloaded	VBN	O	download	_	0	SENT_98	[p7l144t3475r314b3498],
2	from	IN	O	from	_	0	SENT_98	[p7l323t3475r387b3498],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_98	[p7l396t3475r514b3505],
4	at	IN	O	at	_	0	SENT_98	[p7l524t3479r547b3498],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_98	[p7l556t3475r739b3498],
6	on	IN	O	on	_	0	SENT_98	[p7l748t3482r780b3498],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_98	[p7l789t3475r849b3498],
8	5	CD	DATE	5	num	7	SENT_98	[p7l902t3475r924b3502],
9	,	,	DATE	,	_	0	SENT_98	[p7l902t3475r924b3502],
10	2014	CD	DATE	2014	num	7	SENT_98	[p7l935t3475r1007b3498],
11	.	.	O	.	_	0	SENT_98	[p7l935t3475r1007b3498],

1	For	IN	O	for	_	0	SENT_99	[p7l1018t3475r1064b3498],
2	personal	JJ	O	personal	amod	3	SENT_99	[p7l1072t3475r1184b3505],
3	use	NN	O	use	pobj	1	SENT_99	[p7l1194t3482r1237b3498],
4	only	RB	O	only	advmod	3	SENT_99	[p7l1247t3475r1311b3505],
5	.	.	O	.	_	0	SENT_99	[p7l1247t3475r1311b3505],

1	No	DT	O	no	det	3	SENT_100	[p7l1322t3475r1362b3498],
2	other	JJ	O	other	amod	3	SENT_100	[p7l1372t3475r1440b3498],
3	uses	NNS	O	use	_	0	SENT_100	[p7l1448t3482r1504b3498],
4	witl1out	NN	O	witl1out	nn	5	SENT_100	[p7l1514t3475r1615b3498],
5	permission	NN	O	permission	dep	3	SENT_100	[p7l1624t3475r1776b3505],
6	.	.	O	.	_	0	SENT_100	[p7l1624t3475r1776b3505],

1	Copyright	NN	O	copyright	nn	5	SENT_101	[p7l494t3516r629b3546],
2	©	CD	NUMBER	©	num	5	SENT_101	[p7l638t3516r661b3539],
3	2003	CD	DATE	2003	num	5	SENT_101	[p7l672t3516r735b3539],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_101	[p7l746t3517r844b3539],
5	usetts	NNP	O	usetts	_	0	SENT_101	[p7l863t3520r937b3539],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_101	[p7l947t3516r1055b3539],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_101	[p7l1065t3516r1170b3546],
8	.	.	O	.	_	0	SENT_101	[p7l1065t3516r1170b3546],

1	All	DT	O	all	det	2	SENT_102	[p7l1181t3516r1223b3539],
2	rights	NNS	O	rights	nsubj	3	SENT_102	[p7l1232t3516r1306b3546],
3	reserved	VBN	O	reserve	_	0	SENT_102	[p7l1316t3516r1435b3539],
4	.	.	O	.	_	0	SENT_102	[p7l1316t3516r1435b3539],

1	EDITORIALS	NNS	O	editorial	_	0	SENT_103	[p7l979t3621r1181b3640],

1	that	IN	O	that	dep	2	SENT_104	[p8l11t103r174b180],
2	maintains	VBZ	O	maintain	_	0	SENT_104	[p8l189t103r602b180],
3	a	DT	O	a	det	8	SENT_104	[p8l624t129r668b180],
4	stable	JJ	O	stable	amod	8	SENT_104	[p8l688t103r929b180],
5	and	CC	O	and	_	0	SENT_104	[p8l949t103r1102b180],
6	normal	JJ	O	normal	conj_and	4	SENT_104	[p8l1122t103r1423b180],
7	extracellular	JJ	O	extracellular	amod	8	SENT_104	[p8l1444t102r1951b181],
8	milieu	NN	O	milieu	dobj	2	SENT_104	[p8l1968t103r2109b179, p8l9t229r182b307],
9	.	.	O	.	_	0	SENT_104	[p8l1968t103r2109b179, p8l9t229r182b307],

1	The	DT	O	the	det	2	SENT_105	[p8l208t228r367b306],
2	recognition	NN	O	recognition	nsubj	12	SENT_105	[p8l392t229r874b327],
3	that	IN	O	that	complm	6	SENT_105	[p8l899t229r1064b305],
4	they	PRP	O	they	nsubjpass	6	SENT_105	[p8l1084t228r1259b327],
5	are	VBP	O	be	auxpass	6	SENT_105	[p8l1278t254r1402b306],
6	increased	VBN	O	increase	dep	2	SENT_105	[p8l1427t228r1823b306],
7	in	IN	O	in	_	0	SENT_105	[p8l1847t229r1928b304],
8	epi	FW	O	epi	nn	9	SENT_105	[p8l1953t229r2108b327],
9	—	FW	O	—	prep_in	6	SENT_105	[p8l1953t229r2108b327],
10	leptogenic	JJ	O	leptogenic	amod	11	SENT_105	[p8l9t355r456b453],
11	areas	NNS	O	area	dep	9	SENT_105	[p8l484t380r701b432],
12	opens	VBZ	O	open	_	0	SENT_105	[p8l732t379r984b453],
13	potential	JJ	O	potential	amod	15	SENT_105	[p8l1013t355r1393b453],
14	new	JJ	O	new	amod	15	SENT_105	[p8l1422t380r1598b433],
15	avenues	NNS	O	avenue	dobj	12	SENT_105	[p8l1622t380r1957b433],
16	for	IN	O	for	_	0	SENT_105	[p8l1987t354r2111b432],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_105	[p8l11t480r491b579],
18	intervention	NN	O	intervention	prep_for	15	SENT_105	[p8l518t481r1048b574],
19	,	,	O	,	_	0	SENT_105	[p8l518t481r1048b574],
20	such	JJ	O	such	_	0	SENT_105	[p8l1083t481r1275b559],
21	as	IN	O	as	_	0	SENT_105	[p8l1302t506r1385b557],
22	the	DT	O	the	det	23	SENT_105	[p8l1415t481r1542b558],
23	development	NN	O	development	prep_such_as	15	SENT_105	[p8l1571t480r2115b579],
24	of	IN	O	of	_	0	SENT_105	[p8l11t606r110b684],
25	drugs	NNS	O	drug	prep_of	23	SENT_105	[p8l113t607r348b705],
26	that	WDT	O	that	nsubj	27	SENT_105	[p8l371t607r536b683],
27	inhibit	VBP	O	inhibit	rcmod	25	SENT_105	[p8l551t606r834b684],
28	or	CC	O	or	_	0	SENT_105	[p8l850t631r938b684],
29	bypass	VBP	O	bypass	rcmod	25	SENT_105	[p8l957t607r1234b705],
30	overexpressed	JJ	O	overexpressed	amod	33	SENT_105	[p8l1258t607r1846b705],
31	trans	JJ	O	trans	amod	33	SENT_105	[p8l1867t623r2108b683],
32	—	NN	O	—	nn	33	SENT_105	[p8l1867t623r2108b683],
33	porters	NNS	O	porter	dobj	27	SENT_105	[p8l8t749r312b831],
34	and	CC	O	and	_	0	SENT_105	[p8l352t732r508b810],
35	implantable	JJ	O	implantable	amod	36	SENT_105	[p8l545t733r1059b831],
36	devices	NNS	O	device	prep_of	23	SENT_105	[p8l1099t733r1401b811],
37	that	WDT	O	that	nsubj	39	SENT_105	[p8l1442t733r1610b809],
38	can	MD	O	can	aux	39	SENT_105	[p8l1644t757r1788b809],
39	deliver	VB	O	deliver	rcmod	36	SENT_105	[p8l1828t732r2111b811],
40	high	JJ	O	high	amod	41	SENT_105	[p8l10t858r203b957],
41	concentrations	NNS	O	concentration	dobj	39	SENT_105	[p8l237t859r871b936],
42	of	IN	O	of	_	0	SENT_105	[p8l907t858r1007b936],
43	antiseizure	JJ	O	antiseizure	amod	44	SENT_105	[p8l1021t859r1489b937],
44	drugs	NNS	O	drug	prep_of	41	SENT_105	[p8l1523t858r1762b957],
45	directly	RB	O	directly	advmod	39	SENT_105	[p8l1797t858r2113b957],
46	into	IN	O	into	_	0	SENT_105	[p8l9t985r176b1062],
47	epileptogenic	JJ	O	epileptogenic	amod	49	SENT_105	[p8l203t984r767b1083],
48	brain	NN	O	brain	nn	49	SENT_105	[p8l791t985r1008b1062],
49	parenchyma	NN	O	parenchyma	prep_into	39	SENT_105	[p8l1029t985r1566b1083],
50	.	.	O	.	_	0	SENT_105	[p8l1029t985r1566b1083],

1	The	DT	O	the	det	2	SENT_106	[p8l1592t985r1751b1062],
2	study	NN	O	study	nsubj	9	SENT_106	[p8l1776t984r1999b1083],
3	by	IN	O	by	_	0	SENT_106	[p8l2018t985r2114b1083],
4	Siddiqui	NNP	PERSON	Siddiqui	prep_by	2	SENT_106	[p8l12t1110r358b1209],
5	et	FW	O	et	nn	6	SENT_106	[p8l394t1127r470b1188],
6	al.	FW	O	al.	dep	4	SENT_106	[p8l499t1111r592b1188],
7	is	VBZ	O	be	cop	9	SENT_106	[p8l633t1111r697b1187],
8	also	RB	O	also	advmod	9	SENT_106	[p8l734t1110r899b1188],
9	important	JJ	O	important	_	0	SENT_106	[p8l935t1111r1364b1209],
10	in	IN	O	in	_	0	SENT_106	[p8l1393t1111r1473b1186],
11	that	IN	O	that	complm	13	SENT_106	[p8l1509t1111r1674b1187],
12	it	PRP	O	it	nsubj	13	SENT_106	[p8l1703t1111r1763b1187],
13	offers	VBZ	O	offer	prepc_in	9	SENT_106	[p8l1793t1110r2031b1188],
14	a	DT	O	a	det	15	SENT_106	[p8l2067t1136r2111b1187],
15	glimpse	NN	O	glimpse	nsubj	29	SENT_106	[p8l9t1237r344b1335],
16	of	IN	O	of	_	0	SENT_106	[p8l376t1236r475b1314],
17	the	DT	O	the	det	18	SENT_106	[p8l490t1236r617b1314],
18	power	NN	O	power	prep_of	15	SENT_106	[p8l648t1261r911b1335],
19	of	IN	O	of	_	0	SENT_106	[p8l941t1236r1040b1314],
20	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	18	SENT_106	[p8l1052t1236r1884b1335],
21	both	CC	O	both	preconj	23	SENT_106	[p8l1919t1237r2110b1314],
22	to	TO	O	to	aux	23	SENT_106	[p8l11t1379r89b1440],
23	help	VB	O	help	ccomp	13	SENT_106	[p8l110t1363r290b1461],
24	characterize	VB	O	characterize	xcomp	23	SENT_106	[p8l313t1363r816b1440],
25	pathologic	JJ	O	pathologic	amod	26	SENT_106	[p8l836t1362r1283b1461],
26	mechanisms	NNS	O	mechanism	dobj	24	SENT_106	[p8l1304t1363r1833b1440],
27	and	CC	O	and	_	0	SENT_106	[p8l1855t1363r2009b1440],
28	to	TO	O	to	aux	29	SENT_106	[p8l2030t1379r2108b1440],
29	identify	VB	O	identify	conj_and	23	SENT_106	[p8l9t1488r327b1587],
30	potential	JJ	O	potential	amod	32	SENT_106	[p8l346t1489r718b1587],
31	therapeutic	JJ	O	therapeutic	amod	32	SENT_106	[p8l743t1489r1212b1587],
32	strategies	NNS	O	strategy	dobj	29	SENT_106	[p8l1238t1489r1657b1587],
33	.	.	O	.	_	0	SENT_106	[p8l1238t1489r1657b1587],

1	From	IN	O	from	dep	12	SENT_107	[p8l15t1747r169b1802],
2	the	DT	O	the	det	6	SENT_107	[p8l189t1742r288b1802],
3	Department	NNP	O	Department	nn	6	SENT_107	[p8l312t1747r688b1820],
4	ofNeuro	NN	O	ofneuro	nn	6	SENT_107	[p8l705t1741r1115b1821],
5	|	NN	O	|	nn	6	SENT_107	[p8l705t1741r1115b1821],
6	ogy	NN	O	ogy	pobj	1	SENT_107	[p8l705t1741r1115b1821],
7	,	,	O	,	_	0	SENT_107	[p8l705t1741r1115b1821],
8	Columbia	NNP	ORGANIZATION	Columbia	nn	9	SENT_107	[p8l1138t1742r1438b1802],
9	University	NNP	ORGANIZATION	University	appos	6	SENT_107	[p8l1461t1747r1777b1821],
10	,	,	O	,	_	0	SENT_107	[p8l1461t1747r1777b1821],
11	New	NNP	LOCATION	New	nn	12	SENT_107	[p8l1804t1747r1943b1802],
12	York	NNP	LOCATION	York	_	0	SENT_107	[p8l1958t1742r2107b1802],
13	.	.	O	.	_	0	SENT_107	[p8l1958t1742r2107b1802],

1	1	LS	NUMBER	1	_	0	SENT_108	[p8l12t1909r59b1961],
2	.	.	O	.	_	0	SENT_108	[p8l12t1909r59b1961],

1	Perucca	NNP	PERSON	Perucca	nn	3	SENT_109	[p8l136t1907r378b1961],
2	E.	NNP	PERSON	E.	nn	3	SENT_109	[p8l407t1907r465b1961],
3	Pharmacoresistance	NNP	PERSON	Pharmacoresistance	_	0	SENT_109	[p8l499t1902r1131b1961],
4	in	IN	O	in	dep	3	SENT_109	[p8l1161t1903r1222b1960],
5	epilepsy	NNP	O	epilepsy	pobj	4	SENT_109	[p8l1253t1902r1524b1976],
6	:	:	O	:	_	0	SENT_109	[p8l1253t1902r1524b1976],
7	how	WRB	O	how	advmod	11	SENT_109	[p8l1558t1902r1694b1961],
8	should	MD	O	should	aux	11	SENT_109	[p8l1724t1902r1937b1961],
9	it	PRP	O	it	nsubjpass	11	SENT_109	[p8l1967t1903r2012b1960],
10	be	VB	O	be	auxpass	11	SENT_109	[p8l2039t1902r2110b1961],
11	deﬁned	VBN	O	deﬁned	dep	5	SENT_109	[p8l9t1995r272b2055],
12	?	.	O	?	_	0	SENT_109	[p8l9t1995r272b2055],

1	CNS	NNS	O	cn	nn	2	SENT_110	[p8l291t2001r429b2056],
2	Drugs	NNS	O	drug	_	0	SENT_110	[p8l448t2001r638b2072],
3	1998	CD	DATE	1998	dep	2	SENT_110	[p8l661t2001r1134b2068],
4	;	:	O	;	_	0	SENT_110	[p8l661t2001r1134b2068],
5	10:171	CD	NUMBER	10:171	number	6	SENT_110	[p8l661t2001r1134b2068],
6	—	CD	NUMBER	—	dep	2	SENT_110	[p8l661t2001r1134b2068],
7	9	CD	NUMBER	9	dep	6	SENT_110	[p8l661t2001r1134b2068],
8	.	.	O	.	_	0	SENT_110	[p8l661t2001r1134b2068],

1	2	LS	NUMBER	2	_	0	SENT_111	[p8l8t2099r59b2150],
2	.	.	O	.	_	0	SENT_111	[p8l8t2099r59b2150],

1	Berg	NNP	PERSON	Berg	nn	2	SENT_112	[p8l136t2096r283b2166],
2	AT	NNP	O	AT	_	0	SENT_112	[p8l302t2096r401b2162],
3	,	,	O	,	_	0	SENT_112	[p8l302t2096r401b2162],
4	Langﬁtt	NNP	PERSON	Langﬁtt	nn	5	SENT_112	[p8l430t2091r679b2166],
5	J	NNP	PERSON	J	appos	2	SENT_112	[p8l693t2097r737b2162],
6	,	,	O	,	_	0	SENT_112	[p8l693t2097r737b2162],
7	Shinnar	NNP	O	Shinnar	nn	8	SENT_112	[p8l767t2091r1014b2150],
8	S	NNP	O	S	appos	2	SENT_112	[p8l1038t2096r1089b2162],
9	,	,	O	,	_	0	SENT_112	[p8l1038t2096r1089b2162],
10	et	FW	O	et	nn	11	SENT_112	[p8l1119t2103r1175b2149],
11	al.	FW	O	al.	appos	2	SENT_112	[p8l1196t2091r1266b2150],
12	.	.	O	.	_	0	SENT_112	[p8l1196t2091r1266b2150],

1	How	WRB	O	how	advmod	2	SENT_113	[p8l1294t2097r1446b2150],
2	long	RB	O	long	dep	5	SENT_113	[p8l1467t2091r1611b2166],
3	does	VBZ	O	do	aux	5	SENT_113	[p8l1634t2091r1776b2150],
4	it	PRP	O	it	nsubj	5	SENT_113	[p8l1801t2092r1846b2149],
5	take	VB	O	take	_	0	SENT_113	[p8l1867t2091r1995b2150],
6	for	IN	O	for	_	0	SENT_113	[p8l2020t2091r2112b2150],
7	partial	JJ	O	partial	amod	8	SENT_113	[p8l8t2186r210b2261],
8	epilepsy	NN	O	epilepsy	prep_for	5	SENT_113	[p8l228t2186r484b2261],
9	to	TO	O	to	aux	11	SENT_113	[p8l499t2198r558b2244],
10	become	VB	O	become	cop	11	SENT_113	[p8l578t2186r821b2244],
11	intractable	JJ	O	intractable	xcomp	5	SENT_113	[p8l839t2184r1202b2244],
12	?	.	O	?	_	0	SENT_113	[p8l839t2184r1202b2244],

1	Neurology	NNP	O	Neurology	_	0	SENT_114	[p8l1219t2186r1553b2261],
2	2003	CD	DATE	2003	num	1	SENT_114	[p8l1569t2190r2083b2257],
3	;	:	O	;	_	0	SENT_114	[p8l1569t2190r2083b2257],
4	60:186	CD	NUMBER	60:186	number	5	SENT_114	[p8l1569t2190r2083b2257],
5	—	CD	NUMBER	—	dep	1	SENT_114	[p8l1569t2190r2083b2257],
6	90	CD	NUMBER	90	dep	5	SENT_114	[p8l1569t2190r2083b2257],
7	.	.	O	.	_	0	SENT_114	[p8l1569t2190r2083b2257],

1	3	LS	NUMBER	3	_	0	SENT_115	[p8l9t2287r59b2338],
2	.	.	O	.	_	0	SENT_115	[p8l9t2287r59b2338],

1	Sander	FW	O	sander	nn	2	SENT_116	[p8l138t2280r358b2339],
2	JWAS	FW	O	jwas	_	0	SENT_116	[p8l383t2285r581b2348],
3	.	.	O	.	_	0	SENT_116	[p8l383t2285r581b2348],

1	Some	DT	O	some	det	2	SENT_117	[p8l620t2285r795b2339],
2	aspects	NNS	O	aspect	_	0	SENT_117	[p8l829t2293r1060b2354],
3	of	IN	O	of	_	0	SENT_117	[p8l1096t2280r1171b2339],
4	prognosis	NN	O	prognosis	prep_of	2	SENT_117	[p8l1190t2281r1511b2355],
5	in	IN	O	in	_	0	SENT_117	[p8l1546t2281r1607b2337],
6	the	DT	O	the	det	7	SENT_117	[p8l1641t2280r1738b2338],
7	epilepsies	NNS	O	epilepsy	prep_in	4	SENT_117	[p8l1773t2280r2107b2354],
8	:	:	O	:	_	0	SENT_117	[p8l1773t2280r2107b2354],
9	a	DT	O	a	det	10	SENT_117	[p8l8t2395r42b2433],
10	review	NN	O	review	dep	2	SENT_117	[p8l68t2376r283b2434],
11	.	.	O	.	_	0	SENT_117	[p8l68t2376r283b2434],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_118	[p8l305t2376r594b2450],
2	1993	CD	DATE	1993	num	1	SENT_118	[p8l613t2380r1165b2446],
3	;	:	O	;	_	0	SENT_118	[p8l613t2380r1165b2446],
4	34:1007	CD	NUMBER	34:1007	number	5	SENT_118	[p8l613t2380r1165b2446],
5	—	CD	NUMBER	—	dep	1	SENT_118	[p8l613t2380r1165b2446],
6	16	CD	NUMBER	16	dep	5	SENT_118	[p8l613t2380r1165b2446],
7	.	.	O	.	_	0	SENT_118	[p8l613t2380r1165b2446],

1	4	LS	NUMBER	4	_	0	SENT_119	[p8l7t2478r59b2529],
2	.	.	O	.	_	0	SENT_119	[p8l7t2478r59b2529],

1	Mattson	NNP	PERSON	Mattson	nn	2	SENT_120	[p8l134t2475r394b2529],
2	RH	NNP	O	RH	_	0	SENT_120	[p8l414t2475r535b2541],
3	,	,	O	,	_	0	SENT_120	[p8l414t2475r535b2541],
4	Cramer	NNP	PERSON	Cramer	nn	5	SENT_120	[p8l559t2475r795b2529],
5	JA	NNP	O	JA	appos	2	SENT_120	[p8l806t2475r897b2541],
6	,	,	O	,	_	0	SENT_120	[p8l806t2475r897b2541],
7	Collins	NNP	ORGANIZATION	Collins	nn	8	SENT_120	[p8l921t2470r1142b2529],
8	JF	NNP	ORGANIZATION	JF	appos	2	SENT_120	[p8l1157t2475r1231b2541],
9	,	,	O	,	_	0	SENT_120	[p8l1157t2475r1231b2541],
10	et	FW	O	et	nn	11	SENT_120	[p8l1256t2483r1313b2529],
11	al.	FW	O	al.	appos	2	SENT_120	[p8l1329t2470r1400b2529],
12	.	.	O	.	_	0	SENT_120	[p8l1329t2470r1400b2529],

1	Comparison	NN	O	comparison	nsubj	15	SENT_121	[p8l1424t2471r1814b2544],
2	of	IN	O	of	_	0	SENT_121	[p8l1835t2470r1910b2529],
3	carbamazepine	NN	O	carbamazepine	prep_of	1	SENT_121	[p8l1917t2470r2109b2529, p8l9t2565r331b2639],
4	,	,	O	,	_	0	SENT_121	[p8l1917t2470r2109b2529, p8l9t2565r331b2639],
5	phenobarbital	NN	O	phenobarbital	conj_and	3	SENT_121	[p8l356t2564r818b2639],
6	,	,	O	,	_	0	SENT_121	[p8l356t2564r818b2639],
7	phenytoin	NN	O	phenytoin	conj_and	3	SENT_121	[p8l843t2564r1177b2639],
8	,	,	O	,	_	0	SENT_121	[p8l843t2564r1177b2639],
9	and	CC	O	and	_	0	SENT_121	[p8l1203t2565r1319b2623],
10	primidone	NN	O	primidone	conj_and	3	SENT_121	[p8l1339t2564r1670b2639],
11	in	IN	O	in	dep	3	SENT_121	[p8l1691t2565r1752b2621],
12	partial	JJ	O	partial	pobj	11	SENT_121	[p8l1773t2564r1974b2639],
13	and	CC	O	and	_	0	SENT_121	[p8l1995t2564r2111b2623],
14	secondarily	RB	O	secondarily	conj_and	11	SENT_121	[p8l10t2658r368b2733],
15	generalized	VBN	O	generalize	_	0	SENT_121	[p8l389t2658r752b2733],
16	tonic	JJ	O	tonic	amod	19	SENT_121	[p8l776t2659r1163b2717],
17	—	NN	O	—	nn	19	SENT_121	[p8l776t2659r1163b2717],
18	clonic	JJ	O	clonic	amod	19	SENT_121	[p8l776t2659r1163b2717],
19	seizures	NNS	O	seizure	dobj	15	SENT_121	[p8l1188t2659r1458b2717],
20	.	.	O	.	_	0	SENT_121	[p8l1188t2659r1458b2717],

1	N	NN	O	n	nn	2	SENT_122	[p8l1485t2664r1541b2717],
2	EnglJ	NN	O	englj	nsubj	3	SENT_122	[p8l1564t2659r1752b2733],
3	Med	VBD	O	med	_	0	SENT_122	[p8l1773t2659r1912b2717],
4	1985	CD	DATE	1985	dobj	3	SENT_122	[p8l1939t2663r2108b2728],
5	;	:	O	;	_	0	SENT_122	[p8l1939t2663r2108b2728],
6	313:145	CD	NUMBER	313:145	number	7	SENT_122	[p8l10t2758r384b2812],
7	—	CD	NUMBER	—	dep	4	SENT_122	[p8l10t2758r384b2812],
8	51	CD	NUMBER	51	dep	7	SENT_122	[p8l10t2758r384b2812],
9	.	.	O	.	_	0	SENT_122	[p8l10t2758r384b2812],

1	5	CD	NUMBER	5	_	0	SENT_123	[p8l10t2856r59b2907],
2	.	.	O	.	_	0	SENT_123	[p8l10t2856r59b2907],

1	Morrell	NNP	PERSON	Morrell	nn	3	SENT_124	[p8l134t2848r369b2907],
2	M	NNP	O	M	nn	3	SENT_124	[p8l383t2853r486b2919],
3	]	NN	O	]	_	0	SENT_124	[p8l383t2853r486b2919],
4	,	,	O	,	_	0	SENT_124	[p8l383t2853r486b2919],
5	Pedley	NNP	PERSON	Pedley	nn	6	SENT_124	[p8l506t2848r708b2922],
6	TA	NNP	O	TA	appos	3	SENT_124	[p8l719t2853r823b2907],
7	.	.	O	.	_	0	SENT_124	[p8l719t2853r823b2907],

1	“	NN	O	“	_	0	SENT_125	[p8l847t2848r997b2907],
2	The	DT	O	the	det	5	SENT_125	[p8l847t2848r997b2907],
3	Scarlet	JJ	O	scarlet	amod	5	SENT_125	[p8l1015t2848r1226b2907],
4	E	NN	O	e	nn	5	SENT_125	[p8l1239t2853r1332b2907],
5	”	NN	O	”	dep	1	SENT_125	[p8l1239t2853r1332b2907],
6	:	:	O	:	_	0	SENT_125	[p8l1239t2853r1332b2907],
7	epilepsy	NN	O	epilepsy	dep	1	SENT_125	[p8l1352t2848r1608b2922],
8	is	VBZ	O	be	cop	11	SENT_125	[p8l1621t2849r1669b2906],
9	still	RB	O	still	advmod	11	SENT_125	[p8l1689t2848r1801b2907],
10	a	DT	O	a	det	11	SENT_125	[p8l1817t2868r1850b2906],
11	burden	NN	O	burden	rcmod	7	SENT_125	[p8l1866t2848r2106b2907],
12	.	.	O	.	_	0	SENT_125	[p8l1866t2848r2106b2907],

1	Neurology	NNP	O	Neurology	_	0	SENT_126	[p8l7t2942r341b3017],
2	2000	CD	DATE	2000	num	1	SENT_126	[p8l356t2947r871b3013],
3	;	:	O	;	_	0	SENT_126	[p8l356t2947r871b3013],
4	54:1882	CD	NUMBER	54:1882	number	5	SENT_126	[p8l356t2947r871b3013],
5	—	CD	NUMBER	—	dep	1	SENT_126	[p8l356t2947r871b3013],
6	3	CD	NUMBER	3	dep	5	SENT_126	[p8l356t2947r871b3013],
7	.	.	O	.	_	0	SENT_126	[p8l356t2947r871b3013],

1	6	CD	NUMBER	6	_	0	SENT_127	[p8l9t3043r59b3095],
2	.	.	O	.	_	0	SENT_127	[p8l9t3043r59b3095],

1	MacDonald	NNP	ORGANIZATION	MacDonald	nn	2	SENT_128	[p8l134t3036r499b3095],
2	BK	NNP	ORGANIZATION	BK	_	0	SENT_128	[p8l533t3041r643b3107],
3	,	,	O	,	_	0	SENT_128	[p8l533t3041r643b3107],
4	Johnson	NNP	PERSON	Johnson	nn	5	SENT_128	[p8l675t3036r942b3104],
5	AL	NNP	PERSON	AL	appos	2	SENT_128	[p8l974t3041r1077b3107],
6	,	,	O	,	_	0	SENT_128	[p8l974t3041r1077b3107],
7	Goodridge	NNP	ORGANIZATION	Goodridge	nn	8	SENT_128	[p8l1116t3036r1454b3111],
8	DM	NN	ORGANIZATION	dm	appos	5	SENT_128	[p8l1488t3041r1621b3107],
9	,	,	O	,	_	0	SENT_128	[p8l1488t3041r1621b3107],
10	Cockerell	NNP	ORGANIZATION	Cockerell	nn	11	SENT_128	[p8l1660t3036r1956b3095],
11	OC	NNP	ORGANIZATION	OC	appos	5	SENT_128	[p8l1990t3041r2107b3107],
12	,	,	O	,	_	0	SENT_128	[p8l1990t3041r2107b3107],
13	Sander	NNP	PERSON	Sander	nn	14	SENT_128	[p8l11t3130r227b3189],
14	JW	NNP	PERSON	JW	appos	5	SENT_128	[p8l247t3136r352b3201],
15	,	,	O	,	_	0	SENT_128	[p8l247t3136r352b3201],
16	Shorvon	NNP	O	Shorvon	nn	17	SENT_128	[p8l387t3131r646b3189],
17	SD	NN	O	sd	appos	5	SENT_128	[p8l678t3135r780b3189],
18	.	.	O	.	_	0	SENT_128	[p8l678t3135r780b3189],

1	Factors	NNS	O	factor	_	0	SENT_129	[p8l813t3136r1040b3189],
2	predicting	VBG	O	predict	partmod	1	SENT_129	[p8l1070t3130r1395b3205],
3	prognosis	NN	O	prognosis	dobj	2	SENT_129	[p8l1421t3131r1735b3205],
4	of	IN	O	of	_	0	SENT_129	[p8l1767t3130r1842b3189],
5	epilepsy	NN	O	epilepsy	prep_of	3	SENT_129	[p8l1858t3131r2114b3205],
6	after	IN	O	after	_	0	SENT_129	[p8l8t3224r152b3283],
7	presentation	NN	O	presentation	prep_after	2	SENT_129	[p8l197t3225r594b3299],
8	with	IN	O	with	_	0	SENT_129	[p8l638t3225r779b3283],
9	seizures	NNS	O	seizure	prep_with	7	SENT_129	[p8l828t3225r1097b3283],
10	.	.	O	.	_	0	SENT_129	[p8l828t3225r1097b3283],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_130	[p8l1147t3230r1280b3281],
2	N	NNP	O	N	nn	3	SENT_130	[p8l1325t3230r1381b3283],
3	eurol	NN	O	eurol	_	0	SENT_130	[p8l1384t3224r1544b3283],
4	2000	CD	DATE	2000	num	3	SENT_130	[p8l1592t3229r2106b3295],
5	;	:	O	;	_	0	SENT_130	[p8l1592t3229r2106b3295],
6	48:833	CD	NUMBER	48:833	number	7	SENT_130	[p8l1592t3229r2106b3295],
7	—	CD	NUMBER	—	dep	3	SENT_130	[p8l1592t3229r2106b3295],
8	41	CD	NUMBER	41	dep	7	SENT_130	[p8l1592t3229r2106b3295],
9	.	.	O	.	_	0	SENT_130	[p8l1592t3229r2106b3295],

1	[	NN	O	[	_	0	SENT_131	[p8l16t3323r243b3389],
2	Errata	NNP	O	Errata	nn	4	SENT_131	[p8l16t3323r243b3389],
3	,	,	O	,	_	0	SENT_131	[p8l16t3323r243b3389],
4	Ann	NNP	PERSON	Ann	dep	1	SENT_131	[p8l263t3324r396b3375],
5	N	NNP	O	N	rcmod	4	SENT_131	[p8l412t3324r468b3377],
6	eurol	NN	O	eurol	dep	5	SENT_131	[p8l471t3318r631b3377],
7	2001	CD	DATE	2001	num	9	SENT_131	[p8l649t3323r1059b3389],
8	;	:	O	;	_	0	SENT_131	[p8l649t3323r1059b3389],
9	49:547	CD	NUMBER	49:547	dep	6	SENT_131	[p8l649t3323r1059b3389],
10	,	,	O	,	_	0	SENT_131	[p8l649t3323r1059b3389],
11	50:830	CD	NUMBER	50:830	appos	6	SENT_131	[p8l1084t3323r1340b3385],
12	.	.	O	.	_	0	SENT_131	[p8l1084t3323r1340b3385],
13	]	SYM	O	]	dep	5	SENT_131	[p8l1084t3323r1340b3385],

1	7	CD	NUMBER	7	_	0	SENT_132	[p8l11t3420r59b3471],
2	.	.	O	.	_	0	SENT_132	[p8l11t3420r59b3471],

1	Borst	NNP	PERSON	Borst	nn	2	SENT_133	[p8l136t3417r306b3471],
2	P	NN	PERSON	p	_	0	SENT_133	[p8l326t3417r373b3483],
3	,	,	O	,	_	0	SENT_133	[p8l326t3417r373b3483],
4	Evers	NNP	PERSON	Evers	nn	5	SENT_133	[p8l402t3418r566b3471],
5	R	NNP	PERSON	R	appos	2	SENT_133	[p8l592t3417r656b3483],
6	,	,	O	,	_	0	SENT_133	[p8l592t3417r656b3483],
7	Kool	NNP	LOCATION	Kool	nn	8	SENT_133	[p8l684t3412r833b3472],
8	M	NNP	LOCATION	M	appos	2	SENT_133	[p8l856t3417r937b3483],
9	,	,	O	,	_	0	SENT_133	[p8l856t3417r937b3483],
10	Wijnholds	NNP	O	Wijnholds	nn	13	SENT_133	[p8l964t3412r1290b3486],
11	J.	NNP	O	J.	nn	13	SENT_133	[p8l1309t3418r1352b3480],
12	A	NNP	O	A	nn	13	SENT_133	[p8l1379t3417r1428b3469],
13	family	NN	O	family	appos	2	SENT_133	[p8l1451t3412r1648b3486],
14	of	IN	O	of	_	0	SENT_133	[p8l1671t3412r1745b3471],
15	drug	NN	O	drug	nn	16	SENT_133	[p8l1758t3412r1906b3487],
16	transporters	NNS	O	transporter	prep_of	13	SENT_133	[p8l1929t3425r2110b3470, p8l8t3519r251b3581],
17	:	:	O	:	_	0	SENT_133	[p8l1929t3425r2110b3470, p8l8t3519r251b3581],
18	the	DT	O	the	det	21	SENT_133	[p8l273t3506r369b3565],
19	multidrug	JJ	O	multidrug	amod	21	SENT_133	[p8l387t3506r706b3581],
20	resistance	NN	O	resistance	nn	21	SENT_133	[p8l722t3506r1388b3565],
21	—	NN	O	—	dep	2	SENT_133	[p8l722t3506r1388b3565],
22	associated	VBN	O	associate	partmod	21	SENT_133	[p8l722t3506r1388b3565],
23	proteins	NNS	O	protein	dobj	22	SENT_133	[p8l1405t3507r1683b3581],
24	.	.	O	.	_	0	SENT_133	[p8l1405t3507r1683b3581],

1	J	NNP	O	J	nn	4	SENT_134	[p8l1698t3512r1726b3574],
2	Natl	NNP	O	Natl	nn	4	SENT_134	[p8l1741t3507r1875b3565],
3	Cancer	NNP	O	Cancer	nn	4	SENT_134	[p8l1893t3511r2112b3565],
4	Inst	NNP	O	Inst	_	0	SENT_134	[p8l8t3606r132b3658],
5	2000	CD	DATE	2000	num	4	SENT_134	[p8l146t3605r740b3671],
6	;	:	O	;	_	0	SENT_134	[p8l146t3605r740b3671],
7	92:1295	CD	NUMBER	92:1295	num	8	SENT_134	[p8l146t3605r740b3671],
8	—	NN	O	—	dep	4	SENT_134	[p8l146t3605r740b3671],
9	302	CD	NUMBER	302	dep	8	SENT_134	[p8l146t3605r740b3671],
10	.	.	O	.	_	0	SENT_134	[p8l146t3605r740b3671],

1	8	CD	NUMBER	8	_	0	SENT_135	[p8l8t3700r59b3753],
2	.	.	O	.	_	0	SENT_135	[p8l8t3700r59b3753],

1	Tishler	NNP	PERSON	Tishler	nn	2	SENT_136	[p8l134t3694r358b3752],
2	DM	NN	O	dm	_	0	SENT_136	[p8l378t3699r511b3765],
3	,	,	O	,	_	0	SENT_136	[p8l378t3699r511b3765],
4	Weinberg	NNP	PERSON	Weinberg	nn	5	SENT_136	[p8l536t3694r844b3769],
5	KI	NNP	PERSON	KI	dep	2	SENT_136	[p8l864t3700r953b3765],
6	,	,	O	,	_	0	SENT_136	[p8l864t3700r953b3765],
7	Hinton	NNP	PERSON	Hinton	nn	8	SENT_136	[p8l980t3695r1204b3753],
8	DR	NN	O	dr	appos	5	SENT_136	[p8l1226t3699r1343b3765],
9	,	,	O	,	_	0	SENT_136	[p8l1226t3699r1343b3765],
10	Barbaro	NNP	ORGANIZATION	Barbaro	nn	11	SENT_136	[p8l1370t3694r1619b3753],
11	N	NNP	ORGANIZATION	N	appos	5	SENT_136	[p8l1641t3699r1710b3765],
12	,	,	O	,	_	0	SENT_136	[p8l1641t3699r1710b3765],
13	Annett	NNP	ORGANIZATION	Annett	nn	14	SENT_136	[p8l1735t3700r1952b3752],
14	GM	NNP	ORGANIZATION	GM	appos	5	SENT_136	[p8l1971t3699r2106b3765],
15	,	,	O	,	_	0	SENT_136	[p8l1971t3699r2106b3765],

1	Raffel	NNP	PERSON	Raffel	nn	2	SENT_137	[p9l60t358r243b419],
2	C.	NNP	O	C.	_	0	SENT_137	[p9l262t363r324b416],
3	MDR1	NN	O	mdr1	nn	5	SENT_137	[p9l345t363r547b419],
4	gene	NN	O	gene	nn	5	SENT_137	[p9l567t377r713b432],
5	expression	NN	O	expression	dep	2	SENT_137	[p9l733t359r1066b431],
6	in	IN	O	in	_	0	SENT_137	[p9l1085t359r1144b415],
7	brain	NN	O	brain	prep_in	5	SENT_137	[p9l1164t358r1326b416],
8	of	IN	O	of	_	0	SENT_137	[p9l1346t358r1419b416],
9	patients	NNS	O	patient	prep_of	7	SENT_137	[p9l1424t359r1670b431],
10	with	IN	O	with	_	0	SENT_137	[p9l1687t358r1826b416],
11	medically	RB	O	medically	advmod	12	SENT_137	[p9l1846t358r2144b431],
12	intractable	JJ	O	intractable	amod	13	SENT_137	[p9l60t451r392b509],
13	epilepsy	NN	O	epilepsy	prep_with	9	SENT_137	[p9l411t451r672b525],
14	.	.	O	.	_	0	SENT_137	[p9l411t451r672b525],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_138	[p9l693t451r978b525],
2	1995	CD	DATE	1995	num	1	SENT_138	[p9l997t456r1387b520],
3	;	:	O	;	_	0	SENT_138	[p9l997t456r1387b520],
4	36:1	CD	NUMBER	36:1	number	5	SENT_138	[p9l997t456r1387b520],
5	—	CD	NUMBER	—	dep	1	SENT_138	[p9l997t456r1387b520],
6	6	CD	NUMBER	6	dep	5	SENT_138	[p9l997t456r1387b520],
7	.	.	O	.	_	0	SENT_138	[p9l997t456r1387b520],

1	9	CD	NUMBER	9	_	0	SENT_139	[p9l61t551r111b602],
2	.	.	O	.	_	0	SENT_139	[p9l61t551r111b602],

1	Sisodiya	NNP	O	Sisodiya	nn	2	SENT_140	[p9l189t544r443b617],
2	SM	NNP	O	SM	_	0	SENT_140	[p9l466t549r580b614],
3	,	,	O	,	_	0	SENT_140	[p9l466t549r580b614],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_140	[p9l607t545r706b601],
5	WR	NNP	O	WR	appos	2	SENT_140	[p9l726t549r860b614],
6	,	,	O	,	_	0	SENT_140	[p9l726t549r860b614],
7	Harding	NNP	PERSON	Harding	nn	8	SENT_140	[p9l887t544r1148b618],
8	BN	NNP	O	BN	appos	2	SENT_140	[p9l1168t549r1280b614],
9	,	,	O	,	_	0	SENT_140	[p9l1168t549r1280b614],
10	Squier	NNP	ORGANIZATION	Squier	nn	11	SENT_140	[p9l1309t545r1506b617],
11	MV	NNP	ORGANIZATION	MV	appos	2	SENT_140	[p9l1526t549r1641b614],
12	,	,	O	,	_	0	SENT_140	[p9l1526t549r1641b614],
13	Thom	NNP	PERSON	Thom	nn	16	SENT_140	[p9l1665t544r1854b602],
14	M.	NNP	PERSON	M.	nn	16	SENT_140	[p9l1875t549r1955b602],
15	Drug	NNP	PERSON	Drug	nn	16	SENT_140	[p9l1981t549r2142b618],
16	resistance	NN	O	resistance	appos	2	SENT_140	[p9l61t638r371b695],
17	in	IN	O	in	_	0	SENT_140	[p9l405t638r464b694],
18	epilepsy	NN	O	epilepsy	prep_in	16	SENT_140	[p9l499t638r767b711],
19	:	:	O	:	_	0	SENT_140	[p9l499t638r767b711],
20	expression	NN	O	expression	dep	2	SENT_140	[p9l806t638r1138b711],
21	of	IN	O	of	_	0	SENT_140	[p9l1173t637r1247b695],
22	drug	NN	O	drug	nn	24	SENT_140	[p9l1268t637r1415b711],
23	resistance	NN	O	resistance	nn	24	SENT_140	[p9l1446t638r1756b695],
24	proteins	NNS	O	protein	prep_of	20	SENT_140	[p9l1788t638r2045b711],
25	in	IN	O	in	_	0	SENT_140	[p9l2080t638r2139b694],
26	common	JJ	O	common	amod	27	SENT_140	[p9l61t749r341b788],
27	causes	NNS	O	cause	prep_in	20	SENT_140	[p9l359t750r559b788],
28	of	IN	O	of	_	0	SENT_140	[p9l580t730r653b788],
29	refractory	JJ	O	refractory	amod	30	SENT_140	[p9l658t730r960b804],
30	epilepsy	NN	O	epilepsy	prep_of	27	SENT_140	[p9l975t730r1236b804],
31	.	.	O	.	_	0	SENT_140	[p9l975t730r1236b804],

1	Brain	NN	O	brain	_	0	SENT_141	[p9l1257t731r1424b788],
2	2002	CD	DATE	2002	num	1	SENT_141	[p9l1443t735r1951b800],
3	;	:	O	;	_	0	SENT_141	[p9l1443t735r1951b800],
4	125:22	CD	NUMBER	125:22	number	5	SENT_141	[p9l1443t735r1951b800],
5	—	CD	NUMBER	—	dep	1	SENT_141	[p9l1443t735r1951b800],
6	31	CD	NUMBER	31	dep	5	SENT_141	[p9l1443t735r1951b800],
7	.	.	O	.	_	0	SENT_141	[p9l1443t735r1951b800],

1	10	CD	NUMBER	10	_	0	SENT_142	[p9l64t829r147b881],
2	.	.	O	.	_	0	SENT_142	[p9l64t829r147b881],

1	Kwan	NNP	PERSON	Kwan	nn	2	SENT_143	[p9l186t829r364b883],
2	P	NN	O	p	_	0	SENT_143	[p9l389t828r435b894],
3	,	,	O	,	_	0	SENT_143	[p9l389t828r435b894],
4	Sills	NNP	PERSON	Sills	nn	6	SENT_143	[p9l467t823r593b881],
5	G	NNP	O	G	nn	6	SENT_143	[p9l620t828r711b894],
6	]	NN	O	]	appos	2	SENT_143	[p9l620t828r711b894],
7	,	,	O	,	_	0	SENT_143	[p9l620t828r711b894],
8	Butler	NNP	PERSON	Butler	nn	9	SENT_143	[p9l741t823r931b882],
9	E	NNP	O	E	appos	6	SENT_143	[p9l953t828r1010b894],
10	,	,	O	,	_	0	SENT_143	[p9l953t828r1010b894],
11	Gant	NNP	PERSON	Gant	nn	12	SENT_143	[p9l1040t828r1196b881],
12	TVV	NNP	O	TVV	appos	6	SENT_143	[p9l1216t828r1336b894],
13	,	,	O	,	_	0	SENT_143	[p9l1216t828r1336b894],
14	Meldrum	NNP	PERSON	Meldrum	nn	15	SENT_143	[p9l1364t823r1653b882],
15	BS	NNP	O	BS	appos	6	SENT_143	[p9l1677t828r1776b894],
16	,	,	O	,	_	0	SENT_143	[p9l1677t828r1776b894],
17	Brodie	NNP	PERSON	Brodie	nn	18	SENT_143	[p9l1805t823r2009b881],
18	MJ	NNP	PERSON	MJ	appos	6	SENT_143	[p9l2033t828r2136b890],
19	.	.	O	.	_	0	SENT_143	[p9l2033t828r2136b890],

1	Regional	NNP	O	Regional	nn	2	SENT_144	[p9l60t917r337b991],
2	expression	NN	O	expression	_	0	SENT_144	[p9l369t918r702b991],
3	of	IN	O	of	_	0	SENT_144	[p9l734t917r807b975],
4	multidrug	JJ	O	multidrug	amod	6	SENT_144	[p9l826t917r1141b991],
5	resistance	NN	O	resistance	nn	6	SENT_144	[p9l1169t918r1479b975],
6	genes	NNS	O	gene	prep_of	2	SENT_144	[p9l1510t936r1686b991],
7	in	IN	O	in	_	0	SENT_144	[p9l1719t918r1779b974],
8	genetically	RB	O	genetically	advmod	9	SENT_144	[p9l1810t917r2143b991],
9	epilepsy	NN	O	epilepsy	amod	10	SENT_144	[p9l61t1011r521b1084],
10	—	NN	O	—	prep_in	2	SENT_144	[p9l61t1011r521b1084],
11	prone	JJ	O	prone	amod	10	SENT_144	[p9l61t1011r521b1084],
12	rat	NN	O	rat	nn	13	SENT_144	[p9l541t1022r626b1068],
13	brain	NN	O	brain	dep	11	SENT_144	[p9l642t1011r803b1068],
14	after	IN	O	after	_	0	SENT_144	[p9l822t1010r965b1068],
15	a	DT	O	a	det	18	SENT_144	[p9l981t1030r1014b1068],
16	single	JJ	O	single	amod	18	SENT_144	[p9l1034t1010r1217b1084],
17	audiogenic	JJ	O	audiogenic	amod	18	SENT_144	[p9l1237t1010r1579b1084],
18	seizure	NN	O	seizure	prep_after	13	SENT_144	[p9l1599t1011r1834b1068],
19	.	.	O	.	_	0	SENT_144	[p9l1599t1011r1834b1068],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_145	[p9l1857t1010r2142b1084],
2	2002	CD	DATE	2002	num	1	SENT_145	[p9l61t1108r609b1174],
3	;	:	O	;	_	0	SENT_145	[p9l61t1108r609b1174],
4	43:1318	CD	NUMBER	43:1318	number	5	SENT_145	[p9l61t1108r609b1174],
5	—	CD	NUMBER	—	dep	1	SENT_145	[p9l61t1108r609b1174],
6	23	CD	NUMBER	23	dep	5	SENT_145	[p9l61t1108r609b1174],
7	.	.	O	.	_	0	SENT_145	[p9l61t1108r609b1174],

1	11	CD	NUMBER	11	_	0	SENT_146	[p9l64t1204r147b1255],
2	.	.	O	.	_	0	SENT_146	[p9l64t1204r147b1255],

1	Dombrowski	NNP	PERSON	Dombrowski	nn	2	SENT_147	[p9l186t1197r594b1255],
2	SM	NNP	O	SM	_	0	SENT_147	[p9l614t1202r728b1267],
3	,	,	O	,	_	0	SENT_147	[p9l614t1202r728b1267],
4	Desai	NNP	PERSON	Desai	nn	5	SENT_147	[p9l750t1198r922b1255],
5	SY	NNP	O	SY	appos	2	SENT_147	[p9l941t1202r1024b1267],
6	,	,	O	,	_	0	SENT_147	[p9l941t1202r1024b1267],
7	Marroni	NNP	PERSON	Marroni	nn	8	SENT_147	[p9l1045t1198r1300b1255],
8	M	NNP	O	M	appos	2	SENT_147	[p9l1316t1202r1395b1267],
9	,	,	O	,	_	0	SENT_147	[p9l1316t1202r1395b1267],
10	et	FW	O	et	nn	11	SENT_147	[p9l1419t1209r1475b1255],
11	al.	FW	O	al.	appos	2	SENT_147	[p9l1489t1197r1558b1255],
12	.	.	O	.	_	0	SENT_147	[p9l1489t1197r1558b1255],

1	Overexpression	NN	O	overexpression	_	0	SENT_148	[p9l1580t1198r2061b1270],
2	of	IN	O	of	_	0	SENT_148	[p9l2080t1197r2153b1255],
3	multiple	JJ	O	multiple	amod	6	SENT_148	[p9l61t1290r321b1364],
4	drug	NN	O	drug	nn	6	SENT_148	[p9l353t1290r498b1364],
5	resistance	NN	O	resistance	nn	6	SENT_148	[p9l527t1291r836b1348],
6	genes	NNS	O	gene	prep_of	1	SENT_148	[p9l867t1309r1043b1364],
7	in	IN	O	in	_	0	SENT_148	[p9l1075t1291r1135b1347],
8	endothelial	JJ	O	endothelial	amod	9	SENT_148	[p9l1166t1290r1514b1348],
9	cells	NNS	O	cell	prep_in	1	SENT_148	[p9l1545t1290r1679b1348],
10	from	IN	O	from	_	0	SENT_148	[p9l1711t1290r1863b1348],
11	patients	NNS	O	patient	prep_from	1	SENT_148	[p9l1893t1291r2138b1364],
12	with	IN	O	with	_	0	SENT_148	[p9l58t1383r197b1441],
13	refractory	JJ	O	refractory	amod	14	SENT_148	[p9l215t1383r517b1457],
14	epilepsy	NN	O	epilepsy	prep_with	11	SENT_148	[p9l532t1384r793b1457],
15	.	.	O	.	_	0	SENT_148	[p9l532t1384r793b1457],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_149	[p9l814t1384r1099b1457],
2	2001	CD	DATE	2001	num	1	SENT_149	[p9l1116t1388r1626b1453],
3	;	:	O	;	_	0	SENT_149	[p9l1116t1388r1626b1453],
4	42:1501	CD	NUMBER	42:1501	number	5	SENT_149	[p9l1116t1388r1626b1453],
5	-6	CD	NUMBER	-6	dep	1	SENT_149	[p9l1116t1388r1626b1453],
6	.	.	O	.	_	0	SENT_149	[p9l1116t1388r1626b1453],

1	12	CD	NUMBER	12	_	0	SENT_150	[p9l64t1483r147b1534],
2	.	.	O	.	_	0	SENT_150	[p9l64t1483r147b1534],

1	Loscher	NNP	O	Loscher	nn	2	SENT_151	[p9l186t1476r433b1534],
2	W	NNP	O	W	_	0	SENT_151	[p9l446t1481r522b1546],
3	,	,	O	,	_	0	SENT_151	[p9l446t1481r522b1546],
4	Potschka	NNP	PERSON	Potschka	nn	6	SENT_151	[p9l543t1476r825b1534],
5	H.	NNP	PERSON	H.	nn	6	SENT_151	[p9l841t1481r912b1534],
6	Role	NN	PERSON	role	appos	2	SENT_151	[p9l933t1476r1072b1537],
7	of	IN	O	of	_	0	SENT_151	[p9l1091t1476r1164b1534],
8	multidrug	JJ	O	multidrug	amod	9	SENT_151	[p9l1169t1476r1484b1550],
9	transporters	NNS	O	transporter	prep_of	6	SENT_151	[p9l1499t1488r1877b1549],
10	in	IN	O	in	_	0	SENT_151	[p9l1896t1477r1956b1533],
11	pharmacoresistance	NN	O	pharmacoresistance	prep_in	9	SENT_151	[p9l1972t1476r2139b1549, p9l61t1570r542b1627],
12	to	TO	O	to	_	0	SENT_151	[p9l565t1581r623b1627],
13	antiepileptic	JJ	O	antiepileptic	amod	14	SENT_151	[p9l645t1570r1029b1643],
14	drugs	NNS	O	drug	prep_to	11	SENT_151	[p9l1052t1569r1245b1643],
15	.	.	O	.	_	0	SENT_151	[p9l1052t1569r1245b1643],

1	J	NNP	O	J	nn	4	SENT_152	[p9l1263t1575r1291b1636],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_152	[p9l1310t1569r1644b1627],
3	Exp	NNP	O	Exp	nn	4	SENT_152	[p9l1664t1575r1778b1643],
4	Ther	NNP	O	Ther	_	0	SENT_152	[p9l1799t1570r1947b1627],
5	2002	CD	DATE	2002	num	4	SENT_152	[p9l1967t1574r2137b1639],
6	;	:	O	;	_	0	SENT_152	[p9l1967t1574r2137b1639],
7	301:7	CD	NUMBER	301:7	number	8	SENT_152	[p9l62t1668r354b1721],
8	—	CD	NUMBER	—	dep	4	SENT_152	[p9l62t1668r354b1721],
9	14	CD	NUMBER	14	dep	8	SENT_152	[p9l62t1668r354b1721],
10	.	.	O	.	_	0	SENT_152	[p9l62t1668r354b1721],

1	13	CD	NUMBER	13	_	0	SENT_153	[p9l64t1763r147b1814],
2	.	.	O	.	_	0	SENT_153	[p9l64t1763r147b1814],

1	Siddiqui	NNP	PERSON	Siddiqui	nn	2	SENT_154	[p9l189t1756r446b1829],
2	A	NNP	O	A	_	0	SENT_154	[p9l468t1762r531b1826],
3	,	,	O	,	_	0	SENT_154	[p9l468t1762r531b1826],
4	Kerb	NNP	O	Kerb	nn	5	SENT_154	[p9l560t1756r706b1815],
5	R	NNP	O	R	appos	2	SENT_154	[p9l731t1761r794b1826],
6	,	,	O	,	_	0	SENT_154	[p9l731t1761r794b1826],
7	Weale	NNP	ORGANIZATION	Weale	nn	8	SENT_154	[p9l821t1756r1007b1814],
8	ME	NNP	O	ME	appos	2	SENT_154	[p9l1029t1761r1152b1826],
9	,	,	O	,	_	0	SENT_154	[p9l1029t1761r1152b1826],
10	et	FW	O	et	nn	11	SENT_154	[p9l1181t1768r1237b1814],
11	al.	FW	O	al.	appos	2	SENT_154	[p9l1258t1756r1327b1814],
12	.	.	O	.	_	0	SENT_154	[p9l1258t1756r1327b1814],

1	Association	NNP	O	Association	_	0	SENT_155	[p9l1353t1757r1717b1814],
2	of	IN	O	of	_	0	SENT_155	[p9l1743t1756r1816b1814],
3	multidrug	JJ	O	multidrug	amod	4	SENT_155	[p9l1827t1756r2143b1830],
4	resistance	NN	O	resistance	prep_of	1	SENT_155	[p9l61t1850r371b1907],
5	in	IN	O	in	_	0	SENT_155	[p9l390t1850r450b1906],
6	epilepsy	NN	O	epilepsy	prep_in	1	SENT_155	[p9l470t1849r723b1923],
7	with	IN	O	with	_	0	SENT_155	[p9l736t1850r875b1907],
8	a	DT	O	a	det	9	SENT_155	[p9l894t1869r927b1907],
9	polymorphism	NN	O	polymorphism	prep_with	1	SENT_155	[p9l944t1850r1406b1923],
10	in	IN	O	in	_	0	SENT_155	[p9l1425t1850r1485b1906],
11	the	DT	O	the	det	16	SENT_155	[p9l1505t1850r1599b1907],
12	drug	NN	O	drug	nn	16	SENT_155	[p9l1620t1849r2143b1923],
13	—	NN	O	—	nn	16	SENT_155	[p9l1620t1849r2143b1923],
14	transporter	NN	O	transporter	nn	16	SENT_155	[p9l1620t1849r2143b1923],
15	gene	NN	O	gene	nn	16	SENT_155	[p9l61t1961r207b2016],
16	ABCB1	NN	O	abcb1	prep_in	9	SENT_155	[p9l220t1947r434b2000],
17	.	.	O	.	_	0	SENT_155	[p9l220t1947r434b2000],

1	N	NN	O	n	nn	2	SENT_156	[p9l455t1947r510b2000],
2	EnglJ	NN	O	englj	nsubj	3	SENT_156	[p9l526t1942r707b2016],
3	Med	VBD	O	med	_	0	SENT_156	[p9l721t1942r858b2000],
4	2003	CD	DATE	2003	dobj	3	SENT_156	[p9l876t1947r1424b2011],
5	;	:	O	;	_	0	SENT_156	[p9l876t1947r1424b2011],
6	348:1442	CD	NUMBER	348:1442	number	7	SENT_156	[p9l876t1947r1424b2011],
7	—	CD	NUMBER	—	dep	4	SENT_156	[p9l876t1947r1424b2011],
8	8	CD	NUMBER	8	dep	7	SENT_156	[p9l876t1947r1424b2011],
9	.	.	O	.	_	0	SENT_156	[p9l876t1947r1424b2011],

1	14	CD	NUMBER	14	_	0	SENT_157	[p9l64t2042r147b2093],
2	.	.	O	.	_	0	SENT_157	[p9l64t2042r147b2093],

1	Seelig	NNP	O	Seelig	nn	2	SENT_158	[p9l189t2035r373b2109],
2	A	NNP	O	A	_	0	SENT_158	[p9l402t2040r466b2105],
3	,	,	O	,	_	0	SENT_158	[p9l402t2040r466b2105],
4	Blatter	NNP	PERSON	Blatter	nn	5	SENT_158	[p9l504t2035r710b2093],
5	XL	NNP	O	XL	conj_and	2	SENT_158	[p9l741t2040r840b2105],
6	,	,	O	,	_	0	SENT_158	[p9l741t2040r840b2105],
7	Wohnsland	NNP	O	Wohnsland	nn	10	SENT_158	[p9l876t2035r1235b2093],
8	F.	NNP	O	F.	nn	10	SENT_158	[p9l1269t2040r1314b2093],
9	Substrate	NNP	O	Substrate	nn	10	SENT_158	[p9l1355t2035r1642b2093],
10	recognition	NN	O	recognition	conj_and	2	SENT_158	[p9l1678t2036r2036b2109],
11	by	IN	O	by	_	0	SENT_158	[p9l2072t2035r2143b2108],
12	P-glycoprotein	NN	O	p-glycoprotein	prep_by	10	SENT_158	[p9l60t2129r525b2202],
13	and	CC	O	and	_	0	SENT_158	[p9l560t2128r676b2186],
14	the	DT	O	the	det	17	SENT_158	[p9l712t2129r809b2186],
15	multidrug	JJ	O	multidrug	amod	17	SENT_158	[p9l845t2128r1167b2202],
16	resistance	NN	O	resistance	nn	17	SENT_158	[p9l1200t2128r1874b2186],
17	—	NN	O	—	conj_and	2	SENT_158	[p9l1200t2128r1874b2186],
18	associated	VBN	O	associate	partmod	2	SENT_158	[p9l1200t2128r1874b2186],
19	protein	NN	O	protein	nn	20	SENT_158	[p9l1909t2129r2139b2202],
20	MRP1	NN	O	mrp1	dobj	18	SENT_158	[p9l59t2226r268b2283],
21	:	:	O	:	_	0	SENT_158	[p9l59t2226r268b2283],
22	a	DT	O	a	det	23	SENT_158	[p9l290t2241r323b2279],
23	comparison	NN	O	comparison	dep	20	SENT_158	[p9l341t2222r729b2295],
24	.	.	O	.	_	0	SENT_158	[p9l341t2222r729b2295],

1	Int	NN	O	int	nn	5	SENT_159	[p9l750t2227r875b2288],
2	]	CD	NUMBER	]	num	5	SENT_159	[p9l750t2227r875b2288],
3	Clin	NNP	O	Clin	nn	5	SENT_159	[p9l892t2222r1019b2279],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_159	[p9l1036t2222r1370b2279],
5	Ther	NNP	O	Ther	_	0	SENT_159	[p9l1385t2222r1534b2279],
6	2000	CD	DATE	2000	dep	5	SENT_159	[p9l1550t2226r2059b2290],
7	;	:	O	;	_	0	SENT_159	[p9l1550t2226r2059b2290],
8	38:111	CD	NUMBER	38:111	num	9	SENT_159	[p9l1550t2226r2059b2290],
9	-21	CD	NUMBER	-21	dep	5	SENT_159	[p9l1550t2226r2059b2290],
10	.	.	O	.	_	0	SENT_159	[p9l1550t2226r2059b2290],

1	15	CD	NUMBER	15	_	0	SENT_160	[p9l64t2321r147b2372],
2	.	.	O	.	_	0	SENT_160	[p9l64t2321r147b2372],

1	Schinkel	NNP	PERSON	Schinkel	nn	2	SENT_161	[p9l189t2314r454b2372],
2	AH	NNP	O	AH	nsubj	20	SENT_161	[p9l470t2319r590b2384],
3	,	,	O	,	_	0	SENT_161	[p9l470t2319r590b2384],
4	Wagenaar	NNP	PERSON	Wagenaar	nn	5	SENT_161	[p9l612t2319r925b2388],
5	E	NNP	O	E	appos	2	SENT_161	[p9l942t2320r999b2384],
6	,	,	O	,	_	0	SENT_161	[p9l942t2320r999b2384],
7	Mol	NNP	ORGANIZATION	Mol	nn	8	SENT_161	[p9l1020t2314r1144b2372],
8	CA	NNP	O	CA	appos	2	SENT_161	[p9l1163t2319r1271b2384],
9	,	,	O	,	_	0	SENT_161	[p9l1163t2319r1271b2384],
10	van	NNP	PERSON	van	nn	13	SENT_161	[p9l1292t2333r1400b2372],
11	Deemter	NNP	PERSON	Deemter	nn	13	SENT_161	[p9l1419t2319r1686b2372],
12	L.	NNP	PERSON	L.	nn	13	SENT_161	[p9l1704t2319r1757b2372],
13	Pglycoprotein	NNP	PERSON	Pglycoprotein	appos	2	SENT_161	[p9l1780t2314r2139b2388, p9l61t2408r177b2465],
14	in	IN	O	in	_	0	SENT_161	[p9l195t2408r255b2464],
15	the	DT	O	the	det	17	SENT_161	[p9l275t2408r369b2465],
16	blood-brain	JJ	O	blood-brain	amod	17	SENT_161	[p9l389t2407r757b2465],
17	barrier	NN	O	barrier	prep_in	13	SENT_161	[p9l777t2408r986b2465],
18	of	IN	O	of	_	0	SENT_161	[p9l1004t2407r1077b2465],
19	mice	NNS	O	mouse	prep_of	17	SENT_161	[p9l1083t2408r1231b2465],
20	inﬂuences	VBZ	O	inﬂuences	_	0	SENT_161	[p9l1250t2407r1568b2465],
21	the	DT	O	the	det	23	SENT_161	[p9l1588t2407r1683b2465],
22	brain	NN	O	brain	nn	23	SENT_161	[p9l1703t2408r1864b2465],
23	penetration	NN	O	penetration	dobj	20	SENT_161	[p9l1882t2419r2139b2481, p9l61t2501r183b2558],
24	and	CC	O	and	_	0	SENT_161	[p9l200t2500r315b2558],
25	pharmacological	JJ	O	pharmacological	amod	26	SENT_161	[p9l331t2501r855b2574],
26	activity	NN	O	activity	dobj	20	SENT_161	[p9l872t2501r1089b2574],
27	of	IN	O	of	_	0	SENT_161	[p9l1105t2500r1178b2558],
28	many	JJ	O	many	amod	29	SENT_161	[p9l1183t2519r1355b2574],
29	drugs	NNS	O	drug	prep_of	23	SENT_161	[p9l1370t2500r1563b2574],
30	.	.	O	.	_	0	SENT_161	[p9l1370t2500r1563b2574],

1	J	NNP	O	J	nn	3	SENT_162	[p9l1577t2506r1605b2567],
2	Clin	NNP	O	Clin	nn	3	SENT_162	[p9l1621t2501r1748b2558],
3	Invest	NNP	O	Invest	_	0	SENT_162	[p9l1766t2506r1953b2558],
4	1996	CD	DATE	1996	num	3	SENT_162	[p9l1970t2505r2138b2570],
5	;	:	O	;	_	0	SENT_162	[p9l1970t2505r2138b2570],
6	97:2517	CD	NUMBER	97:2517	number	7	SENT_162	[p9l61t2599r432b2652],
7	—	CD	NUMBER	—	dep	3	SENT_162	[p9l61t2599r432b2652],
8	24	CD	NUMBER	24	dep	7	SENT_162	[p9l61t2599r432b2652],
9	.	.	O	.	_	0	SENT_162	[p9l61t2599r432b2652],

1	16	CD	NUMBER	16	_	0	SENT_163	[p9l64t2694r147b2745],
2	.	.	O	.	_	0	SENT_163	[p9l64t2694r147b2745],

1	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	2	SENT_164	[p9l187t2687r522b2760],
2	S	NNP	O	S	_	0	SENT_164	[p9l541t2692r591b2757],
3	,	,	O	,	_	0	SENT_164	[p9l541t2692r591b2757],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_164	[p9l615t2687r767b2745],
5	o	NN	O	o	appos	2	SENT_164	[p9l784t2692r849b2758],
6	,	,	O	,	_	0	SENT_164	[p9l784t2692r849b2758],
7	von	NN	PERSON	von	nn	9	SENT_164	[p9l870t2706r983b2745],
8	Richter	NNP	PERSON	Richter	nn	9	SENT_164	[p9l1002t2687r1229b2749],
9	O	NNP	PERSON	O	appos	2	SENT_164	[p9l1247t2692r1312b2757],
10	,	,	O	,	_	0	SENT_164	[p9l1247t2692r1312b2757],
11	et	FW	O	et	nn	12	SENT_164	[p9l1337t2699r1394b2745],
12	al.	FW	O	al.	appos	2	SENT_164	[p9l1409t2687r1478b2745],
13	.	.	O	.	_	0	SENT_164	[p9l1409t2687r1478b2745],

1	Functional	JJ	O	functional	amod	4	SENT_165	[p9l1502t2687r1834b2745],
2	polymor	JJ	O	polymor	amod	4	SENT_165	[p9l1853t2687r2139b2760],
3	—	NN	O	—	nn	4	SENT_165	[p9l1853t2687r2139b2760],
4	phisms	NNS	O	phism	_	0	SENT_165	[p9l60t2780r287b2854],
5	of	IN	O	of	_	0	SENT_165	[p9l307t2780r381b2838],
6	the	DT	O	the	det	10	SENT_165	[p9l385t2781r480b2838],
7	human	JJ	O	human	amod	10	SENT_165	[p9l498t2781r718b2838],
8	multidrug	JJ	O	multidrug	amod	10	SENT_165	[p9l735t2780r1050b2854],
9	resistance	NN	O	resistance	nn	10	SENT_165	[p9l1065t2781r1374b2838],
10	gene	NN	O	gene	prep_of	4	SENT_165	[p9l1391t2799r1556b2854],
11	:	:	O	:	_	0	SENT_165	[p9l1391t2799r1556b2854],
12	multiple	JJ	O	multiple	amod	14	SENT_165	[p9l1576t2780r1836b2854],
13	sequence	NN	O	sequence	nn	14	SENT_165	[p9l1855t2799r2139b2854],
14	variations	NNS	O	variation	dep	4	SENT_165	[p9l58t2874r362b2931],
15	and	CC	O	and	_	0	SENT_165	[p9l381t2873r496b2931],
16	correlations	NNS	O	correlation	dep	4	SENT_165	[p9l514t2873r883b2931],
17	of	IN	O	of	_	0	SENT_165	[p9l903t2873r976b2931],
18	one	CD	NUMBER	one	num	19	SENT_165	[p9l982t2892r1094b2931],
19	allele	NN	O	allele	prep_of	14	SENT_165	[p9l1112t2873r1272b2931],
20	with	IN	O	with	_	0	SENT_165	[p9l1287t2873r1427b2931],
21	P-glycoprotein	NN	MISC	p-glycoprotein	nn	22	SENT_165	[p9l1444t2874r1898b2947],
22	expression	NN	O	expression	prep_with	19	SENT_165	[p9l1917t2892r2139b2947, p9l62t2967r192b3024],
23	and	CC	O	and	_	0	SENT_165	[p9l210t2966r324b3024],
24	activity	NN	O	activity	conj_and	22	SENT_165	[p9l342t2967r559b3040],
25	in	FW	O	in	prep	14	SENT_165	[p9l573t2967r633b3023],
26	vivo	FW	O	vivo	pobj	25	SENT_165	[p9l648t2967r788b3024],
27	.	.	O	.	_	0	SENT_165	[p9l648t2967r788b3024],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_166	[p9l809t2971r947b3024],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_166	[p9l963t2967r1096b3024],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_166	[p9l1111t2966r1265b3024],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_166	[p9l1285t2967r1372b3024],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_166	[p9l1390t2972r1440b3024],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_166	[p9l1459t2971r1490b3024],
7	A	NNP	O	A	_	0	SENT_166	[p9l1507t2972r1556b3023],
8	2000	CD	DATE	2000	num	7	SENT_166	[p9l1572t2971r2081b3036],
9	;	:	O	;	_	0	SENT_166	[p9l1572t2971r2081b3036],
10	97:3473	CD	NUMBER	97:3473	number	11	SENT_166	[p9l1572t2971r2081b3036],
11	—	CD	NUMBER	—	dep	7	SENT_166	[p9l1572t2971r2081b3036],
12	8	CD	NUMBER	8	dep	11	SENT_166	[p9l1572t2971r2081b3036],
13	.	.	O	.	_	0	SENT_166	[p9l1572t2971r2081b3036],

1	17	CD	NUMBER	17	_	0	SENT_167	[p9l64t3067r147b3117],
2	.	.	O	.	_	0	SENT_167	[p9l64t3067r147b3117],

1	Zhang	NNP	PERSON	Zhang	nn	2	SENT_168	[p9l186t3059r387b3133],
2	L	NNP	PERSON	L	_	0	SENT_168	[p9l398t3064r452b3129],
3	,	,	O	,	_	0	SENT_168	[p9l398t3064r452b3129],
4	Ong	NNP	O	Ong	nn	5	SENT_168	[p9l471t3064r607b3133],
5	WY	NN	O	wy	appos	2	SENT_168	[p9l616t3064r735b3129],
6	,	,	O	,	_	0	SENT_168	[p9l616t3064r735b3129],
7	Lee	NNP	PERSON	Lee	nn	9	SENT_168	[p9l754t3064r858b3117],
8	T.	NNP	PERSON	T.	nn	9	SENT_168	[p9l871t3064r925b3117],
9	Induction	NN	PERSON	induction	appos	2	SENT_168	[p9l943t3059r1246b3117],
10	of	IN	O	of	_	0	SENT_168	[p9l1262t3059r1336b3117],
11	P-glycoprotein	NN	O	p-glycoprotein	nn	12	SENT_168	[p9l1337t3059r1791b3133],
12	expression	NN	O	expression	prep_of	9	SENT_168	[p9l1807t3060r2140b3132],
13	in	IN	O	in	_	0	SENT_168	[p9l60t3153r121b3209],
14	astrocytes	NNS	O	astrocyte	prep_in	12	SENT_168	[p9l154t3164r459b3226],
15	following	VBG	O	follow	_	0	SENT_168	[p9l494t3152r795b3226],
16	intracerebroventricular	JJ	O	intracerebroventricular	amod	18	SENT_168	[p9l826t3152r1542b3210],
17	kainite	NN	O	kainite	nn	18	SENT_168	[p9l1574t3152r1784b3210],
18	injections	NNS	O	injection	prep_following	14	SENT_168	[p9l1818t3153r2137b3226],
19	.	.	O	.	_	0	SENT_168	[p9l1818t3153r2137b3226],

1	Exp	NN	O	exp	nn	2	SENT_169	[p9l60t3251r174b3319],
2	Brain	NN	O	brain	_	0	SENT_169	[p9l192t3246r360b3303],
3	Res	NNP	O	Res	dep	2	SENT_169	[p9l377t3250r487b3307],
4	1999	CD	DATE	1999	num	3	SENT_169	[p9l509t3250r1054b3315],
5	;	:	O	;	_	0	SENT_169	[p9l509t3250r1054b3315],
6	126:509	CD	NUMBER	126:509	number	7	SENT_169	[p9l509t3250r1054b3315],
7	—	CD	NUMBER	—	dep	2	SENT_169	[p9l509t3250r1054b3315],
8	16	CD	NUMBER	16	dep	7	SENT_169	[p9l509t3250r1054b3315],
9	.	.	O	.	_	0	SENT_169	[p9l509t3250r1054b3315],

1	18	CD	NUMBER	18	_	0	SENT_170	[p9l64t3344r147b3396],
2	.	.	O	.	_	0	SENT_170	[p9l64t3344r147b3396],

1	Kerb	NN	O	kerb	nn	2	SENT_171	[p9l187t3338r334b3397],
2	R	NN	O	r	_	0	SENT_171	[p9l365t3343r428b3408],
3	,	,	O	,	_	0	SENT_171	[p9l365t3343r428b3408],
4	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	5	SENT_171	[p9l463t3338r797b3411],
5	S	NNP	O	S	appos	2	SENT_171	[p9l828t3343r878b3408],
6	,	,	O	,	_	0	SENT_171	[p9l828t3343r878b3408],
7	Brinkmann	NNP	PERSON	Brinkmann	nn	9	SENT_171	[p9l913t3338r1267b3396],
8	U.	NNP	PERSON	U.	nn	9	SENT_171	[p9l1298t3343r1361b3396],
9	ABC	NNP	PERSON	ABC	appos	2	SENT_171	[p9l1393t3343r1530b3396],
10	drug	NN	O	drug	nn	11	SENT_171	[p9l1564t3338r1710b3412],
11	transporters	NNS	O	transporter	dep	9	SENT_171	[p9l1739t3350r2137b3411],
12	:	:	O	:	_	0	SENT_171	[p9l1739t3350r2137b3411],
13	hereditary	JJ	O	hereditary	amod	14	SENT_171	[p9l61t3431r377b3505],
14	polymorphisms	NNS	O	polymorphism	dep	2	SENT_171	[p9l397t3431r888b3505],
15	and	CC	O	and	_	0	SENT_171	[p9l914t3432r1028b3489],
16	pharmacological	JJ	O	pharmacological	amod	17	SENT_171	[p9l1051t3431r1574b3505],
17	impact	NN	O	impact	dep	2	SENT_171	[p9l1598t3432r1815b3505],
18	in	IN	O	in	_	0	SENT_171	[p9l1835t3432r1895b3488],
19	MDR1	NN	O	mdr1	prep_in	17	SENT_171	[p9l1916t3436r2136b3501],
20	,	,	O	,	_	0	SENT_171	[p9l1916t3436r2136b3501],
21	MRP1	NN	O	mrp1	conj_and	19	SENT_171	[p9l59t3529r247b3586],
22	and	CC	O	and	_	0	SENT_171	[p9l266t3524r380b3582],
23	MRP2	NN	O	mrp2	conj_and	19	SENT_171	[p9l396t3529r603b3586],
24	.	.	O	.	_	0	SENT_171	[p9l396t3529r603b3586],

1	PharmacogenomicsJ	NN	O	pharmacogenomicsj	_	0	SENT_172	[p9l624t3524r1280b3598],
2	2001	CD	DATE	2001	num	1	SENT_172	[p9l1296t3529r1728b3594],
3	;	:	O	;	_	0	SENT_172	[p9l1296t3529r1728b3594],
4	2:51	CD	TIME	2:51	number	5	SENT_172	[p9l1296t3529r1728b3594],
5	-64	CD	NUMBER	-64	dep	1	SENT_172	[p9l1296t3529r1728b3594],
6	.	.	O	.	_	0	SENT_172	[p9l1296t3529r1728b3594],

1	19	CD	NUMBER	19	_	0	SENT_173	[p9l64t3624r147b3675],
2	.	.	O	.	_	0	SENT_173	[p9l64t3624r147b3675],

1	Kerb	NNP	O	Kerb	nn	2	SENT_174	[p9l187t3617r334b3676],
2	R	NNP	O	R	_	0	SENT_174	[p9l350t3622r413b3687],
3	,	,	O	,	_	0	SENT_174	[p9l350t3622r413b3687],
4	Aynacioglu	NNP	PERSON	Aynacioglu	nn	5	SENT_174	[p9l431t3617r780b3691],
5	AS	NNP	O	AS	appos	2	SENT_174	[p9l793t3622r894b3687],
6	,	,	O	,	_	0	SENT_174	[p9l793t3622r894b3687],
7	Brocl	NNP	O	Brocl	appos	2	SENT_174	[p9l914t3617r1355b3687],
8	<	JJR	O	<	amod	9	SENT_174	[p9l914t3617r1355b3687],
9	mollerJ	NN	O	mollerj	dep	7	SENT_174	[p9l914t3617r1355b3687],
10	,	,	O	,	_	0	SENT_174	[p9l914t3617r1355b3687],
11	et	FW	O	et	nn	12	SENT_174	[p9l1376t3629r1432b3675],
12	al.	FW	O	al.	appos	2	SENT_174	[p9l1444t3617r1513b3675],
13	.	.	O	.	_	0	SENT_174	[p9l1444t3617r1513b3675],

1	The	DT	O	the	det	3	SENT_175	[p9l1531t3617r1650b3675],
2	predictive	JJ	O	predictive	amod	3	SENT_175	[p9l1665t3617r1967b3690],
3	value	NN	O	value	_	0	SENT_175	[p9l1980t3617r2140b3675],
4	of	IN	O	of	_	0	SENT_175	[p9l61t3710r135b3768],
5	MDR1	NN	O	mdr1	nn	7	SENT_175	[p9l153t3715r373b3780],
6	,	,	O	,	_	0	SENT_175	[p9l153t3715r373b3780],
7	CYPZC9	NN	O	cypzc9	prep_of	3	SENT_175	[p9l410t3715r676b3780],
8	,	,	O	,	_	0	SENT_175	[p9l410t3715r676b3780],
9	and	CC	O	and	_	0	SENT_175	[p9l713t3710r827b3768],
10	CYPZC19	NN	O	cypzc19	nn	11	SENT_175	[p9l861t3715r1147b3768],
11	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_175	[p9l1180t3710r1672b3784],
12	for	IN	O	for	_	0	SENT_175	[p9l1706t3710r1797b3768],
13	phenytoin	NN	O	phenytoin	nn	15	SENT_175	[p9l1827t3711r2141b3784],
14	plasma	NN	O	plasma	nn	15	SENT_175	[p10l60t17r285b90],
15	levels	NNS	O	level	prep_for	3	SENT_175	[p10l301t16r488b74],
16	.	.	O	.	_	0	SENT_175	[p10l301t16r488b74],

1	Pharmacogenomicsl	NNP	O	Pharmacogenomicsl	_	0	SENT_176	[p10l509t16r1165b90],
2	2001	CD	DATE	2001	num	1	SENT_176	[p10l1181t21r1652b86],
3	;	:	O	;	_	0	SENT_176	[p10l1181t21r1652b86],
4	1:204	CD	NUMBER	1:204	number	5	SENT_176	[p10l1181t21r1652b86],
5	—	CD	NUMBER	—	dep	1	SENT_176	[p10l1181t21r1652b86],
6	10	CD	NUMBER	10	dep	5	SENT_176	[p10l1181t21r1652b86],
7	.	.	O	.	_	0	SENT_176	[p10l1181t21r1652b86],

1	Copyright	NN	O	copyright	_	0	SENT_177	[p10l63t120r296b183],
2	©	CD	NUMBER	©	num	6	SENT_177	[p10l317t125r369b177],
3	2003	CD	DATE	2003	num	6	SENT_177	[p10l393t123r514b168],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_177	[p10l536t120r889b168],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_177	[p10l910t120r1104b168],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_177	[p10l1121t122r1300b182],
7	.	.	O	.	_	0	SENT_177	[p10l1121t122r1300b182],

1	RECEIVE	VB	O	receive	_	0	SENT_178	[p10l969t420r1074b437],
2	THE	DT	O	the	det	3	SENT_178	[p10l1086t420r1137b436],
3	jOURNAL	NN	O	journal	poss	5	SENT_178	[p10l1145t414r1297b444],
4	'S	POS	O	's	_	0	SENT_178	[p10l1145t414r1297b444],
5	TABLE	NN	O	table	dobj	1	SENT_178	[p10l1309t420r1386b436],
6	OF	IN	O	of	_	0	SENT_178	[p10l1399t420r1434b437],
7	CONTENTS	NNS	O	contents	prep_of	5	SENT_178	[p10l1446t420r1588b437],

1	EACH	NNP	SET	EACH	nn	4	SENT_179	[p10l1129t461r1196b478],
2	WEEK	NNP	SET	WEEK	nn	4	SENT_179	[p10l1211t461r1282b478],
3	BY	NNP	O	BY	nn	4	SENT_179	[p10l1296t461r1325b478],
4	E-MAIL	NNP	O	E-MAIL	_	0	SENT_179	[p10l1339t462r1428b478],

1	To	TO	O	to	aux	2	SENT_180	[p10l1039t514r1070b536],
2	receive	VB	O	receive	purpcl	35	SENT_180	[p10l1080t513r1165b535],
3	the	DT	O	the	det	4	SENT_180	[p10l1175t513r1213b535],
4	table	NN	O	table	dobj	2	SENT_180	[p10l1223t513r1283b536],
5	of	IN	O	of	_	0	SENT_180	[p10l1293t512r1323b536],
6	contents	NNS	O	contents	prep_of	4	SENT_180	[p10l1327t517r1434b536],
7	of	IN	O	of	_	0	SENT_180	[p10l1444t512r1473b536],
8	the	DT	O	the	det	11	SENT_180	[p10l1477t513r1516b535],
9	New	NNP	LOCATION	New	nn	11	SENT_180	[p10l1027t554r1076b575],
10	England	NNP	LOCATION	England	nn	11	SENT_180	[p10l1085t552r1177b581],
11	journal	NN	O	journal	prep_of	6	SENT_180	[p10l1182t552r1267b581],
12	of	IN	O	of	_	0	SENT_180	[p10l1277t552r1302b582],
13	Medicine	NN	O	medicine	prep_of	11	SENT_180	[p10l1305t552r1404b575],
14	by	IN	O	by	_	0	SENT_180	[p10l1412t552r1441b581],
15	e-mail	JJ	O	e-mail	prep_by	2	SENT_180	[p10l1449t552r1528b575],
16	every	DT	SET	every	det	18	SENT_180	[p10l966t599r1029b621],
17	Wednesday	NNP	DATE	Wednesday	nn	18	SENT_180	[p10l1036t592r1180b621],
18	evening	NN	TIME	evening	dep	15	SENT_180	[p10l1188t592r1286b621],
19	and	CC	O	and	_	0	SENT_180	[p10l1294t592r1340b615],
20	access	NN	O	access	prep_by	2	SENT_180	[p10l1349t599r1428b615],
21	our	PRP$	O	we	poss	22	SENT_180	[p10l1438t599r1481b615],
22	archives	NNS	O	archive	nsubj	26	SENT_180	[p10l1489t592r1590b615],
23	of	IN	O	of	_	0	SENT_180	[p10l1046t631r1076b654],
24	research	NN	O	research	nn	25	SENT_180	[p10l1080t631r1186b654],
25	articles	NNS	O	article	prep_of	22	SENT_180	[p10l1195t631r1284b654],
26	(	VBP	O	(	rcmod	20	SENT_180	[p10l1296t633r1336b658],
27	>	JJR	O	>	amod	31	SENT_180	[p10l1296t633r1336b658],
28	6	CD	DURATION	6	num	29	SENT_180	[p10l1296t633r1336b658],
29	months	NNS	NUMBER	month	tmod	27	SENT_180	[p10l1346t631r1442b654],
30	old	JJ	DURATION	old	amod	31	SENT_180	[p10l1452t631r1509b659],
31	)	NN	O	)	dobj	26	SENT_180	[p10l1452t631r1509b659],
32	,	,	O	,	_	0	SENT_180	[p10l1452t631r1509b659],
33	you	PRP	O	you	nsubj	35	SENT_180	[p10l1018t678r1063b700],
34	can	MD	O	can	aux	35	SENT_180	[p10l1073t678r1115b694],
35	sign	VB	O	sign	_	0	SENT_180	[p10l1125t671r1178b700],
36	up	RP	O	up	prt	35	SENT_180	[p10l1187t678r1218b700],
37	through	IN	O	through	_	0	SENT_180	[p10l1228t671r1329b700],
38	our	PRP$	O	we	poss	40	SENT_180	[p10l1339t678r1382b694],
39	Web	NN	O	web	nn	40	SENT_180	[p10l1389t671r1444b694],
40	site	NN	O	site	prep_through	35	SENT_180	[p10l1454t671r1497b694],
41	at	IN	O	at	prep	35	SENT_180	[p10l1506t676r1535b694],
42	:	:	O	:	_	0	SENT_180	[p10l1506t676r1535b694],

1	http	NN	O	http	_	0	SENT_181	[p10l1142t710r1415b740],
2	:	:	O	:	_	0	SENT_181	[p10l1142t710r1415b740],
3	IIwww.nejm.org	NN	O	iiwww.nejm.org	dep	1	SENT_181	[p10l1142t710r1415b740],

1	1482	CD	DATE	1482	num	2	SENT_182	[p10l149t857r225b879],
2	N	NN	O	n	_	0	SENT_182	[p10l902t859r916b875],
3	ENG	NNP	O	ENG	nn	4	SENT_182	[p10l931t859r980b875],
4	L	NNP	O	L	rcmod	2	SENT_182	[p10l988t859r997b874],
5	J	NNP	O	J	prep	4	SENT_182	[p10l1007t859r1015b881],
6	MED	NNP	O	MED	dep	5	SENT_182	[p10l1030t859r1083b874],
7	348	CD	NUMBER	348	num	6	SENT_182	[p10l1095t853r1175b881],
8	;	:	O	;	_	0	SENT_182	[p10l1095t853r1175b881],
9	'	''	O	'	_	0	SENT_182	[p10l1095t853r1175b881],
10	I5	NN	O	i5	dep	2	SENT_182	[p10l1095t853r1175b881],
11	WWW	NN	O	www	dep	10	SENT_182	[p10l1210t859r1304b875],
12	.	.	O	.	_	0	SENT_182	[p10l1210t859r1304b875],

1	N	NN	O	n	nn	3	SENT_183	[p10l1210t859r1304b875],
2	EJ	NN	O	ej	nn	3	SENT_183	[p10l1312t859r1330b881],
3	M.oRG	NN	O	m.org	_	0	SENT_183	[p10l1338t859r1421b875],
4	APRIL	NN	DATE	april	nn	6	SENT_183	[p10l1458t859r1530b874],
5	‘	CD	NUMBER	‘	num	6	SENT_183	[p10l1542t859r1577b879],
6	Io	NNP	O	Io	dep	3	SENT_183	[p10l1542t859r1577b879],
7	,	,	O	,	_	0	SENT_183	[p10l1542t859r1577b879],
8	2003	CD	DATE	2003	appos	6	SENT_183	[p10l1591t859r1654b881],

1	The	DT	O	the	det	4	SENT_184	[p10l935t892r986b916],
2	New	NNP	O	New	nn	4	SENT_184	[p10l995t893r1057b916],
3	England	NNP	O	England	nn	4	SENT_184	[p10l1066t892r1177b923],
4	Journal	NNP	O	Journal	_	0	SENT_184	[p10l1186t892r1283b916],
5	of	IN	O	of	_	0	SENT_184	[p10l1293t892r1322b916],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_184	[p10l1329t892r1454b916],

1	Downloaded	VBN	O	download	_	0	SENT_185	[p10l377t933r547b956],
2	from	IN	O	from	_	0	SENT_185	[p10l556t933r620b956],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_185	[p10l629t933r747b963],
4	at	IN	O	at	_	0	SENT_185	[p10l758t937r781b956],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_185	[p10l789t933r972b956],
6	on	IN	O	on	_	0	SENT_185	[p10l981t940r1014b956],
7	January	NNP	DATE	January	prep_on	1	SENT_185	[p10l1022t933r1125b963],
8	5	CD	DATE	5	num	7	SENT_185	[p10l1135t933r1158b960],
9	,	,	DATE	,	_	0	SENT_185	[p10l1135t933r1158b960],
10	2014	CD	DATE	2014	num	7	SENT_185	[p10l1168t933r1241b956],
11	.	.	O	.	_	0	SENT_185	[p10l1168t933r1241b956],

1	For	IN	O	for	_	0	SENT_186	[p10l1251t933r1298b956],
2	personal	JJ	O	personal	amod	3	SENT_186	[p10l1306t933r1418b963],
3	use	NN	O	use	pobj	1	SENT_186	[p10l1427t940r1471b956],
4	only	RB	O	only	advmod	3	SENT_186	[p10l1481t933r1545b963],
5	.	.	O	.	_	0	SENT_186	[p10l1481t933r1545b963],

1	No	DT	O	no	det	3	SENT_187	[p10l1556t933r1596b956],
2	other	JJ	O	other	amod	3	SENT_187	[p10l1606t933r1674b956],
3	uses	NNS	O	use	_	0	SENT_187	[p10l1682t940r1738b956],
4	without	IN	O	without	_	0	SENT_187	[p10l1748t933r1849b956],
5	permission	NN	O	permission	prep_without	3	SENT_187	[p10l1858t933r2010b963],
6	.	.	O	.	_	0	SENT_187	[p10l1858t933r2010b963],

1	Copyright	NN	O	copyright	_	0	SENT_188	[p10l727t974r862b1005],
2	©	CD	NUMBER	©	num	6	SENT_188	[p10l871t974r895b998],
3	2003	CD	DATE	2003	num	6	SENT_188	[p10l905t974r969b998],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_188	[p10l979t974r1170b998],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_188	[p10l1180t974r1288b998],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_188	[p10l1299t974r1404b1005],
7	.	.	O	.	_	0	SENT_188	[p10l1299t974r1404b1005],

1	All	DT	O	all	det	2	SENT_189	[p10l1415t974r1456b998],
2	rights	NNS	O	rights	nsubj	3	SENT_189	[p10l1465t974r1540b1005],
3	reserved	VBN	O	reserve	_	0	SENT_189	[p10l1550t974r1669b998],
4	.	.	O	.	_	0	SENT_189	[p10l1550t974r1669b998],

